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ABSTRACT 
Exercise and psychological stress can cause a transient decrease in salivary IgA (s-
lgA) and regular intense physical activity can result in a chronic decrease in s-IgA. 
Epidemiological evidence supports the concept of an association between low levels of 
s-lgA and the incidence of upper respiratory tract infections (URTI) and overtraining 
syndrome (OTS). However, the relationships are not strong. 
The impact of stress on immune function is of interest to the Australian Defence 
Force. Soldiers are often subjected to high levels of physiological and psychological 
stress, and thus susceptible to impaired mucosa] immune function and an increased risk 
of URTI, which could reduce their performance. Newly enlisted recruits may also be 
susceptible to OTS as they do not necessarily have a very high level of physical fitness. 
The purpose of this study was to assess the usefulness of s-lgA as an indicator of 
mucosa! immune function, the effect of a variety of stressors on mucosa! immune 
function and its relationship to the incidence of symptoms of illness and OTS. 
Preliminary work raised some concerns regarding the reliability of s-lgA. The 
main weaknesses identified were the possible effects of diurnal variation, the large 
biological variation, the standardisation of the s-IgA assay, and the collection, handling 
and storage methods of saliva samples. These issues were addressed by several 
preliminary experiments and recommendations were made (Chapter 2). ~!though s-IgA 
can be expressed in several ways (as a concentration, a secretion rate, a ratio to secreted 
protein, or as a ratio to osmolality), only s-lgA secretion rate and s-IgA:osmolality ratio are 
used in the experimental chapters 3 to 5. 
An 82 km ultra-endurance running race was the first opportunity to test the 
methods developed for the collection, storage and transport of saliva under "field 
conditions" (Chapter 3). The race resulted in a transient decrease in s-lgA and several 
other immune parameters. 
Soldiers who engaged in two hours of load carriage (Chapter 4) experienced 
changes in heart rate, metabolic rate, core temperature and perceptions of effort and 
thermal strain. These changes were greater with higher environmental temperatures and 
humidity. Only the hottest, most humid environment resulted in a significant decline of 
s-lgA. Therefore, it seems that if exercise at an intensity that by itself does not cause a 
significant mucosa! immunosuppression is performed in a harsh climate, the resulting 
hyperthermia can magnify the s-lgA response. 
ix 
A six week army common recruit training course (Chapter 5) resulted in a high 
incidence ofmucosal immunosuppression and self-reported symptoms ofURTI. There 
was also a significant incidence of OTS symptoms. 
Despite these findings, this work does not lend strong support to the notion that s-
IgA could be a practical tool to monitor mucosa} immune function or physiological 
strain in the military. Nor does it seem a good predictor of ill health or early states of 
OTS. 
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GENERAL INTRODUCTION 
1.1 The immune system 
The body is under constant attack by pathogenic organisms such as bacteria and 
viruses. Invasion by these organisms can result in infection and disease. To protect 
itself, the body has a built-in defence: the immune system. Its essential function is 
illustrated by the often-lethal results of an impaired immune system, for instance due to 
genetic defects or infection by the AIDS virus (Elliott and Elliott, 1997). The immune 
system consists of two major components, the non-specific or innate immune system, 
and the specific or adaptive immune system. 
The innate immune system is the body's first line of defence against pathogens. It 
is present from birth until death; it is always prepared and responds almost immediately; 
it has no memory because it does not remember if a pathogen has been encountered 
before. It consists of three components- physico-chemical, humoral, and cellular. 
Physical barriers that prevent the entry of micro-organisms are the external body 
membranes (intact skin and mucous membranes), secretions, and cilia. Mucous 
membranes line all body cavities that are in contact with the exterior - the digestive, 
respiratory, urinary, and reproductive tracts. Secretions continuously wash and cleanse 
mucosal surfaces and cilia help with the removal of debris and foreign matter. Although 
these surface barriers are very effective, they are breached occasionally. When micro-
organisms penetrate them, the humoral and cellular parts of the innate immune system 
are called upon. These internal, non-specific mechanisms use cellular and chemical 
devices to protect the body. Anti-microbial proteins (e.g. complement, opsonins, and 
interferon), proteolytic enzymes, as well as phagocytes (e.g. neutrophils) and natural 
killer cells inhibit the spread of pathogens throughout the body. 
The specific immune system is not present at birth but is gained during maturation 
and by exposure to pathogens. It recognises specific pathogens and acts to immobilise, 
neutralise, or destroy them. Unlike the non-specific system, the specific immune system 
must be "primed" by an initial exposure to an antigen before it can protect the body 
against further attacks by the same antigen. However, once it has learned to identify an 
antigen, future defences can be mobilised more quickly. An antigen is any foreign 
substance that generates a response by the immune system. The specific immune 
response is characterised by three aspects. It is antigen-specific as it recognises and is 
directed against particular antigens. It is not restricted to the initial infection site, 
therefore, it is systemic. It has memory because after an initial exposure it recognises 
and mounts even stronger attacks on a previously encountered antigen. The specific 
immune system has two separate but overlapping components: (1) the cellular or cell-
mediated immune system, and (2) the humoral or antibody-mediated immune system. 
Although these systems respond to virtually the same antigens, they do it in different 
ways. 
The response provided by the cellular immune system uses living cells as 
protective elements - lymphocytes. They target virus or parasite infected tissue cells, 
cancer cells and cells of foreign grafts. The lymphocytes act either directly by lysing the 
foreign cells, or indirectly by releasing chemicals that enhance an inflammatory 
response or activate other lymphocytes or macrophages to lyse the foreign cells. 
Immunoglobulins are an important component ofhumoral immunity to infectious 
agents such as bacteria, bacterial toxins, viruses and parasites. Immunoglobulins 
circulate freely in body fluids (humours) like serum, lymph, tissue fluids and in mucosa} 
secretions such as saliva. An antibody is an immunoglobulin produced in response to an 
antigen that has the ability to bind specifically to that particular antigen. 
Immunoglobulins are produced by activated B-lymphocytes (B-cells) and their 
descendants, the antibody-forming cells and plasma cells found in blood, lymphoid 
organs and other tissues. Because each lymphocyte is only capable ofrecognising one 
of an infinite number of antigens, an adequate immune response depends on the 
proliferation of antigen-specific cells. 
Antibodies themselves do not destroy pathogens. Their primary role is to bind to 
antigens, initiating a variety of responses that act, both directly and indirectly, to combat 
the foreign agent carrying the antigen. Direct antibody actions include binding to 
antigens on micro-organisms and inhibiting their access to the host's cells. More 
prevalent, however, are indirect actions that stimulate the recruitment, direction, 
recognition and binding of antibacterial effector mechanisms such as complement, 
phagocytes, or other cytotoxic cells which themselves cannot recognise foreign 
organisms. This process results in lysing of bacterial and virally infected cells. Other 
functions of antibodies include a direct binding to bacterial toxins, thus neutralising 
their deleterious effect, interfering with movement and binding of bacteria to the host's 
cells, and inhibiting the uptake of essential nutrients by bacteria. Antibodies bind 
directly to extra-cellular viruses, preventing them from gaining entry to the body and 
facilitate recognition and killing by cytotoxic lymphocytes. Antibodies also enhance 
phagocytosis and cytotoxicity against parasites. 
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Antibodies are grouped into five classes, each with slightly different structure and 
function. These five classes are, in order of abundance in the body, lgG, lgA, lgM, lgD, 
and IgE. The antibodies of each class have slightly different biological roles and 
locations in the body. IgA, the second most abundant immunoglobulin, exists either as a 
monomer, a single IgA molecule, or as a dimer, in which two IgA molecules are joined 
together by a polypeptide (J chain). IgA is abundant in serum and is the dominant 
antibody in the mucosal immune system. In humans IgA occurs as two subclasses, IgAl 
that predominates in serum and IgA2 that predominates in most mucosa} secretions. 
The secretory or mucosa} immune system is made up of a network of immune 
structures that form the first line of defence at mucosa} surfaces. It incorporates the gut-
associated lymphoid tissue, uro-genital tract mucosa, lacrimal glands, lactating 
mammary glands and in the respiratory tract, the bronchus-associated lymphoid tissue, 
nasal-associated lymphoid tissue and salivary glands. When antigens present at a 
mucosa} surface specific antibodies are secreted. The main mucosa} antibody found in 
secretions is secretory lgA (SlgA). It is a dimer, containing part of a polypeptide called 
secretory component (SC). Secretory lgA is found in saliva, sweat, lung ,fluids, 
bronchial fluid, gastrointestinal secretions, tears, breast milk, and vaginal secretions. As 
most infectious agents enter the host via the mucosal membranes, a secretory IgA 
deficiency represents a reduced level of protection for the body, and an increased risk of 
infection. Therefore, a decreased concentration of secretory lgA is a potential indicator 
of increased disease risk. 
Secretory lgA protects the mucosa! surfaces by several mechanisms: exclusion 
(Lamm, 1976), neutralisation (Mazanec et al., 1992), and elimination (Kaetzel et al., 
1991). Exclusion is the mechanism whereby secretory lgA antibodies bind with 
exogenous substances at the luminal surface and prevent their attachment to the 
epithelial cells of the mucosa or entry into the body across the epithelium (Lamm, 
1976). 
The protective function of secretory IgA is not limited to the external secretions. 
Because secretory lgA migrate from plasma cells across epithelial cells to the lumen, 
they have the opportunity to encounter pathogens infecting the same cell. Specific 
secretory IgA antibodies can neutralise viruses at intracellular level by binding to viral 
proteins within the mucosal epithelium, thereby limiting or disrupting viral replication 
(Mazanec et al., 1993b). Thus, secretory IgA can not only prevent infection by keeping 
viruses from invading cells, it also appears capable of aiding recovery after infection. 
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Another site of secretory IgA defence is the lamina propria. Because secretory IgA 
is p.roduced by most of the plasma cells in the mucosa} lamina propria, a high local 
concentration of antibodies is present in the extra-cellular fluid. These antibodies have 
an opportunity to combine, at the basolateral surface of the mucosa! epithelium, with 
specific antigens that have crossed it, or have been produced in the sub-mucosa and 
would be present in the same extra-cellular fluid (Lamm et al., 1995). Rather than being 
absorbed into the circulation, these immune complexes can be transported across the 
epithelium into the mucosa! lumen for elimination and excretion (Mazanec et al., 
1993b). 
1.2 Salivary lgA 
The salivary glands are the main source of salivary IgA (s-IgA)2 (Miletic et al., 
1996). Another source of secretory IgA in the upper respiratory tracts is the tonsils. The 
release of s-lgA into saliva is a well-regulated process (Mayhall, 197 5). It is produced 
by IgA-secreting plasma cells that migrate, for instance from the gut and the uro-genital 
tract, to the salivary glands. There they reside beneath the epithelial cells which make 
up the surface of the mucous membranes (Brandtzaeg, 1989). Since these cells adhere to 
their neighbours by tight junctions, diffusion of macromolecules like secretory IgA 
(SJgA) across the epithelial layer is prevented and thus requires transport (Mazanec et 
al., l 993a). The molecule which acts as both a receptor and· trans-epithelial transporter 
for IgA is secretory component (SC). When secreted from the plasma cell, the J-chain of 
the dimeric SlgA binds to SC. Next, the SC-SlgA complex is incorporated by 
endocytosis into the cytoplasm of the epithelial cell, crosses it towards the luminal 
surface and is finally secreted by exocytosis into the lumen (Brandtzaeg and Prydz, 
1984). At this point, the SC-SigA complex is cleaved, releasing the dimeric IgA with a 
portion of the SC still attached. This process is shown in Figure 1. 
The immune system in general is influenced by a variety of factors and stressors 
that can be broadly categorised as physical (e.g. exercise, age, gender), environmental 
(e.g. heat and humidity), psychological (e.g. mood states) and lifestyle factors (e.g. 
nutrition). Most of these factors can also influence s-IgA secretion (Bratthall and 
Widerstrom, 1985; Gleeson, 2000a; Miletic et al., 1996; Pyne et al., 2000). After a 
discussion on several methodological issues, the following review is limited to the 
effects of exercise, heat and humidity, and psychological stress. 
2 The use of the abbreviation "s-IgA" for salivary JgA should not be confused with the abbreviation "SlgA" for 
secretory IgA. At the start of a sentence "S-IgA" is used for salivary IgA. 
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Figure 1: General scheme of secretary lgA transport across the mucosa! epithelium. 
From Mackinnon (1999a), Advances in Exercise Immunology, page 179. © 1999 
by Laurel T MacKinnon. Reprinted with permission from Human Kinetics 
(Champaign. IL). 
1.3 Methodological issues 
Saliva is the mucosal secretion of choice for the majority of studies of the mucosa} 
immune system. It is more acceptable to donors than blood, urine, tears or lymph 
because its collection is easy, non-invasive and mostly painless. 
Unfortunately, it is often difficult to compare studies on s-lgA because of different 
collection and storage methods, analytical methods and ways of expressing s-IgA levels. 
It is important to report the physiological conditions under which saliva is collected 
because they can have a significant influence on the s-IgA concentration, irrespective of 
the acute or chronic influence of exercise. Factors to consider are the source of the 
saliva (i.e. which gland), whether the subject is fasting, and whether saliva flow was 
stimulated. Careful handling and processing of saliva samples is required during the 
collection, transport, storage, and analytical phase of experiments because s-lgA could 
be subject to degradation over time. 
1.3. 1 Salivary sources 
To interpret and compare results on saliva flow rate and s-lgA during exercise, it 
is important to know if the saliva was whole mixed saliva or saliva from a single gland. 
The variations in s-JgA levels across studies can sometimes be explained by the fact that 
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the saliva came from different glands and that the contribution of each salivary gland 
varies with stimulation (Dawes, 1974). The concentration oflgA is lower in the parotid 
glands and this may account for lower concentrations oflgA in stimulated saliva 
secretions where the proportion of parotid secretions is increased to 50% of the total 
(Gleeson, 2000a). Because whole saliva provides a more complete picture of s-IgA 
immune status than saliva from a single gland, it is advisable to collect whole saliva 
rather than single gland saliva (Jemmott and McClelland, 1989). 
1.3.2 Saliva flow rate 
Saliva flow rate is a major factor governing the rate at which s-IgA is supplied to 
the oral cavity. Saliva flow rate is under neural control, predominantly by the autonomic 
nervous system. It is stimulated or influenced by a variety of factors including age, time 
of day, body position, food ingestion, sensory stimulation (e.g. light vs. dark; smell), 
drugs, smoking, body position, stress, exercise and degree of hydration (Ben-Aryeh et 
al., 1984; Dawes, 1974; Ferguson and Botchway, 1980; Gutman and Ben-Aryeh, 1974; 
Miletic et al., 1996). Parasympathetic stimulation causes vasodilation of the vessels 
supplying the salivary glands, resulting in an increase in blood flow and higher rates of 
salivary secretion (Chicharro et al., 1998b). Conversely, stimulation by the sympathetic 
nervous system, for instance during exercise, causes vasoconstricfion of the blood 
vessels to the salivary glands, leading t<? a reduction in saliva secretion (Chicharro et al., 
1998b ). The effects of short, intense exercise on saliva flow rate remain controversial 
(Chicharro et al., l 998b ). Studies at sub-maximal or maximal intensity show no changes 
in flow rate (Walsh et al.~ 1999), increased flow rate, or decreased flow rate after 
exercise (Blannin et al., 1998; Mackinnon and Jenkins, 1993). The few studies 
examining the effect of prolonged exercise suggest that low-moderate intensity exercise 
has ,little effect on saliva flow rate, while prolonged exercise above anaerobic threshold 
causes a decrease in salivary secretion (Bishop et al., 2000). The fall in saliva flow rate 
can be explained by a combination of a loss of saliva water by evaporation when 
breathing through the mouth and a reduction in saliva secretion due to dehydration 
(Blannin et al., 1998). Assuming saliva flow rate during exercise is affected by 
hydration levels, studies should indicate whether steps were taken to prevent or to 
minimise this by regular fluid intake. 
Saliva flow rate and s-IgA concentration also depend on whether saliva flow was 
stimulated and how, and whether the subject was fasting. A commonly used method is 
the application of citric acid or sour lemon drops to the tongue. Stimulation causes an 
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increase in saliva flow rate (Dawes, 1974; Miletic et al., 1996), resulting in a decrease in 
s-lgA concentration (Mandel and Khurana, 1969) and/or an increase in s-lgA secretion 
rate (s-lgA output can be up to four times higher in stimulated samples as compared to 
unstimulated samples) (Bratthall and Widerstrom, 1985). It also causes a variation in 
the contribution of each salivary gland (Dawes, 1974). In fasting subjects, changes in 
flow rates may account for the higher levels of s-lgA (Gleeson et al., 1990; Mandel and 
Khurana, 1969). Therefore, it is essential that studies mention whether stimulated or 
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unstimulated saliva samples were obtained and wether subjects were fasting or not. 
1.3.3 The salivary lgA assay method 
Changes in assay methods have not had a significant impact on the accuracy of s-
IgA measurement (Gleeson, 2000a). Nevertheless, when comparing studies, one has to 
take into consideration that differences in analytical methods can have an impact on the 
interpretation of results. Three aspects that need to be considered are the assay method, 
the source of the calibration material, and the specificity of the antisera. The most 
commonly used assay is (in-house) enzyme linked immunosorbtion assay (ELISA). 
Other methods include radial immunodiffusion (Winzer et al., 1999), 
immunoelectrophoresis (Guhad and Hau, 1996) and nephelometry (Deinzer et al., 
2000), which is the method used by our laboratory. 
Direct comparison of results from older studies is difficult because of a lack of 
information on the sources of the calibration material used for the assays (Gleeson, 
2000a). In 1994 a certified reference material (CRM 470) was prepared by the 
International Federation of Clinical Chemists (IFCC). The use of any calibrator 
standardised against this reference now allows for direct comparison between studies. A 
literature search revealed, however, that not all recently published reports have 
referenced CRM 470. The calibration standards used in our laboratory are referenced 
against CRM 4 70. 
The major analytical difference between reports of s-IgA concentrations is _due to 
the differences in specificity of the antisera (Gleeson, 2000a). S-IgA exists in two 
forms, IgAl and IgA2, which are present in almost eq~al proportion in saliva (Delacroix 
et al., 1982). Therefore, it is important to select an antiserum that it is able to detect both 
subclasses. The Dade-Behring antiserum used by our laboratory detects both IgA 
subclasses (RalfEvelbauer, Dade-Behring Technical Support Group Plasma Proteins, 
personal communication, 4 September 2002). 
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1.3.4 The collection of saliva samples 
Differences and errors in the collection method of saliva may explain some of the 
biological variation and differences between studies. The most common methods are 
spitting, dribbling (collection of drool), suction, and the use of absorbent swabs (Dawes, 
1987). Spitting requires subjects to be seated in a comfortable position, with slightly 
lowered head, allowing spontaneous saliva flow in the mouth (Miletic et al., 1996). 
Saliva is expectorated at predetermined time intervals into a receptacle. Dribbling 
requires subject to be seated with the head tilted forward and the mouth slightly open, 
allowing saliva to drip from the lower lip into a receptacle (Dawes, 1972). During the 
last few seconds of the collection time, saliva accumulated in the mouth is spat out. No 
other conscious movements of the oral musculature are allowed during the collection 
period. In the suction method, saliva is sucked continuously from the floor of the mouth 
with a suction tube (or pipette) and allowed to accumulate in a receptacle (Dawes, 
1987). Suction tubes are also used to extract saliva directly from specific glands. The 
method that uses absorbent swabs requires the subjects to hold a small cylinder of a 
cotton-wool-like substance in the mouth. The saliva absorbed by the swab is removed 
by centrifugation. Several commercial devices are available, for instance Salivettes 
(Sarstedt, Numbrecht, Germany), OraSure (Epitope, Beaverton, Oregon), Oracol 
(Malvern Medical Development Ltd., Worcester, United Kingdom) and Omni-Sal 
(Saliva Diagnostic Systems Inc., Brooklyn, New York). For the accurate measurement 
of saliva flow and the calculation of s-lgA secretion rate it is essential that all saliva 
present in the mouth is collected. This requires the full cooperation of the subject.. 
Imprecise timing of the collection can also introduce errors when measuring the 
secretion rate of IgA. 
It is possible that the s-lgA concentration is influenced by the saliva collection 
method. Two studies have found s-lgA conce,ntration to be lower in saliva collected by 
the cotton swab (Salivette) method than in saliva collected by other methods (Aufricht 
et al., 1992; Strazdins et al., 2005). This was ascribed to an unspecific adsorption of s-
lgA to the material of the swab. It is not clear if this problem has been overcome since 
then by the use of a different material (polyester) for the swab. If not, this method 
contains a potential source of error. In another study, however, comparing four different 
collection methods (drooling, suction, OraSure and Oracol) the collection method had 
only a minor effect on antibody concentration (Nurkka et al., 2003). In any study ons-
lgA, the collection 'method should be accurately described. 
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A standardised collection method, using Salivettes with polyester swabs, was 
developed early in this study and used in all related projects. An accurate description of 
this method can be found in the "methods" section of chapter 2. 
1.3.5 The storage of saliva samples 
If saliva samples are left at room temperature, s-lgA is possibly subject to 
proteolysis, the degradation by proteases produced by bacteria in the respiratory tract 
(Dawes, 1974). Therefore, it is recommended that saliva is either analysed straight away 
(Butler et al., 1990) or, if this is not possible, frozen immediately, either by snap-
freezing in liquid nitrogen or in a -70°C freezer (Nurkka et al., 2003). For added 
"protection" a protease inhibitor can be added (Ogra et al., 1999). If no freezer is 
available samples should be placed preferably in dry ice within 30 minutes of collection 
or otherwise placed directly into normal ice (M. Gleeson, personal communication 
01/09/02). 
It is possible, especially in field testing situations, that saliva samples are collected 
in situations where no cold storage facilities are available and ambient temperature is 
quite high (e.g. remote regions of the tropics). Therefore, to be of any use in those 
circumstances, it is essential that s-IgA remains stable until samples arrive at the 
laboratory. 
Several studies have investigated how saliva and various salivary proteins are 
affected by storage conditions (Mortimer- and Parry, 1988; Nimmagudda et al., 1997; 
Stark et al., 1993; Th we et al., 1999). However, only a few have assessed the stability of 
s-IgA._In one study, saliva samples were stored at 4°C, -20°C and -70°C, with or without 
glycerol and a protease inhibitor for various periods (Butler et al., 1990). S-IgA activity 
to S. mutans decreased significantly after one week when stored at 4°C and -20°C. l:oss 
of activity was significant in the first 24 h. The addition of 50% glycerol and storage at -
70°C prevented this degradation. Samples stored for 18 months at -20°C lost all 
antibody activity for S. mutans. In another study, s-IgA concentration remained stable 
for up to 3 months at -30°C, then declined with increasing storage time and after 8 
months had decreased by more than 10% in the majority of the samples (Ng et al., 
2003). Nurkka et al. (2003) compared the effect of three storage protocols on the 
concentrations of s-IgA antibodies to pneumococcal capsular antigens. Samples were 
either snap-frozen with glycerol in liquid nitrogen, stored at +4°C either with or without 
the addition of protease inhibitors, or stored at -70°C for a week. Samples which were 
not frozen immediately yielded IgA concentrations approximately 30% lower than the 
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snap frozen samples. The addition of a protease inhibitor made no difference to this 
result. However, the advantage of snap-freezing was lost if not applied immediately 
after collection of the saliva. 
From these results it seems that long-term storage can cause some degradation of 
s-IgA even at-30°C but that storage at-70°C can prevent loss of s-IgA. It is not clear if 
repeated freeze-thawing cycles affect s-IgA concentration. According to M. Gleeson 
(personal communication 01/09/02) s-IgA is stable for approximately 5 repeat freeze-
thaws providing the sample is not left at room temperature for any more that 10 minutes 
during each thaw. However, repeated freeze-thaws should possibly be avoided, as the 
concentration of other proteins (e.g. albumin, IgG) has been shown to decrease by 10% 
with each additional thaw 
1.3.6 Measures of salivary lgA 
There remains some controversy and confusion about the best way to express s-
IgA levels - as an absolute concentration (in mg L-1), as a ratio to total protein, as a ratio 
to albumin, as a ratio to osmolality, or as a secretion rate (in µg min-1). Each of these 
measures is associated with methodological problems. The lack of uniformity in 
expressing s-IgA makes comparison of published effects of physical activity on mucosal 
immunity difficult. 
The IgA concentration in saliva is influenced by the saliva flow rate. It is quite 
common that saliva flow is reduced by exercise-induced dehydration. This, and 
evaporative loss of saliva water when breathing through the mouth during exercise, can 
have a concentrating effect on the saliva (Blannin et al., 1998; Stone et al., 1987). Ifs-
IgA output and transport remain constant, absolute s-IgA concentration could be 
artificially increased because of the reduced saliva volume as a result of the dehydrating 
effect of the exercise. Conversely, a decreased s-IgA output and transport during 
physical activity may not be detected. Therefore, reporting the s-IgA concentration can 
be misleading and make it difficult to interpret the effect of exercise. Absolute s-IgA 
concentration should only be used when saliva flow rate remains constant. 
Expressing s-IgA concentration as a ratio with another salivary solute, which is 
not actively transported and therefore is insensitive to most physiological changes, 
should account for changes in saliva water volume. A commonly used indirect quantity 
for assessing s-IgA levels is the ratio of the s-lgA concentration to the total protein or 
albumin concentration. Proponents of these measures claim that they give a better 
indication of the effects of exercise on s-lgA because, compared to s-IgA concentration, 
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they are independent of salivary flow and thus effectively correct for a loss of saliva 
water. 
However, the use of total protein has been criticised because certain salivary 
proteins are sensitive to physiological conditions and may influence total protein 
secretion rate (Gleeson, 2000b ). Increases in protein concentration have been found 
(Hilbner-Wozniak et al., 1997; Ljungberg et al., 1997) even when s-IgA concentration 
remained unaffected (Walsh et al., 1999). Several authors have claimed that the ratio of 
s-lgA to protein may be misleading as the saliva flow rate alters during exercise, leading 
to a higher output of total protein without necessarily a parallel change in the output of 
s-IgA (Blannin et al., 1998; Gleeson, 2000a; Miletic et al., 1996). 
Using the IgA:albumin ratio would be preferable because albumin is passively 
transported into saliva from plasma, where it is under homeostatic control. However, 
even albumin concentration or transportation can be affected by several factors such as 
plasma volume, postural change, pregnancy, congestive heart failure, severe 
malnutrition and liver failure. 
Another way to correct for loss of saliva water is to express s-IgA relative to 
osmolality, which increases in proportion to the fall in saliva flow rate (Blannin et al., 
1998). Osmolality is a measure of the total dissolved particle concentration. Because 
inorganic electrolytes rather than proteins(< 1 %) contribute most-to the osmolality of 
saliva, the overall concentration of solutes (or osmolality) should not be affected by 
most physiological conditions (Blannin et al., 1998). However, the measurement of 
osmolality requires additional equipment. 
The protective effect of s-lgA in the upper respiratory tract depends on its 
secretion rate (Mackinnon and Hooper, 1994), which determines the total amount of s-
lgA available at the mucosa} surface. Therefore, the s-IgA secretion rate (expressed 'in 
µg·min- 1) would appear to be a good way to express s-IgA. A drawback of this method 
is that it requires the correct assessment of total saliva flow rate without any losses (e.g. 
due to swallowing). It also requires exact timing of the period of sampling. Poor 
compliance of subjects adversely affects this measurement. 
Unfortunately the s-lgA measurement chosen can alter the interpretation of 
experimental results. This is illustrated by the results from a pilot study (Pacque et al., 
2002). Fifteen males and six females completed two laboratory stress tests (walking at 
5km h-1). Albumin and s-IgA were measured in saliva samples collected immediately 
upon completion of each test and at timed intervals up to 24 hours later: For each 
subject the results from both tests were averaged. Although there were significant 
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changes in each measure in the first hour post exercise, the trend was for an increase in 
s-lgA concentration, an immediate decrease in secretion rate followed by-an increase, 
and a suppression oflgA:albumin for at least one hour. 
1.3. 7 Diurnal variation of salivary /gA 
Dawes (1972) established that the flow rate and concentration of several 
components (IgA was not measured) of unstimulated whole saliva show a significant 
circadian rhythm. It was concluded that "the presence of circadian rhythms in salivary 
flow rate and composition must influence the concept of normal values and in any study 
on saliva the time of day of sampling could have an important bearing on the results" 
(Dawes, 1972). For this reason in any comparative study, saliva samples should ideally 
be collected at the same time of day. The possible presence of a diurnal variation has, 
however, not always been considered in the design or interpretation of past research on 
the effects of exercise or stress on s-IgA. 
Findings on the magnitude and pattern of a possible diurnal variation are 
equivocal. Several authors have reported that there is an early morning P,igh, followed 
by a fall to a lower stable base in the afternoon (Gleeson et al., 2001; Hucklebridge et 
al., 1998; Richter et al., 1980; Walsh et al., 2002). However, no clear pattern has 
emerged as not all investigators have measured s-IgA at the same times of day. For 
instance, in one study (Richter et al., 1980), s-IgA concentration was highest at 5:00, 
whereas in others it was highest at 8:00 (Gleeson et al., 2001) or at the time of 
awakening (mean awakening time was 7:30, range 6:00-10:30) (Hucklebridge et al., 
1998). Others observed no differences in s-lgA concentration be~een mid-morning and 
mid-afternoon (Gleeson et al., 1990). Dimitriou et al. (2002) found significantly higher 
s-lgA concentrations in samples taken at 6:00, but secretion rate was significantly 
higher at 18:00. Butler et al. (1990) found some fluctuations in s-lgA concentration and 
secretion rate but commented that these were more characteristic of the subjects than the 
time of sampling. Miletic et al. (1996) found significantly higher morning s-lgA 
secretion rates compared with the afternoon in 20-30 years old subjects but not in 60-80 
years old subjects. Based on these findings there is some evidence that s-lgA 
concentration and secretion rate exhibit a high early in the morning, followed by a 
decrease leading to a plateau from midday until evening. However, the evidence is not 
conclusive. 
Several mechanisms have been proposed to explain a possible morning high. A 
first theory is that, as s-IgA secretion is influenced by sympathetic nervous system 
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activity, s-IgA secretion increases when a subject is relaxed (as when asleep) (Green 
and Green, 1987) and suppressed when a subjects is stressed (Jemmott et al., 1983). A 
second theory is that bright light exposure during the daytime can result in an increase 
in nocturnal melatonin levels due to a relaxation of the sympathetic nervous system, 
resulting in an elevated s-IgA secretion (Park and Tokura, 1999). A decrease in 
melatonin concentration in the morning would then result in a decrease on s-IgA. The 
mechanism by which melatonin exerts its stimulating effects on s-IgA is at present 
unknown. An attractive third theory is that the morning fall in s-IgA concentration and 
secretion rate is due to the acute stress caused by the awakening process and is 
negatively associated with the increase in cortisol levels observed over the same period 
(Hucklebridge et al., 1998). 
A preliminary study conducted by the present author, found no evidence to 
confirm the existence of a diurnal pattern (Pacque et al., 2002). There was a trend for 
higher early morning values (after waking), reasonably stable values during the day and 
a second smaller peak late in the evening. However, the data showed a wide scatter of 
results for time of day and a repeated measures analysis of variance revealed no 
significant effect of time. The number of subjects in this study was limited (N = 19). 
The effect of fasting or eating on the diurnal variation of s-IgA is not clear. In 
one study, s-IgA concentration was found to be higher in fasting samples (range 25-600 
mgL-1) than in post-prandial samples (9-125 mgL-1) (Gleeson et al., 1990) but no other 
studies have specifically investigated this. 
1.3.8 Biological variation of salivary lgA 
The literature indicates that there is a large within-subject (day-to-day and 
within day) and a large between-subject biological variation in s-IgA. Sometimes tbese 
variations seem to be of greater importance/magnitude than the changes caused by the 
experimental intervention. One study found that s-IgA concentrations within-subjects 
can vary by a factor of2.53 between days (Gleeson et al., 1990), whereas in another 
study, there was a daily variation in s-lgA secretion rates in elderly (60-80 years old) 
but not in young subjects (20-30 years old) (Miletic et al., 1996). S-IgA concentration 
can differ 15-fold between individuals (Bratthall and Widerstrom, 1985). Individual 
differences in saliva flow rate, which influences s-lgA concentration, can be as great as 
30-fold (Mayhall, 1975). The individual variability of s-lgA can be affected by the 
activity level and fitness of individuals as shown by Francis et al. (2005). 
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Our own observations have confirmed the existence of a large biological 
variation. Using a cohort of 21 adults, early morning (fasting) saliva samples were 
collected three times a week for eight weeks (Pacque et al., 2002). The mean within-
subject biological variation CV1 was 42.5% for s-IgA concentration and 44.9% for s-
IgA secretion rate. The between-subject variation CV a was 48.8% and 70.6% 
respectively and the index of individuality (II= CV1 /CV a) was 0.87 and 0.64 
respectively. 
1.3.9 Reference interval of salivary lgA 
One published reference interval for s-IgA concentration for Australian adults is 
10-105 mgL-1 (non-fasting samples) and 20-500 mgL-1 (fasting samples) (Gleeson et 
al., 1990). Our own work, based on a group of21 adults resulted in a fasting reference 
interval of 20-160 mg L" 1 (Pacque et al., 2002). 
The large biological variation and low index of individuality (II) for measures of 
s-JgA cast some doubt on its value as a biomarker of stress if an individual's 
measurements are compared with a population-based reference interval. If the II is < 0.6 
then an unacceptable high degree of individuality exists for the measurement and a 
population-based reference interval may not be very helpful for detecting significant 
change in repeated measurements for an individual (Solberg, 1994). Individuals may 
have an unusual measurement result for them, but still fall within the healthy reference 
interval or conversely, a measurement might be usual for an individual but fall outside 
the reference interval (Fraser, 1994). Therefore, using s-IgA in this way may have little 
value in predicting risk of ill health for an individual. 
However, s-IgA may be useful to detect trends in the mucosa! immunity of an 
individual if measurements can be compared against the individual's healthy baseline 
values. This would make it necessary to establish an individual's personal reference 
interval. In the case of athletes this might be problematic as physical activity levels 
seem to have an impact on baseline levels. For instance, baseline levels of s-IgA 
concentration of competitive cross-country skiers during heavy training were 
significantly lower than of sedentary controls (Tomasi et al., 1982) and baseline levels 
of collegiate swimmers during the competitive season were significantly lower than 
preseason values (Tharp and Barnes, 1990). From these studies, it appears that high 
volumes of intensive training depress baseline s-IgA levels. Many athletes have 
possibly been competing and training for a long time. Therefore, it is possible that low 
resting levels of s-IgA represent a cumulative effect over the years of training of 
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exercise-induced immunosuppression (Fricker et al., 1999). Because it is not easy to 
persuade athletes to interrupt their training even for a day, it may be difficult to 
determine their real "resting levels". 
Finally, the possible presence of circadian rhythms makes it difficult to compare 
measurements with reference values. As the time of day that samples are taken may, 
have a bearing on results, it is advised that in any comparative study, saliva samples 
should ideally be collected at the same time of day. 
1.4 Exercise and immune function 
There is both anecdotal and epidemiological evidence, albeit rather weak, that 
regular moderate intensity exercise reduces the risk of infections by boosting the 
immune system and for instance is associated with a reduced vulnerability to upper 
respiratory tract infections (URTI) (Nieman et al., 1990b). Intense and repeated 
endurance exercise, on the other hand, may perturb or compromise several components 
of the immune system (e.g. natural killer cells, lymphokine-activated killer cells, 
leucocytes, lymphocytes, neutrophils, cytokines, etc). Many of the changes of immune 
function are seen in peripheral blood; however, there is no strong evidence that either total cell 
numbers or activity is changed in the body as a whole. Changes are generally transitory, 
usually returning to normal within hours of most types of exercise. A possible exception 
is very prolonged exercise, such as ultra marathon running, which may induce long 
lasting (24 hours or beyond) changes (Schobersberger et al., 2000). 
It has been proposed that after exercise there is an "open window" period of 
impaired immunity during which there is an increased susceptibility to infections by 
viruses and bacteria (Mackinnon et al., 1993b; Peters, 1997) and that the degree and 
duration of immunosuppression depends on the intensity and duration of the exercise 
(Pedersen et al., 1996). Although the open window concept is an attractive hypothesis, 
Nieman (2000) stated that there is no proof that the athletes showing the most extreme 
immunosuppression following heavy exertion are those that contract an infection during 
the following period. According to Pedersen et al. (1994) post exercise 
immunosuppression may actually confer a benefit: since severe physical stress is 
associated with tissue breakdown and presentation of new antigens to the immune 
system, autoimmune reactions could be avoided. 
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1.5 Salivary lgA and upper respiratory tract infections 
Nieman (1994) postulated there is a J-shaped relationship between physical 
activity and susceptibility to upper respiratory tract infections (URTI) (Figure 2). He 
suggested that regular, moderate intensity physical activity reduces the risk of URTI. In 
a recent study by Ciloglu (2005), moderate intensity aerobic exercise was indeed 
associated with fewer episodes ofURTI in healthy women. On the other hand, very 
high intensity or large amounts of exercise would increase the risk. According to this 
hypothesis, one would expect elite and endurance athletes to have a higher incidence of 
URTI than non-athletes or moderately exercising subjects. Roberts (1986) suggested 
that URTI is the most common infection in highly trained athletes and URTI have been 
cited as comprising on average 96-98% of"all types of pathological cases" in athletes 
(Levando et al., 1988). For instance, in a rare yearlong study of American football 
players, Fahlman and Engels (2005) found that a season of training resulted in an 
increase in the incidence ofURTI. Pyne (1999) suggested that URTI are the main cause 
of missed training in elite athletes and may have a deleterious effect on an athlete's 
ability to compete. According to Gleeson (2000c) the period of highest vulnerability 
often coincides with the intense training undertaken immediately prior to or during a 
competition and may not follow the normal seasonal patterns observed in the general 
community. The J-shaped hypothesis is not universally accepted. Shephard (2000) 
warned that because it was largely built on a composite of results drawn from small and 
disparate studies it needs further substantiation. 
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Figure 2: "J"-shaped model of the relationship between amount of exercise and risk of 
VRTI From Nieman (1994), page 129. Reproduced with permission from Lippincot, 
Williams & Wikins. 
Secretory lgA is the body's first line of defence against invasion from certain 
pathogens. It is possible that there is a critical concentration of s-lgA required to 
provide adequate protection from URTI (Gleeson et al., 1999b) and that a lack of s-lgA 
or the inability to produce specific lgA antibodies can lead to an increased susceptibility 
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to URTI. Although according to Gleeson et al. (1999a) the precise association between 
e-xercise, URTI and immunosuppression remains unclear, transient changes in s-lgA 
levels or low resting s-lgA levels induced by exercise could contribute to the increased 
susceptibility of infection in athletes (Blannin et al., 1998; Mackinnon and Hooper, 
1994; Tomasi et al., 1982). Nevertheless, it is yet to be unequivocally demonstrated that 
depressed levels of s-lgA predispose an individual to URTI. 
For ethical reasons, experiments attempting to determine the influence of physical 
activity on the susceptibility of humans to instilled infection are unlikely to be 
undertaken. Epidemiological data are much more readily available. Findings suggest 
there is a dose-response relationship between the volume of physical activity and the 
likelihood of respiratory symptoms. In young adults, moderate exercise seemed to have 
little influence on the risk ofURTI (Schouten et al., 1988). On the other hand, there is a 
strong consensus that very heavy exercise and/or training increases the prevalence 
and/or the persistence ofrespiratory symptoms (Shephard and Shek, 1999a). As early as 
the late 1970's increased levels of perceived URTI were reported in conditioned athletes 
(Douglas and Hanson, 1987). The first report of a direct association between URTI and 
s-IgA in athletes during periods of maximum intensity training came from a study of 
Russian Olympic athletes (Levando et al., 1988). Other studies have found temporal 
relationships between exercise, URTI, and possibly s-IgA, in athletes involved in 
various sports such as swimming (Gleeson etal., 1999a), squash (Mackinnon et al., 
1992), hockey (Mackinnon et al., 1993 b ), and (ultra )marathon running (Nieman et al., 
1990a; Peters and Bateman, 1983). In other studies, however, such temporal 
associations were not found. For instance, no association was found between the 
incidence ofURTI and s-IgA concentration in a group of swimmers over a 12-week 
training period (Gleeson et al., 2000b ), in a group of elite rowers (Nehlsen-Cannarella et 
al., 2000), and in a group of exercising post-menopausal Turkish women (Ciloglu, 
2005). In a recent study on the incidence ofURTI in French soldiers during four weeks 
of commando training Tiollier et al. (2005) found no relation between URTI and s-IgA. 
The methodology, and therefore the conclusions of some of the studies that looked 
at the association between exercise and URTI can be criticised. Some studies possibly 
had a number of subjects that was too small to detect a significant effect. The subjects in 
many studies are only representative for a particular sub-population (e.g. elite 
swimmers) and findings can thus not be generalised. Some studies compared highly 
active with less-active individuals, without regard for differences in lifestyle, and many 
studies do not report the fitness level of their subjects at all. The diagnosis and 
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assessment of the severity and frequency ofURTI ranged from subjective self-reporting 
(e.g. by questionnaire) to diagnosis by a medical practitioner. When questionnaires are 
used rather ~han clinical examination, the findings can be questionable for several 
reasons. There is the danger that return rates are low, that URTI prevalence is over- or 
under-reported, or that symptoms are misinterpreted. The aetiology ofURTI depends on 
many factors other than the participation in strenuous exercise. The likelihood of 
contact with other infected people (e.g. spouse, children), the frequency of exposure to 
pathogens, gender, age, season, exposure to extremes of heat and cold, overall levels of 
(psychological) stress, overall levels of health, sleep deprivation, nutritional status and 
the use of dietary supplements, and an individual's ability to elicit specific immune and 
non-immune responses are a few factors that can influence the prevalence ofURTI 
(McDowell et al., 1991; Shephard, 2000). Consequently, epidemiological data may not 
always provide a valid measure of prevalence of UR TI. 
1.6 Salivary lgA as a biomarker 
The Australian Defence Force (ADF) 2000 Health Status Report suggested that 
the high usage of medications for treating coughs, colds and infections indicates that 
URTI is common within the ADF (Department of Defence, 2000). The susceptibility of 
soldiers to URTI has also been observed in several field studies. A 21-day Royal 
Australian Air Force survival course in northern Australia (Townsville) resulted in 
significantly reduced s-lgA levels which were associated with the incidence ofURTI 
(Carins and Booth, 2002). A high incidence ofURTI was also observed in 482 male 
soldiers engaged in heavy special warfare training (Linenger et al., 1993), in 477 Navy 
Special Forces trainees during 2 weeks of intense training (Gray et al., 2001 b), and in 
21 male cadets during commando training (Tiollier et al., 2005). In this last study the 
incidence ofURTI was not related to s-lgA. 
The danger of encountering unfamiliar viruses when soldiers (or athletes) congregate in 
groups for an extended period of time (e.g. at training camps) is real. The presence of URTI in 
athletes or soldiers during periods of intense training and competitions is of particular 
concern because URTI can decrease their capability to perform optimally. Early 
identificatio-n of individuals at risk of developing an URTI would allow training to be 
altered before performance (or operational readiness) deteriorates. Research is now 
directed towards identifying markers that could be used to this effect. Much attention 
has focused on s-IgA as it is the only immune parameter so far to be directly associated 
with the appearance ofURTI (Carins and Booth, 2002; Gleeson et al., 1999b; 
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Mackinnon, 2000; Mackinnon et al., 1991; McKenzie, 1999). It is hoped that 
monitoring s-IgA levels at regular intervals could provide-an indirect method for the 
assessment of immune status and to determine the risk of infection. S-IgA may also be a 
marker to detect over training syndrome (OTS) as this condition has been associated 
with high rates ofURTI (Mackinnon and Hooper, 1994; McKenzie, 1999; Shephard and 
Shek, 1998). 
Despite saliva sampling appearing to be convenient for field-based work, some 
caution is warranted with the use of this methodology. In an excellent recent review of 
the exercise immunology literature, Gleeson and co-workers summarised the limitations 
of the method (Gleeson et al., 2004). For example, the conditions of saliva collection 
can affect the measured IgA concentration (e.g. the source of the saliva; whether flow 
rate was stimulated or not; "fasting" or "non-fasting" state of subjects); careful handling 
of saliva samples is required during the transport, storage, and the analytical phase of 
experiments since s-IgA degrades over time; there is no uniformity in the analytical 
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methods used to determine s-lgA concentration (instrumentation, technique, analytes); 
there is no sensitive and practical screening test for s-IgA that can be implemented in 
normal training; and there is no consensus about the best way to express s-IgA levels. 
Furthermore, s-IgA has a considerable biological variation and may be also subject to 
diurnal variation. These issues are addressed in Chapter 2. 
A decrease in s-IgA has not been proven to be a valid indicator of the risk of 
URTI or excessive training (Shephard and Shek, 1998). There is as yet no clear 
understanding of the dose-response effect of intensity and duration of physical activity 
on s-lgA and the exact concentration (or secretion rate) at which this immune factor 
becomes predictive is still unknown (Nieman, 1994). It is not well understood how 
rapidly s-IgA levels return to baseline after a period of suppression in response to a 
stressor. Resting s-lgA measurements and the response to exercise may depend on 
factors such as fitness and activity levels and environmental conditions. Finally there is 
little information on the relationship between s-lgA and other biomarkers of immune 
function or OTS. These issues are addressed in the experiments described in Chapters 3, 
4 and 5. 
1. 7 Salivary lg A and exercise 
Tomasi et al. (1982) were the first to publish research on the effects of exercise on 
s-lgA. Compared with age-matched controls, they found significantly lower s-lgA 
concentration in cross country skiers before a race. S-IgA concentrations decreased 
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further following the competition. The authors speculated that a temporary antibody 
deficiency on the mucosa} surface might lead to a susceptibility to acquiring viral an~ 
bacterial infections, especially immediately after strenuous exercise. 
Since this initial study, various investigations have looked at the effects of 
exercise on s-IgA in a diverse range of individual and team sports, with athletes of a 
wide variety of age, fitness level, experience and training background. Studies of elite 
athletes have found transient decreases of 5-65% in s-IgA levels following intense 
endurance exercise in swimmers (Tharp and Barnes, 1990), distance runners (Cameron 
and Priddle, 1990), kayakers (Mackinnon et al., I 993a), triathletes (Steerenberg et al., 
1997), cyclists (Mackinnon et al., 1989), and rowers (Nehlsen-Cannarella et al., 2000). 
In contrast, increases in s-IgA concentration, secretion rate and/or ratio to osmolality 
were reported in recreational athletes after maximal intensity exercise (Schouten et al., 
1988), in marathon runners after a race (Ljungberg et al., 1997), in subjects of mixed 
physical fitness after ergometer cycling (Blannin et al., 1998) and in moderately 
exercising walkers and joggers (Buckwalter et al., 1996). Finally, s-IgA secretion rate 
did not change as a result of high-intensity intermittent ergometer cycling in well 
trained subjects (Walsh et al., 1999) or treadmill running in recreational and competitive 
rnnners (Mackinnon and Hooper, 1994). 
The variety of responses in these reports may be explained in various ways, 
including major differences in their experimental design. For instance, the fitness level 
of subjects, the level of competition, the frequency, intensity and duration of exercise, 
and the metabolic energy source (aerobic versus anaerobic), can affect the s-IgA 
response to exercise (Gleeson et al., 2004; Hoffinan-Goetz and Pedersen, 1994; 
Mackinnon, 1996; Nieman, 2000; Nieman and Nehlsen-Cannarella, 1991; Pedersen et 
al., I 994; Shephard, 2000). The disparity in findings may also arise from differences in 
the analytical methods. The non-uniformity of the s-IgA method and the differences in 
the interpretation of results, depending on the way in which s-IgA is expressed, are the 
biggest barrier to understanding the literature and determining the usefulness of s-IgA 
as a marker. Comparative analysis of published results is not valid unless the authors 
were measuring s-lgA in the same way. The table in Appendix A illustrates some of the 
differences in the methodology used (e.g. saliva source, collection method, assay 
methodology, antisera used and whether referenced to the international standard, and s-
IgA measure reported. 
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1. 7. 1 Intensity and duration of exercise 
The role of the intensity of physical activity on the s-IgA response remains 
unclear. Several studies, both under standardised laboratory conditions and under field 
conditions, have failed to show that changes in s-IgA in subjects of mixed physical 
fitness were related to exercise intensities between 50-100% of V02max (Blannin et al., 
1998; Mackinnon and Hooper, 1994; McDowell et al., 1991; Walsh et al., 1999). Other 
studies, however, found that s-IgA levels were lowest after heavy workouts or during 
periods of peak training intensity (Dorrington et al., 2003; Levando et al., 1988; 
Mackinnon et al., l 993a; Tharp and Barnes, 1990). 
The effect of the duration of exercise seems to be of secondary importance. 
Decreased levels of s-IgA have been observed after intense prolonged exercise such as 
several hours of competitive cross-country skiing (Tomasi et al., 1982) and ultra 
marathon running (Peters and Bateman, 1983), but also after intense exercise of short 
and very short duration. Changes in s-IgA were found to be similar following 15, 30 and 
45 minutes of treadmill running at 60% ofV02max (McDowell et al., 1991) and 
decreases of s-IgA secretion rate were observed after five 60-second bouts of supra-
maximal interval exercise separated by 5 min rest (Mackinnon and Jenkins, 1993). 
The cautious conclusion could be that exercise intensity rather than duration is the 
more important factor determining changes in s-IgA and that high-intensity physical 
activity is more likely to cause mucosa) immune suppression than more moderate 
exercise. However, it is not clear if immunosuppression occurs at a threshold intensity 
and ifthere is a consistent dose-response. Additional well-designed studies are required 
to clarify the sometimes divergent findings and to determine whether exercise 
influences mucosal immune parameters in a uniform manner at specific intensities and 
duration. So far there is no evidence that changes in s-IgA caused by exercise are 
directly related to fitness or activity levels. 
1. 7.2 Long term effect of exercise 
It is possible that exercising on a frequent basis may have a cumulative 
(suppressant) effect on the resting s-lgA concentration or secretion rate and on its 
response to acute exercise. However, in contrast to the large number of studies on the 
acute effects of exercise, much less is known about the long-term effect of physical 
activity on mucosal immune function. In an excellent review of the practical 
applications of exercise immunology, Nieman (1997) concluded that this is largely due 
to the difficulties in separating fitness effects from the actual physical exercise and that 
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ideally, such a study would require a large group oftest subjects plus a control group to 
be followed for a relatively long period (e.g. one year). Although such a study has not 
been conducted to date, a few small longitudinal and cross-sectional studies have 
attempted to determine whether years of athletic training elicited significant changes in 
mucosa} immunity. Cross-sectional studies have compared highly trained athletes with 
recreational athletes or sedentary individuals and longitudinal studies have monitored 
long-term changes in mucosa} immune responses in athletes undertaking intensive 
training programs. 
Lower resting s-IgA concentrations were reported in elite cross-country skiers, 
compared with control subjects (Tomasi et al., 1982) and in Russian Olympic athletes 
(Levando et al., 1988). In contrast, the resting s-IgA concentration was higher in trained 
rowers than in non-athletes (Nehlsen-Cannarella et al., 2000), and in a group of elite 
swimmers the pre-exercise levels of s-IgA were significantly higher than in a 
moderately exercising control group (Gleeson et al., 1999b). There was no difference 
between resting s-lgA concentration in competitive cyclists and age matched untrained 
control subjects (Mackinnon et al., 1987). Differences between study design, for 
instance the particular sport, the athletes' fitness levels, and the amount of 
psychological stress they were under, can all contribute to these conflicting findings. 
Several longitudinal studies have found evidence of a cumulative suppressant 
effect of regular exercise on s-IgA. S-IgA concentration declined over 2-3 weeks of 
intensive training in elite kayakers (Gleeson et al., 2000a; Mackinnon et al., 1993a). 
Mackinnon et al. (1993a) found that the greatest decline in the lgA secretion rate 
occurred after the most intense training session at the end of a week of intense training. 
While it is possible that this was due to the training intensity, it may also reflect the 
cumulative effect of prior loads. Although there were no changes in s-IgA concentration 
in wrestlers over a 16 day training camp, when related to salivary protein, significantly 
decreased values were observed towards the end of the camp {Hilbner-Wozniak et al., 
1998). S-lgA secretion rate decreased over three consecutive days of intense treadmill 
running in a group of distance runners (Mackinnon and Hooper, 1994) and s-
IgA:protein ratio decreased progressively over 5 days of competition in female hockey 
players (Mackinnon et al., 1992). 
Progressive declines in s-IgA concentration were reported in swimmers over both 
a 3-month (Tharp and Barnes, 1990) and a 7-month training season (Gleeson et al., 
l 999a). Although a major difference between these two studies was that whereas in the 
first study s-IgA levels partially recovered in the tapering period leading up to 
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competition, they continued to decline in the second. In her excellent book on exercise 
immunology, Mackinnon stated that it is possible that the taper was of insufficient 
length to overcome the long-term immunosuppression or that the psychological stress 
associated with the upcoming competition may have prevented the recovery of s-IgA 
despite the reduction in physical stress (Mackinnon, 1999a). Two similar studies of elite 
swimmers on the other hand showed either no change in resting s-IgA concentrations 
over a 6-month season (Mackinnon and Hooper, 1994) or a small but significant 
increase over a 12-week training program (Gleeson et al., 2000b ). 
These studies suggest that regular training may indeed have a cumulative 
suppressive effect on mucosa] immunity, and that lower resting s-IgA concentration can 
occur within a few days of training. More extended periods (i.e. several months) of 
sustained high intensity training may be required for persistent immunosuppression to 
occur. 
1. 7.3 Recovery after exercise 
The rate at which s-IgA returns to pre-exercise or resting levels seems variable. In 
most studies, recovery occurred within one hour of the completion of exercise, as was 
the case for a marathon run (Ljungberg et al., 1997), a 10.5 km sub-maximal run 
(Cameron and Priddle, 1990) and a cycling ergometer exercise (Blannin et al., 1998). In 
this case the open window period of impaired immunity during which there is an 
increased susceptibility to infections (see section 1.4) is limited. However, other studies 
involving both elite and recreational athletes have documented slower recovery rates 
after exhaustive exercise. S-IgA levels remained depressed one hour after an 
incremental treadmill test to exhaustion in novice runners (McDowell et al., 1992a) and 
in competitive cyclists after a two-hour cycle ergometer tests (Mackinnon et al., 1987) 
and 90 min after two hours of rowing training (Nehlsen-Cannarella et al., 2000). S-IgA 
concentrations took 24 hours to return to pre-exercise levels after a bout of exhaustive 
cycling (Mackinnon et al., 1989). 
1. 7.4 Exercise in heat and humidity 
Exercise in extreme heat and humidity could contribute considerably to the 
physiological stress of exercise as it introduces competing demands on the 
cardiovascular system: the need to supply oxygen to the working muscles and to the 
skin for cooling (Powers and Howley, 1997). It is essential for the body to maintain an 
internal temperature within narrow limits to prevent overheating independent of the 
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external environment. Despite the fact that elaborate temperature-regulating 
mechanisms are available, a combination of exercise and severe environmental 
conditions can impair or overwhelm homeostatic temperature regulation mechanisms 
and induce hyperthermia (Aoyagi et al., 1997; Brenner et al., 1995; Sutton, 1994). The 
heat liberated by the muscles during physical activity results in cutaneous vasodilation, 
increasing skin blood flow (Powers and Howley, 1997). Body heat is transported to the 
skin surface where it is eliminated largely through the evaporation of sweat. However, 
because homeostasis favours the maintenance of arterial blood pressure and circulation 
to the vital organs, blood is rerouted at the expense ofthermoregulation when body core 
temperature reaches a critical value around 3 8°C (Aoyagi et al., 1997). This means that, 
under extreme climatic conditions and even when the exercise load remains constant, 
little further vasodilation is seen even if a further increase in core temperature occurs 
(Powers and Ho_wley, 1997). If body temperature continues to go up, this will 
eventually lead to collapse (Sutton, 1994). As humidity increases, the body's major 
route of heat loss, evaporation, and therefore its ability for thermoregulation, diminishes 
(Powers and Howley, 1997). Evaporation accounts for about 25% of the heat loss at 
rest, but it is the most important means of heat loss during exercise (Nadel, 1988). As 
the relative humidity approaches 100%, this way of heat loss becomes increasingly 
reduced, eventually failing altogether. Although sweat is produced, it·cannot evaporate 
and is lost to the cooling process (Powers and Howley, 1997). 
There is little information available on immune responses to physical activity in a 
hot and humid environment. This is somewhat surprising for several reasons. According 
to Shepha~d ( 1998) the potential of exercise in hot and humid conditions to cause 
fatigue, exhaustion, and heat stress is well known. Second, Brenner et al. (1995) stated 
that physical activity in hot and humid environments is more likely to result in higher 
levels ofhyperthermia which could contribute substantially to the immune system's 
response to exercise. 
Some of the effects of hyperthermia on the immune system are similar to the 
changes caused by physical exercise (Hoffinan-Goetz and Pedersen, 1994; Shephard 
and Shek, 1999b). For instance, both exercise and hyperthermia can result in changes in 
leukocyte counts and in increases in the blood concentration of stress hormones, such as 
adrenalin, noradrenalin and cortisol (Hoffman-Goetz and Pedersen, 1994; Kappel et al., 
I 997). It is therefore possible that some of the alleged exercise-induced changes in 
immune function may actually be temperature-induced (Brenner et al., 1995). 
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The effects of hyperthermia on immune function can be positive or negative 
(Shephard and--Shek, l 999b ). In their review on heat exposure and immune function, 
Brenner et al. (1995) concluded that in general, it seems that mild hyperthermia has 
little effect and that moderate hyperthermia enhances the immune system. They 
suggested that some forms of passive body heating, such as a sauna, allegedly augment 
immune function and have been advocated as a means ofreducing the susceptibility to 
viral infections (Brenner et al., 1995). Shephard and Shek (1999b) state that the reason 
for any benefit is unknown and that it is unclear whether moderate hyperthermia has a 
direct enhancing effect on immune function or a deleterious effect on the viability of 
invading micro-organisms. Beyond the "therapeutic range" ofhyperthermia, immune 
function becomes compromised (Brenner et al., 1995). 
Given the general similarity in immune response to hyperthermia and vigorous 
exercise, one would anticipate an additive response to the combined stimuli. Shephard 
(1998) suggested that an intensity of physical activity or heat stress that is stimulatory 
or beneficial by itself could cause immunosuppression if the body is challenged by the 
two stimuli simultaneously. If vigorous exercise, severe enough to have an 
immunosuppressive effect by itself, is undertaken in a very hostile environment this 
effect is likely be more pronounced. 
As early as 1982, it was suggested that studies were needed to "determine the 
separate influences of ambient temperature versus exercise" on mucosa! antibodies 
(Tomasi et al., 1982). Nevertheless, little research has been done on the combined or 
separate effects of environmental stressors and exercise on s-lgA. A decline in s-lgA 
concentration has been reported as a result of occupational heat stress (Scheller et al., 
1977) but, to the best of our knowledge, there are only three studies on the combined 
effects of heat, humidity and exercise on s-IgA. The findings of the first of these suggest 
that moderate intensity exercise, at a wide range of ambient temperatures, does not 
increase the susceptibility to URTI by decreasing s-IgA (Housh et al., 1991). Relative 
humidity (RH), which can contribute considerably to environmental stress in hot 
environments, was not a variable tested in this study. More recently, the s-IgA response 
to two hours of cycling at moderate intensity (63% ofV02max) in a hot environment 
(30.3°C, 76% RH) was found to be no different from the same activity in temperate 
condition (20.4°C, 60% RH) (Laing et al., 2005). The third study investigated the 
combined effects of load carriage and environmental stress on s-lgA in Army reservists, 
aged 18 - 54 years (Pacque et al., 2002). The thermal and cardiovascular strain 
experienced during a 2 hour march at 5 km hf1 with a 20kg load in cool-dry (19°C; 51 % 
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RH) and hot-humid (28°C; 80% RH) environments caused significant post-exercise 
changes in s-IgA concentration and s-IgA..secretion rate with each variable returning to 
pre-exercise levels by 2 h post-exercise. However, there was no difference between the 
effects of the two environments. 
1.7.5 Mechanisms underlying exercise-induced changes in 
salivary lgA 
In a major review of the literature, Mackinnon (1999a) concluded that the exact 
mechanisms for changes in s-lgA concentration and secretion rate caused by exercise 
are still not fully understood. Possible mechanisms include changes in the mucosa! 
surface of the mouth {Tomasi et al., 1982), suppression oflgA secretion and/or SC-
mediated transport across the mucosa! epithelium, and reduced migration of lgA-
secreting plasma cells to the oral mucosa (Mackinnon, 1996). It is likely that both the 
neural and endocrine systems are involved and that the effects of exercise may be 
mediated through the actions of stress hormones, cytokines and haematological factors 
(Housh et al., 1991; McDowell et al., l 992a). Moreover, it appears that a reduction of 
saliva flow rate accounts in part for this response (Fahlman et al., 2001; Mackinnon and 
Jenkins, 1993) 
During exercise a combination of high respiratory flow rates and a switch from 
nose to mouth breathing causes progressive cooling and drying of the respiratory 
mucosa. It was therefore postulated that the decrease in s-lgA levels following a 
competitive cross-country ski race might have been due, in part, to "a large inflow of 
cold air which would likely lower the temperature of the mucous membranes" (Tomasi 
et al., 1982)). Since this is where the plasma cells reside that secrete s-IgA, the authors 
reasoned that cooling of the mucous membrane might alter or impair the function of the 
plasma cells thereby reducing antibody secretion. The fact that s-IgA concentr~tion or 
secretion can also be reduced by exercise when conducted in the warm and humid 
environments, such as in a swimming pool, somewhat refutes the temperature argument 
(Tharp and Barnes, 1990). 
It is possible that intense exercise alters the process of production and secre~ion of 
s-lgA by plasma cells or affects the migration of plasma cell precursors to the oral 
mucosa (Mackinnon et al., 1987). However, Hucklebridge et al. (1998) suggested that 
the fact that changes in s-IgA secretion occur rather rapidly possibly reflects changes of 
the trans-epithelial transport mechanism rather than regulation at the level of plasma cell 
production oflgA, a process requiring days rather than minutes. To reach the mucosa! 
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surface, s-lgA must be transported from the basal to the luminal face of the epithelium 
by secretory component and this process is possibly influenced by exeJ"Cise (Mackinnon, 
l 999a). 
The decrease of s-IgA levels may be due to a decrease in saliva flow. It is, 
however, not clear which mechanisms are responsible for this (Mackinnon and Jenkins, 
1993), as it is a complex process, involving input from the parasympathetic and the 
sympathetic nervous systems (Mackinnon, 1999a). 
There is a close relationship between the immune and neuroendocrine systems 
(Nieman, 1994) -they produce and use many of the same signal molecules in the form 
of hormones, lymphokines, and monokines for communication and regulation. Exercise, 
especially when the intensity is high, stimulates the neuroendocrine system, causing an 
increase in the blood concentration of a number of stress hormones, such as adrenalin, 
noradrenalin, growth hormone, P-endorphin and cortisol (Hoffinan-Goetz and Pedersen, 
1994). Although salivary cortisol has also been shown to increase in response to 
strenuous exercise (OConnor and Corrigan, 1987) and emotional stress (Tharp and 
Barnes, 1990), cortisol does not appear to mediate changes in the secretory process of s-
IgA with exercise (Hucklebridge et al., 1998; McDowell et al., 1992b). 
1.8 The overtraining syndrome 
Overtraining has been described as "a combination of signs and symptoms which 
typicaUy cause the sufferer to feel mentally fatigued in the absence of physical fatigue 
and causes deterioration of performance" (Kent, 1994). Overtraining syndrome (OTS) 
is a complex clinical condition with numerous potential contributing factors that vary 
considerably among individuals (Kuipers and Keizer, 1988; Lehman et al., 1993). The 
term OTS is most often used to describe athletes suffering from prolonged fatigue and 
impaired athletic performance, following a period of heavy training or competition, 
resulting from an imbalance between training and recovery (Budgett, 1990). It may 
appear when training sessions are too intense and/or prolonged, or when the duration of 
recovery periods is too short (Kuipers and Keizer, 1988; Lehman et al., 1993). The 
prevalence of OTS varies by sport and is thought to be highest in endurance sports 
requiring high volumes of intense training (Mackinnon, 2000). OTS is more likely to 
develop when physical training is combined with other stresses such as psychological 
stress and inadequate nutrition (Chicharro et al., 1998a; Mackinnon, 2000). For 
instance, carbohydrate-poor diets or training programs that chronically deplete glycogen 
stores can lead to OTS (Budgett, 1990). An individual's susceptibility to OTS will 
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depend on factors such as their exercise capacity, recovery potential and ability to cope 
with stress. 
1.8.1 Symptoms and markers of overtraining 
Many symptoms have been associated with OTS (Adlercreutz et al., 1986; 
Budgett, 1990; Chicharro et al., l 998a; Fry et al., 1992; Mackinnon, 2000; McKenzie, 
1999): persistent fatigue and insomnia; under performance, decreased aerobic capacity 
and decreased anaerobic power; a "loss of purpose", energy and competitive drive; 
-feelings of helplessness and incompetence; being trapped in a routine; loss of libido; 
emotional lability, increased anxiety and depression, mood-state disturbances, 
irritability; loss of appetite, weight Joss, diarrhoea; muscle soreness, excessive sweating, 
increased resting heart rate, increased resting blood pressure, increased maximal plasma 
lactate concentration, decreased serum ferritin; immune suppression; and hormonal 
changes. OTS has also been associated with a high frequency of URTI (Fitzgerald, 
' 
1991 ). However, other than persistent fatigue and a decrement in performance, few have 
been consistently documented and some are not supported by the research literature at 
all (Mackinnon, 2000). Many of these factQrs also appear as symptoms of other 
conditions or diseases (Budgett, 1990). For instance, OTS-has several similarities with 
chronic fatigue syndrome and clinical depression (Derman et al., 1997). Therefore, 
individually, none of these factors is as yet considered a reliable and valid indicator of 
OTS. At this stage, OTS is still more easily detected by decreases in physical 
performance and alterations in mood state. 
There is as yet no single biological indicator that has been identified as a reliable 
marker of OTS (McKenzie, 1999) and there is no accepted gold standard for its 
diagnosis (Budgett, 1990). Several indicators have been proposed (clinical, 
neuroendocrine, physiological, psychological or biochemical) but unfortunately most of 
these vary considerably among individuals (Kuipers and Keizer, 1988; Lehman et al., 
1993). Following markers have identified and investigated as possible indicators of 
OTS: 
• physiological variables (weight, physical performance); 
• fatigue and mood states (Fry et al., 1994); 
• haematological variables (leukocytes; neutrophils; lymphocytes; 
monocytes; neutrophil to lymphocyte ratio; haemoglobin) (Lehmann et 
al., 1997) 
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• biochemical variables (norepinephrine and epinephrine (Hooper et al., 
1993 ); cytokines (Sharp and Koutedakis, 1992; Smith, 2000); lactate 
(Jeukendrup and Hesselink, 1994); C-reactive protein (Thomas et al., 
2000); TNFa (Sharp and Koutedakis, 1992); ferritin (Gastmann et al., 
1998); free testosterone (Hoogeveen and Zonderland, 1996); cortisol 
(Verde et al., 1992); FTCR (Budgett, 1990; Vervoom et al., 1991)). 
According to Budgett (1990) the most promising marker to date seems the 
serum free testosterone to cortisol ratio (FTCR) which represents a balance between 
anabolic and catabolic activity within the tissues. The FTCR is related to physical 
performance (Hakkinen et al., 1985; Mujika et al., 1996) and a condition of overtraining 
may exist in an athlete if the FTCR decreases by 30% as this indicates an increased 
catabolic state (Adlercreutz et al., 1986; Chicharro et al., 1998a). However, not all 
studies agree with this. Although decreases in FTCR of up to 50% were observed in a 
group of elite rowers during a nine month period leading up to the 1988 Olympic 
Games, this was attributed to inadequate recovery from intensive training rather than to 
overtraining (Vervoom et al., 1991 ). And in a study of professional cyclists it was 
concluded that a decreased FTCR does not necessarily lead to performance decrements 
or overtraining (Hoogeveen and Zonderland, 1996). 
1.8.2 Mechanism of overtraining 
The mechanisms causing OTS have not been clearly identified and it is unlikely 
that the diverse symptoms can be explained by a single mechanism (Budgett, 1994; 
Mackinnon, 2000; McKenzie, 1999). Although neuroendocrine changes may underlie 
many of the effects and symptoms of OTS (Budgett, 1990; McKenzie, 1999), the effects 
of heavy physical exercise on the neuroendocrine system and its relationship to 
overtraining are as yet unclear. The physical stress of intense exercise training may 
cause elevated stress hormone levels that may ultimately lead to autonomic dysfunction 
(Mackinnon, 2000). One hypothesis suggests that increased cytokine production is 
implicated (Smith, 2000). Repetitive, high volume exercise with inadequate rest may 
cause micro-trauma to joints, muscles and connective tissue. According to Smith (2000) 
this could activate monocytes to produce and release inflammatory cytokines which 
would then initiate a 'whole-body' response, involving chronic systemic inflammation, 
suppressed immune function, and mood state changes. 
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1.8.3 Salivary lgA and overtraining 
Severe immunosuppression may occur in athletes who do not allow their immune 
system to recover, but initiate a new bout of exercise while it is still compromised 
(Pedersen et al., 1996). It is therefore not surprising that the OTS has been associated 
with immunosuppression (Budgett, 1990), recurrent infections and a high rate ofURTI 
in athletes (Fitzgerald, 1991). One possible reason for a correlation between OTS and an 
increase in URTI in elite athletes could be that in overtrained athletes the open window 
of opportunism for pathogens to cause an infection is longer and the degree of 
immunosuppression more pronounced. 
There is some evidence that s-IgA is suppressed in athletes during prolonged 
periods of intense exercise training leading to OTS. Among 14 elite swimmers over a 6-
month season, s-lgA levels were lower in overtrained swimmers compared with those 
who did not show signs of overtraining (Mackinnon and Hooper, 1994). However, the 
concept that OTS is associated with an increased risk ofURTI is not universally 
supported and it has been suggested that the risk ofURTI is elevated in athletes during 
periods of intense training, regardless of whether such training leads to symptoms of 
OTS (Mackinnon, 2000). Nevertheless, as there is possibly an increased risk ofURTI 
among endurance athletes, and a dose-response relationship between training volume 
and incidence ofURTI, it appears that both OTS and URTI could result from a common 
cause: excessive training with insufficient rest and possibly a lack of variety in training. 
1.9 Salivary lgA, psychological stress and mood states 
It is well established that the autonomic nervous system (ANS), and the immune 
system are intimately linked. There is considerable research evidence that the immune 
system can be depressed following high levels of stress, emotional trauma, and by 
certain personality attributes (Jemmott et al., 1983). Neuroendocrine factors, such as 
stress hormones (e.g. catecholamines and cortisol), are thought to mediate at least some 
of the stress-induced changes in immunity (Kugler et al., 1996; Mackinnon et al., 1989). 
As saliva secretion is also regulated by the ANS (Chicharro et al., 1998b ), it is hardly 
surprising that salivary immunoglobulin levels are down-regulated by chronic 
psychological stress (Hucklebridge et al., 1998) and that, similar to intense exercise, 
stress has been associated with an increased susceptibility to infections (Graham et al., 
1988). 
Significant associations have been found between chronic psychological stress and 
s-IgA (Graham et al., 1988; Jemmott et al., 1983). Transient decreases in s-lgA 
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secretion rates have been reported in a variety of stressful situations, for instance in 
dental students with increasing stress levels over an academic year leading up to 
examinations (Jemmott et al., 1983). Transient increases in s-lgA concentration were 
also found in soccer coaches under stress during matches (Kugler et al., 1996) and 
progressive suppression of s-lgA concentration and secretion rate was observed in 
subjects exposed to examination stress (Deinzer and Schuller, 1998). On the other hand, 
there were no significant changes in s-lgA in 26 subjects despite elevated anxiety levels 
before an important interview (Somer et al., 1993). Negative mood states other than' 
anxiety (e.g. depression) have also been associated with decreased s-lgA concentrations 
(Graham et al., 1988; Jemmott et al., 1983; Mackinnon, 1999b) .. Others have found 
positiv~ associations of s-IgA concentrations with positive mood states (Hucklebridge et 
al., 2000; Stone et al., 1987). Conversely, one study found mood states in everyday life 
to be unrelated to s-IgA concentration (Kugler et al., 1992). 
The association between exercise induced mucosa! immunosuppression and stress 
in athletes is not clear. Mackinnon and Hooper (1994) assumed that it is likely that the 
psychological stress of training and competing at the elite level can have an additive 
effect to that of physical stress on mucosa! immune function. Others found no 
correlation between anxiety scores and s-lgA concentrations over a 7-month training 
season in swimmers (Gleeson et al., l 999b ). So far there are no convincing arguments 
for either stress- or mood-induced immunosuppression or enhancement. 
The widely used Profile of Mood States (POMS) questionnaire (Mc Nair et al:, 
1971) could be useful in identifying athletes who are immunosupressed and possibly, on 
the verge of overtraining (Morgan et al., 1987). However, so far neither a consistent nor 
a simple pattern of results has emerged from the few studies that have tried to 
investigate this. One study in swimmers after high-intensity training, found a significant 
association between the POMS tension-anxiety subscale and changes in s-IgA (Tharp 
and Barnes, 1990). Another study of elite swimmers, however, showed no such 
association (Gleeson et al., l 999b ). Of course, it is possible that the POMS scale is not • 
sensitive enough to measure the emotional states, which might suppress the immune 
system. Although some of these studies suggest that acute psychological stress produces 
a temporary decrease in s-lgA, a strong correlation between s-lgA and stress or anxiety 
caused by exercise has yet to be established. 
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1.10 Purpose of this study 
Exercise can cause a transient suppression of s-lgA and training at an intense level 
over many years often results in a chronic suppression of s-IgA in athletes (Gleeson, 
2000a; Gleeson et al., 2000b; Steerenberg et al., 1997). There is also evidence that high 
levels of psychological stress are associated with a decrease in s-lgA levels and an 
increased susceptibility to infections (Graham et al., 1988; Jemmott et al., 1983). 
Therefore, it is not surprising that it has been demonstrated that soldiers, exposed to 
physiologically and psychologically stressful situations, are susceptible to mucosal 
immunosuppression and an increased risk ofURTI (Booth et al., 2003; Brenner et al., 
2000; Gomez-Merino et al., 2003; Gomez-Merino et al., 2005; Gray et al., 2001a). 
Soldiers can also be susceptible to OTS. Army units are often composed of 
recruits who upon enlistment are not necessarily very fit. Thus, strenuous physical 
activity might be especially stressful for them. For instance, about one third of army 
recruits were classified as overtrained after an eight week physically demanding training 
program (Chicharro et al., l 998a). Symptoms of overtraining have also been 
documented during military training in the USA (Kramer et al., 1997) and Norway 
(Opstad, 200 I). 
A simple diagnostic test to assess the effect of military training and to monitor 
soldiers for an increased vulnerability to illness or early states of OTS would be very 
useful. With the assistance of such a biomarker, practices such as altered work-rest 
cycles, improved diet and psychological techniques could be used to minimise the 
impact of training on the health of military personnel. S-lgA could be useful for this 
purpose but because there are still several limitations, further work seemed warranted to 
investigate this marker. 
The purpose of the work described in Chapter 2 was to address several 
methodological issues. Our preliminary work on s-IgA raised some concerns regarding 
its reliability as a biomarker (Pacque et al., 2002). The main weaknesses identified were 
the possible effects of diurnal variation of s-IgA, its large biological variation, the way 
s-lgA is expressed, the standardisation of the s-lgA assay, and finally the collection, 
handling and storage of saliva samples. 
The main purpose of the experiment described in Chapter 3 was to test the 
methods developed for the collection, storage and transport of saliva samples under 
"field conditions". It also assessed the effect of an ultra-endurance exercise on mucosa! 
and humoral immunity and if changes in s-lgA and serum lgA correlated with changes 
in the incidence of upper respiratory tract infections. 
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The purpose of the study described in Chapter 4 was to determine whether a 
typical military field activicy_such as load carriage would result in decreased mucosa! 
immunity. The impact of heavy physical work on soldiers' immune function is of 
particular interest to the ADF since it could have a direct effect on the health of their 
personnel. An infection resulting from immunosuppression in soldiers is likely to 
reduce performance and operational readiness, just as URTI in athletes may have a 
negative effect on their ability to train and compete optimally (Pyne, 1999). 
The purpose of the work described in Chapter 5 was to investigate if changes in s-
IgA were related to the incidence ofURTI over the course of a seven week recruit 
training course. During basic military training, recruits are subject to both physiological 
and psychological stress, which could lead to ill health and OTS. By seeking an 
association between s-IgA measures and other variables identified as possible indicators 
of OTS it was investigated if s-lgA could be a useful predictor of OTS. 
Overall, although this study seems to be heavily weighted towards the military, it 
aimed to contribute to the understanding of s-IgA as a potential biomarker to assess 
mucosa! immune function and as a predictor of ill health or excessive physiological 
strain and diminished performance, not only in soldiers but also in athletes and in the 
general population. 
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METHODOLOGICAL CONSIDERATIONS 
ASSOCIATED WITH THE MEASUREMENT OF 
SALIVARY IgA 
2.1 Introduction 
Differences in methods and procedures often make it difficult to compare the 
results of studies that have measured s-IgA. Therefore, the first aim of this study was to 
optimise and standardise a method of saliva collection and storage before any further 
work was undertaken: In the first part of this chapter, the results of work that address 
this need are presented and recommendations are made. 
The collection of saliva samples has several advantages over serum. It is low risk, 
easily retrieved and can be collected as many times as needed. However, there are 
several methodological limitations and disadvantages that make the usefulness of s-IgA 
for health monitoring open to question. Most of these limitations are related to the way 
people operate, not necessarily limitations to the potential use of s-IgA: 
• There i~ inadequate uniformity in the laboratory procedures used to measure s-
IgA in saliva; 
• All measures of s-IgA (concentration, secretion rate, ratio to albumin, ratio to 
total protein, ratio to osmolality) have limitations; 
• The method of saliva collection can influence the s-IgA concentration. One has 
to consider for instance the source of the saliva, the equipment used and whether 
saliva flow was stimulated or not; 
• Careful handling of saliva samples is required during transport, storage, and the 
analytical phase to avoid possible degradation of s-IgA over time. Although 
anecdotal evidence has shown that s-IgA remains stable at room temperatures 
for a short period, this has not been previously investigated methodically by our 
laboratory. 
Commercially available immunoassays and a Dade Behring BN ProSpec 
nephelometer (Dade Behring, Marburg, Germany) were used for the determination of 
IgA and albumin concentration in saliva samples. The accuracy, precision and linearity 
of the assays were established and the analytical coefficients of variation for the 
methods were verified for various sample pre-dilutions. The interference of a 
preservative on the assays was investigated. The stability of s-lgA under various 
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conditions of storage, including the effects of freeze-thawing was tested. Finally, quality 
control procedures were set up. 
It has been suggested that s-lgA concentration and secretion rate are subject to a 
diurnal variation (Hucklebridge et al., 1998; Richter et al., 1980). If this is correct, this 
should be taken into account when interpreting the effect of any intervention on s-IgA. 
It would be essential to know whether any changes in s-lgA were caused, for instance, 
by exercise or were merely manifestations of its normal diurnal variation. Unfortunately 
the possible presence of diurnal variation in s-lgA has not always been considered in the 
design or interpretation of past research. On the other hand, its existence has not been 
established beyond doubt. So far findings are inconsistent and there is no consensus 
about the magnitude and the exact pattern of possible diurnal variations. Although in 
general studies suggest that s-IgA concentration and secretion rate are high in the 
morning, followed by lower stable values from mid-morning until early evening, there 
is no conclusive evidence of a distinct pattern. 
In most previous studies early morning saliva samples were obtained after an 
overnight fast. Therefore, it was postulated that the nutritional status of the subject 
might be of some importance. However, to the best of our knowledge no-one has 
determined if eating could affect the diurnai variation of s-IgA, i.e. if there is a possible 
post-prandial effect. Although in one study s-lgA concentration has been found to be 
significantly higher in fasting samples than in post-prandial samples, the post-prandial 
samples were taken several hours rather than immediately after the meal (Gleeson et al., 
1990) and more research seemed warranted to investigate this. 
The second aim of this study was therefore to further test the hypothesis that s-IgA 
is subject to diurnal variation; to investigate the effect of sustained fasting; and to 
determine the duration and magnitude of possible post-prandial changes in s-lgA. Ass-
lgA displays a large biological variation, this study investigated ifthere is a time of day 
when the variability in s-IgA is at it lowest and if so, if this would be the most 
appropriate time to determine s-lgA in a group of subjects. 
To allow the interpretation of s-IgA measurements, a suitable reference interval is 
necessary. Although ~eference intervals for s-lgA concentration have been published 
previously, for instance by the DSTO (Pacque, 2001) and by Gleeson et al. (1990), the 
final aim of the work described in this chapter was to establish a reference interval using 
the methodology established for this study. 
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2.2 Methods 
Approval for the projects described in this and all further chapters of this PhD 
study was obtained from the Northern Tasmania Health & Medical Human Research 
Ethics Committee and the Australian Defence Human Research Ethics Committee 
(ADHREC) if military personnel were involved. The procedures of all projects 
conformed to the guidelines for human research ethics described in the Declaration of 
Helsinki (1989). For each project, subjects gave written informed consent after 
explanation of its nature, purpose and possible effects. 
2.2.1 Subjects 
To obtain the saliva samples needed to establish the methodology of this project 
and to investigate the stability of s-IgA, 24 subjects (ten females) were recruited from 
the staff of the School for Human Life Sciences at the University of Tasmania and of 
the Defence Science and Technology Organisation (DSTO) in Scottsdale. 
To establish the diurnal and biological variation of s-lgA, and to investigate the 
effects of fasting, sixteen subjects (5 males, 11 females; aged 18 - 57), were recruited 
from the staff and students of the University of Tasmania and from the Launceston 
population. 
The International Federation of Clinical Chemistry (IFCC) suggests that to 
establish a meaningful reference interval the minimum number of individuals required 
is 120 (Fraser, 2001). Therefore, to establish reference intervals for s-lgA, 134 subjects 
(93 males, 41 females; mean age 31, range 18 - 57) were recruited from staff and 
students of the University of Tasmania, DSTO staff and Australian Defence Force 
personnel. 
Subjects had no self-reported signs or symptoms of an infection or infectious 
disease, were not on immunosuppressive drugs and were non-smokers. 
2.2.2 Sample collection, preparation and storage 
Saliva was collected in Salivette tubes with polyester swab (Sarstedt, Numbrecht, 
Germany). Sample collection was supervised by the investi~ator in most cases. After 
rinsing the mouth completely with water, and then waiting for one minute, saliva was 
collected over 2 minutes. This ensured a suitable volume of saliva for the various assays 
(0.5 mL). To avoid contamination with food or blood, saliva was not donated 
immediately after food consumption or within 45 minutes of tooth brushing, flossing or 
using a tooth pick. The polyester swab was tipped into the mouth without the fingers 
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touching it. So as not to stimulate saliva flow, the swab was kept still in the cheek or 
under the tongue. Talking, chewing or swallowing was not allowed. After two minutes, 
the saturated swab and any saliva that had accumulated in the mouth were expectorated 
into the Salivette. Care was taken not to swallow or spill any saliva. In order to measure 
saliva flow rate, saliva volume was determined by weight(± O.Olg) and the saliva 
collection timed accurately(± 1 sec). Saliva density was assumed to be 1.00 g·mL-1• 
Saliva was recovered from the Salivettes by centrifugation for 4 min @ 4000 rpm 
(IEC Centra MP4R centrifuge; International Equipment Company, Needham Heights, 
Massachusetts, USA). Unless specified otherwise, samples were frozen at -80°C for 
later analysis (Econofreezer, Forma Scientific Inc., Marietta, Ohio, USA - or - Ultima 
Ultra Low Temperature Freezer, Revco Scientific Inc., Asheville, NC, USA). Samples 
collected at home were temporarily stored in a domestic freezer (-4°C) and delivered to 
the University within 48 hours. 
For experiments requiring pooled saliva (e.g. for internal quality control samples), 
the saliva from nine subjects (4 females) was gently mixed before being aliquoted for 
storage. To investigate the requirement for a protease inhibitor, sodium azide (final 
concentration 0.2 mg-L-1) was added to some of these pooled samples. 
To determine the stability of s-IgA, samples were stored at varying temperatures 
\ (28°C; 21°C, 4°C and -4°C) for periods ranging from 15 minutes to 15 days, with and 
without sodium azide. These temperatures were chosen to simulate typical field trial 
conditions. Another set of samples was stored at the more traditional -80°C for a period 
up to 90 weeks. To determine the effect of repeated freeze-thawing, multiple samples 
were frozen at -80°C, thawed, analysed and refrozen 6 times. 
2.2.3 The commercial lgA and albumin immunoassays 
The most common way of measuring salivary lgA concentration is by ELISA (see 
Appendix A). However, our laboratory used a Dade Behring BN ProSpec nephelometer 
with Dade Behring supplied consumables (diluent, reaction buffer, reagents, standards 
and controls) to measure s-IgA and albumin concentration. A similar method has beeri 
used by other teams (Aufricht et al., 1992; Tiollier et al., 2005). The lgA assay is a 
particle enhanced nephelometric immunoassay (PENIA). The commercial N Latex IgA 
test kit is made up of an lgA reagent (freeze-dried polystyrene particles coated with 
rabbit anti-human lgA); an lgA standard (a mixture of human sera) referenced to the 
International Federation of Clinical Chemists Certified Reference Material-470; an IgA 
supplementary reagent A (an aqueous solution of pyrrolidone and Tween); an lgA 
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supplementary reagent B (animal and human proteins as well as pyrrolidone); and an 
lgA control (a mixture of human sera). The Dade-Behring antisera detect both lgA 
subclasses (personal communication: RalfEvelbauer, Dade-Behring Technical Support 
Group Plasma Proteins, 4 September 2002). For the salivary albumin assay an 
antiserum for human albumin, an SL protein standard, and various protein controls were 
used. Further information is available from the commercial assay kit inserts (Dade 
Behring, Marburg, Germany). All reagents, controls and standards were reconstituted 
with ultra-pure water from a Modulab Analytical - Research Grade VF/Polishing 
System (Continental Water Systems, San Antonio, TX, USA). The Dade Behring 
commercial assays for lgA in cerebra-spinal fluid (BN ProSpec protocol #62) and for 
albumin in urine (BN ProSpec protocol #27) were used. The addition of sodium azide 
(final concentration 0.2 mg·L-1) to saliva samples at various dilutions did not interfere 
with these assays (Table 1 ). Data on the reproducibility of the lgA and albumin assays is 
provided in section 2.3.2. 
Table 1: lgA and albumin concentration in saliva samples at various dilutions, with and 
without sodium azide preservative (final concentration 0.2 mg·L-1) 
lgA concentration (mg·L"') 
Dilution factor 
protocol # 62 
Without With 
NaAzide NaAzide 
1:5 (N"".~) 25.7± 0.6 25.6 ± 1.1 
1:25 (N=l5) 97.8 ± 8.1 97.l ± 6.0 
1:50 (N=5) 104.8±2.I 104.7 ± 1.5 
All data are mean± SD. 
Al!Jumin concentration (mg·L-1) 
protocol # 27 
Without 
Na Azide 
42.9± 1.0 
44.3 ± 2.6 
41.6 ± 2.0 
With 
Na Azide 
42.8 ± 0.4 
44.5± 2.0 
41.l ± 4.8 
To establish the dynamic linear range of assay protocol #62, a series of dilutions 
were made of a serum control material to obtain known lgA concentrations in the range 
4 - 103 mg·L-1and measured values compared with expected values. A linear regression 
analysis showed that linearity of the assay was excellent (P < 0.001; k = 0.997; N = 25; 
y = 1.24x - 1.31 mg-L-1 ). However, the measured values over that range differed 
significantly (P = 0.007) from expected values by 8.1 ± 10.0% (range -9 .6% - 22.6% ). 
For the range 4-10.3 mg-L-1 there was less bias (P < 0.001; R2 = 0.978; N= 13; y = 
I .06x -0.26) and measured values did not differ significantly from expected values (P = 
0.384; deviation 0.6 ± 6.6%; range -9.6%- 13.7%). It seems there was only a small 
systematic error at low concentrations, whereas it was quite large at high concentrations. This 
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indicated that the optimum range for the determination oflgA using assay #62 is 4 -
10.3 mg-L-1• 
2.2.4 Salivary osmola/ity 
Salivary osmolality, using the freezing point depression method, was measured on 
undiluted saliva samples with an Advanced Micro Osmometer, (Model 3300, Advanced 
Instruments Inc., Norwood, Massachusetts, USA). The reference solution and 
calibration standards were also provided by Advanced Instruments. Accuracy of the 
method was determined by repeatedly analysing a commercial control over seven days 
(N = 34). The average within run CV A was 1.1 % and did not exceed 1.8%. The between 
run CV A was 1.2%. The intra and inter-assay precision were evaluated by repeatedly (N 
= 26) analysing an undiluted pooled sample on four separate days. The average within 
run CV A was 1.9% and did not exceed 3.6%. The between run CV A was 4.9%. 
2.2.5 Diurnal variation 
Seven saliva samples were obtained from sixteen fasting subjects in a single day 
(at 7:00, 9:00, 12:00, 14:00, 16:00, 18:00 and 20:30). Subjects were encouraged to have 
a late snack the evening before but then fasted from waking until after the 20:30 sample. 
At least 4 days later they provided another ten saliva samples: seven samples at times 
corresponding with those of the fasting day plus an additional sample at 7:30, 12:30 and 
18:30 shortly after a non-standardised meal consumed at 7:00 (breakfast), 12:00 (lunch) 
and 18:00 (dinner). Subjects were not allowed to eat in between these meals. On both 
days, they were only allowed to drink water ad libitum and were specifically asked not 
to consume drinks containing alcohol or caffeine. Strenuous activity was avoided during 
both days. Samples were analysed in two batches (batch 1 = fasting day; batch 2 = non-
fasting day) to reduce between run analytical error. 
2.2.6 Reference interval 
One hundred arid thirty four subjects donated a single saliva sample. To minimize 
the possible effects of diurnal variation and eating, all samples were obtained at least 
two hours post-prandial and no early morning or late evening samples were used. These 
samples were analysed in 4 batches. 
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2.2. 7 Quality control 
The quauty of the various assays was assessed by Levey-Jennings plots of in-
house internal quality control (IQC) samples and commercial controls (Tietz, 1987). 
With a few exceptions (5 out of 65 for IgA and 2 out of 42 for albumin) commercial 
quality control values were within the manufacturers' specified control limits; Likewise, 
only a few albumin (3 out of 45) and osmolality (7 out of 69) measurements ofIQC 
samples were outside their control limits, confirming the accuracy and precision of the 
methods. However, from week 68 onwards, the s-IgA concentration in the majority of 
IQC control samples was below the lower control limit. As the commercial controls 
analysed during this period remained within their control limits, it was unlikely that 
there was a problem with the accuracy of the method. This apparent downward shift in 
s-lgA concentration therefore suggested a breakdown of s-lgA after 68 weeks in 
samples stored at -80°C (see 2.3.3). 
2.2.8 Statistical analysis 
All statistical analyses for the experiments described in this and other chapters of 
this study were performed with SPSS (Statistical Package for the Social Sciences, 
versions 11.0 and 12.0, SPSS Inc, Chicago, USA). Data were tested for normality by 
visual inspection of histogram, by coefficients of skewness and kurtosis and by the 
Kolmogorov-Smimov test. Data that were not distributed normally were either 
transformed by natural logarithm (In) before further analysis by parametric tests or 
alternatively non-parametric tests were used. Descriptive statistics are presented as 
mean (M) and standard deviation (SD) or standard error of the mean (SEM). 
Significance was accepted at P values less than 0.05 for all statistical tests. 
2.2.8.1 Methodology 
To assess the. effect of sodium azide as a preservative on the IgA and albumin 
assays, differences in means were compared by student t-test. Comparison between the 
expected and observed lgA concentrations to determine the linearity of the assay was 
performed by linear regression analysis. To compare the precision of the assays at 
various dilution factors, a repeated measures ANOV A was used. S-lgA stability over 
time at various storage conditions was assessed by repeated measures ANOV A and 
independent t-test. 
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2.2.8.2 Diurnal variation 
Because the data sets were small, nooutliers were removed. As data were not 
normally distributed, the non-parametric Wilcoxon signed ranks test was used to 
compare data sets. The possible effect of fasting was assessed by pair wise comparison 
of (1) all the fasting and non-fasting samples combined and (2) the seven corresponding 
time points of the fasting and the non-fasting days (i.e. the post-prandial samples of the 
non-fasting day were ignored). Changes across time on both days were assessed by pair 
wise comparison of the first sample with all subsequent samples (e.g. 7:00 and 9:00; 
7:00 and 12:00; etc.) and by pair wise comparison of each pair of successive samples 
(e.g. 7:00 and 9:00; 9:00 and 12:00; etc.). To assess the effect of meals, pre-and post-
prandial samples were compared (7:00 and 7:30; 12:00 and 12:30; 18:00 and 18:30). 
2.2.8.3 Reference interval 
Outliers in the data sets were removed using Reed's criterion (Fraser, 2001): 
extreme values were rejected if the difference between this value and the next highest 
(or lowest) was more than one-third of the absolute range of values. If several values 
were high (or low) compared to the others, then all of these values were rejected if 
Reed's criterion applied to the lowest (or highest) of them. As none of the distrihutions 
was normal, following non-parametric method recommended by the IFCC (Solberg, 
1994) was used: 
• The data were sorted in ascending order and ranked from I (minimum value) to 
n (maximum value). 
• As the reference interval was defined as the central 95% interval bounded by the 
2.5th and 97.5th percentiles of the distribution, the limits of the reference interval 
had rank numbers 0.025 * (n + 1) and 0.975 * (n + 1). 
• The reference limits were the values that corresponded to these computed rank 
numbers. As these were not whole numbers, reference limits were found by 
interpolating between two appropriate values. 
Differences between the means for the male and female subjects were assessed by 
independent t-test on natural log (In) transformed data. 
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2.3 Results 
2.3. 1 Biological variation of salivary lgA 
The biological variation for s-IgA was calculated using the samples from the 
subjects in the diurnal variation experiments. The average within-subject coefficient of 
variation CVi. the between-subjects coefficient of variation CV a and the index of 
individuality II (II= CV1/CV a) were calculated as suggested by Fraser (1994) and 
Fraser and Harris (1989). There was a large within and between-subject variation in all 
s-IgA measures (Figure 3; Table 2; see Appendix B for a table with the raw data and the 
CV1 for each individual). For some subjects the results on both days were very similar 
(e.g. subject 6), whereas for others they were dissimilar (e.g. subject 10). The CV1 and 
CV a were somewhat lower in the fasting samples, suggesting that there was some effect 
of eating. In addition, the measures of s-IgA with the lowest variability tend to be the 
ratios and secretion rate. Table 3 shows the between-subject variability at different 
times of day. Again, the variability of s-IgA on the fasting day tends to be lower and the 
period oflowest variability tends to be between 12:00 and 18:00. 
Table 2: Within-subject (CV1) and between-subject (CVa) coefficient of variation and 
index of individuality (II) for s-IgA measures on a fasting and a non-fasting day 
s-IgA measure 
s-lgA concentration 
s-lgA secretion rate 
s-IgA:albumin ratio 
s-lgA:osmolality ratio 
s-IgA con_centration 
s-IgA secretion rate 
s-IgA:albumin ratio 
s-lgA:osmolality ratio 
s-lgA concentration 
s-lgA secretion rate 
s-lgA:albumin ratio 
s-lgA:osmolality ratio 
Non-fasting day (all 
Fasting day 
samples) 
Non-fasting day 
(excluding post-
prandial samples) 
Mean (range) of within-subject CV1 (in%) 
73 (29-132) 64 (24-137) 55 (17-129) 
60 (19-139) 60 (26-98) 52 (22-94) -
45 (20-79) 57 (40-94) 44 (26-89) 
59(22-114) 55 (19-125) 44(19-115) 
Between-subject CV G (in %) 
108 106 98 
95 I 14 109 
72 78 69 
76 82 73 
Index of individuality (II) 
0.68 0.60 0.56 
0.63 0.53 0.48 
0.63 0.73 0.64 
0.78 0.67 0.60 
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Table 3: Between subject coefficient of variation (CV a) for s-IgA measures at different 
times of day 
Time of day 
s-IgA measures Q Q Q Q Q Q Q Q Q Q 
Q t"l Q Q t"l Q Q Q t"l t"l 
r.: r.: co\ t'i t'i -.i v!J oO oO d 
-
.... 
- - -
.... M 
Between subject coefficient CV G (in%) on fasting day 
s-lgA concentration 88 n/a 126 44 n/a 82 67 74 n/a 50 
s-lgA secretion rate 121 n/a 75 44 n/a 57 79 60 n/a 43 
s-lgA:albumin ratio 72 n/a 71 83 n/a 54 65 58 n/a 60 
s-lgA:osmolality ratio' 73 n/a 83 43 n/a 71 66 63 n/a 43 
Between subject coefficient CVG (in%) on non-fasting day 
s-IgA concentration 89 
s-lgA secretion rate 125 
s-lgA:albumin ratio 105 
s-IgA:osmolality ratio 78 
Fasting day 
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Figure 3: The average and absolute range of s-lgA concentration (a & b) and s-IgA 
secretion rate (c & d) for each individual during a fasting and a non-fasting day show 
the variability of these measures. The dashed lines represent the reference interval 
' calculatedfor a group of 134 subjects (see Table JO). 
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2.3.2 Analytical variation of the assays 
Analytical variation is expressed as the coefficient of variation of an assay. The 
accuracy of the lgA and albumin assays was determined by analysing multiple samples 
of commercial lgA (N = 65) and protein (N = 42) controls of known CC?ncentration. The 
between run analytical coefficients of variation (CV A) for lgA was 4.9% and 8.3% for 
albumin. The precision of the two assays at various sample dilutions was determined by 
analysing five internal quality control (IQC) samples on up to six consecutive days. 
Albumin measurements were unaffected by the dilution factor but dilution had a 
significant effect on the s-IgA concentration. This can possibly be explained by the fact 
that the calibration curves established for albumin supported a much wider range of 
albumin concentrations that the calibration curve for s-IgA which supported only a 
narrow range. This would also mean that the linearity of the albumin assay was better 
over a wider range of albumin concentrations than that of the IgA assay (see section 
2.4.1). The intra-assay and inter-assay analytical coefficients of variation CV A are 
represented in Table 4. The best results were obtained with dilutions of 1 :25 to 1 :50 for 
s-IgA and 1 : 10 to 1 :25 for albumin determinations. 
Table 4: Analytical variation of s-IgA and albumin concentration in Internal Quality 
Control samples (pooled saliva) at various dilutions 
Sample 
s-IgA concentration (mg·L-1) Albumin concentration (mg·L-1) 
dilution Mean SD 
Intra assay Inter assay 
Mean SD 
Intra assay Inter assay 
CVA CVA CVA CVA 
1:5 (N= 10) 23.9 4.3 4.9% 18.0% 43.0 2.2 4.9%. 5.2% 
1:10 (N= 5) 65.6 5.5 8.4% n/a 43.2 1.3 3.0% n/a 
1:25 (N= 30) 98.2 7.4 1.9% 7.5% 45.2 2.9 2.9% 6.5% 
1:50 (N=30) 105.9 5.5 1.8% 5.2% 44.0 4.1 6.3% 9.4% 
1:71.5 (N = 5) 102.7 2.3 2.2% n/a 42.8 2.3 5.3% n/a 
2.3.3 Salivary lgA stability 
At various time points, specified in Table 5 & Table 7, two saliva samples were 
analysed at a 1 :50 dilution, one with and one without the sodium azide preservative. As 
the s-IgA and albumin concentrations in these samples were identical, the results were 
averaged. A visual inspection of the results shows that there were some changes in both 
s-IgA and albumin concentration with time. At the higher temperatures {Table 5), most 
of these changes were smaller than the inter-assay coefficient of variation CV A (Table 
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4). At 4°C and -4°C (Table 6), the s-IgA concentration increased considerably at first, 
then declined again. As only 2 samples were analysed at each time point, no statistical 
analysis was performed on these results. 
Table 5: Stability of s-IgA and albumin at 28°C and 21°C 
s-lgA (mg·L-1) s-IgA (mg·L-1) Albumin (mg·L-1) Albumin (mg·L-1) 
Time 
@28°C @21°C @28°C @21°C 
% O/o O/o 
% change 
change change change 
Baseline 96.3 n/a 96.6 n/a 31.9 n/a 31.0 n/a 
15 min 99.2 +3.0 93.6 -3.1 32.3 +1.3 32.0 +3.2 
30 min 100.0 +3.8 95.9 -0.7 31.6 -0.9 32.3 +4.2 
1 h 100.8 +4.7 ' 95.6 -1.0 32.5 +1.9 32.0 +3.2 
2h 102.0 ·+5.9 100.1 +3.6 32.4 +1.6 32.0 +3.2 
6h 96.1 -0.2 100.2 +3.7 35.2 +10.3 33.1 +6.7 
24 h 94.7 -1.7 88.4 -8.5 32.9 +3.1 30.5 -1.6 
52.5 h 92.5 -3.9 84.7 -12.3 33.1 +3.8 30.4 -1.9 
Table 6: Stability of s-lgA at 4°C and-4°C 
s-lgA (mg·L-1) s-lgA (mg·L-1) 
Time 
@4°C @-4°C 
% 
% change 
change 
Baseline 73.7 n/a 71.0 n/a 
3h 86.9 +17.9 n/a n/a 
6h 91.2 ' +23.7 n/a n/a 
24 h 101 +37.0 79.6 +12.1 
32.5 h 100.2 +36.0 n/a n/a 
2 days 100.5 +36.4 n/a n/a 
6 days 79.6 +8.0 87.1 +22.7 
15 day~ 77.7 +5.4 76.3 +7.5 
198 days n/a n/a 74.9 +5.5 
There were no changes in s-lgA concentration in samples stored at -80°C for the first 70 
weeks (Table 7). S-lgA concentration was significantly lower in the period from week 
71 to 80 and 91 to 90 than during weeks 21-30. Albumin concentration remained 
constant over the 90-week period. 
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Table 7: Stability of s-IgA and albumin concentration at -80°C 
Period (week) s-lgA (mg·L-) Albumin (mg·L-) 
21-30 (N=6) 105.9± 5.5 44.0± 3.1 
41-SO(N=4) 122.3 ± 16.8 n/a 
51-60(N=10) 100.7 ± 11.2 40.7± 5.4 
61-70(N=17) 98.8 ± 9.5 43.9 ± 5.7 
71-80 (N= 8) 80.2 ± 5.5* 46.2± 3.7 
81-90(N=10) 87.4± 9.3* 44.1±6.6 
All values are mean± SD. *significantly (P < 0.05) lower than weeks 21-70 
A visual inspection of the data in Table 8 indicates that s-IgA and albumin 
concentration remained relatively unchanged after repeated freeze-thaw cycles and did 
not differ much from s-IgA and albumin concentration in control samples. No statistics 
were performed on these data as only two samples were analysed at each freeze-thaw 
cycle. 
Table 8: Effect of freeze-thawing on s-lgA and albumin concentration 
Base Cycle 1 Cycle2 Cycle3 Cycle 4 
s-lgA (mg·L-1) 61.0 67.2 65.3 62.8 65.3 
JgA control (mg·L-1) 61.0 67.8 69.8 69.2 66.6 
Albumin (mg·L-1) 35.8 40.0 43.6 40.4 46.5 
Albumin control (mg·L-1) 35.8 40.0 38.1 39.8 38.1 
2.3.4 Reference interval 
Tabie 9: Descriptive statistics for s-IgA in a group of 134 subjects 
s-lgA measure All subjects (n = 134) Males (n = 93) 
Concentration 129.7 ± 102.6; 97.1; 151.5 ± 111.3; 125.5; 
(mg·L-1) 13.7-483.0 14.7-483.0 
Secretion rate 70.9±61.1; 50.7 84.1 ± 68. 7; 71.7; 
(µg·min- 1) 6.6-313.7 6.6-313.7 
lgA:albumin 4.2 ± 3.9; 3.4; 4.4 ± 4.2; 3.5; 0.3-27.1 0.6-27.1 
s-lgA:osmolality 2.3 ± 1.5; 1.9 2.7 ± 1.6; 2.2; 
(mg·m0smor1) 0.3 -7.3 0.6-7.3 
Cycles Cycle 6 
60.7 58.8 
62.9 66.2 
41.2 39.2 
42.9 38.6 
Females (n = 41) 
81.8 ± 56.5*; 64.7; 
13.7-233.0 
44.9±28.7*; 36.7; 
7.3 -134.0 -
3.6 ± 3.3; 2.9; 
0.3-17.2 
1.6 ± 1.0*; 1.2; 
0.3 -3.6 
All data are: mean± SD; median; range. P < 0.05: * significantly different from males 
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To calculate a reference range, s-IgA was measured in a single sample donated by 
-1-34 subjects. Outliers were removed according to Reed's criterion (Fraser, 2001). The 
descriptive statistics are summarised in Table 9 and the frequency distribution of the s-
IgA concentration and secretion rate data is shown in Figure 4. Calculated reference 
intervals are shown in Table I 0. 
Table 10: Reference interval for s-IgA measures for a group of 134 subjects 
s-lgA measure Lower limit Upper limit 
Concentration (mg· L- ) 15.9 414.5 
Secretion rate (µg·min-1) 7.2 234.9 
lgA:albumin 0.4 19.0 
lgA:osmolality ratio (mg·m0smor1) 0.6 8.9 
50 100 150 200 250 300 350 400 450 500 
s-lgA concentration (mg/L) 
30 90 150 210 270 330 
s-lgA secretion rate (µg/min) 
a 
40 -
30 
~ 
c: 
~ 20 
er 
I!! 
u.. 
10 
c 
b 
1 2 3 4 5 6 7 8 9 10 11 
s-lgA:osmolality (mg/mOsmol) 
Figure 4: The frequency distribution for s-IgA concentration (a), s-IgA secretion rate 
(b) and s-lgA:osmolality ratio (c) in a group of I 34 subjects were all skewed. 
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A stratified reference interval may be n:~quired ifthe difference between the means 
of potential subgroups is gr-eater than 25% of the 95% reference interval for the entire 
group (Fraser, 2001). According to this criterion, stratification by gender was not 
necessary despite the fact that there were significant differences between the means of 
males and females for s-lgA concentration (P < 0.001), s-lgA secretion rate (P = 0.006), 
and s-lgA:osmolality ratio (P < 0.001). 
2.3.5 Measures of s-JgA 
So far in this chapter s-IgA levels have been expressed in four different ways: as a 
concentration, as a secretion rate, as a ratio to albumin, and as a ratio to osmolality. It is 
difficult to conclude which of the s-IgA measures is the best. As summarised in Chapter 
l, each of them has disadvantages, some of which compromise the validity of the 
results. In the remainder of this chapter and in all subsequent chapters, only s-lgA 
secretion rate and s-lgA:osmolality ratio are reported. Theoretically, these two measures 
are the most valid and meaningful of the four measures. S-IgA secretion rate most 
accurately describes the amount of s-lgA available at the mucosa! surface and by 
expressing s-IgA as a ratio to osmolality, changes in saliva flow and evaporation are 
corrected for. In addition, the present data indicate that the biological variation of the s-
IgA:osmolality ratio is among the lowest. The s-lgA:osmolality ratio has the second 
lowest CV1 and CV 0 for fasting samples and the second highest index of individuality 
(i.e. optimal) of all for samples. 
2.3. 6 Diurnal variation of salivary lgA 
Comparing the seven common time points on a fasting and a non-fasting day, 
there was no consistency in the behaviour displayed by the s-lgA secretion rate and the 
s-IgA:osmolality ratio (Table 11 and Figure 5). There was a significant effect of time on 
s-IgA:osmolality during the fasting day (F4,61 = 4.644; N = 16; P = 0.002) and the non-
fasting day (F6•60 = 2.829; N= 12; P =O .017). On the fasting day, compared to the early 
morning, the s-IgA:osmolality ratio was lower at 14:00, 18:00 and 20:30 but not at 
16:00. On the non-fasting day, when post-prandial effects were ignored, s-
IgA:osmolality ratio was significantly lower at 12:00 and 18:00. 
There was also a significant effect of time on s-IgA secretion rate on the non-
fasting day (F3,38 = 2.997; N= 12; P = 0.036) but not on the fasting day (F4,62= 1.525; 
N = 16; P = 0.205). S-JgA secretion rate remained unchanged throughout the fasting 
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day with the exception of a rise at 16:00. On the non-fasting day, when post-prandial 
effects were ignored, there were significant increases at-12:00 & 14:00. 
There was no evidence for a morning high in s-IgA secretion rate which at no time 
was different from the 7.00 samples. S-IgA:osmolality ratio was lower than the early 
morning value at limited times only. 
As illustrated by the graphs in Figure 5, s-IgA has a large biological variation. 
This makes it difficult to detect significant differences in small population groups. 
2.3.6.1 The effect of a day of fasting on salivary lgA 
There were no differences between the s-lgA secretion rate and the s-
lgA:osmolality ratio on the fasting and the non-fasting day. Neither were there any 
differences for s-IgA secretion rate at any individual time point. For s-IgA:osmolality 
ratio there was a significant difference between both days at 20:30 only (P = 0.046) 
(Table 11). 
Table 11: Changes in s-IgA secretion rate and ratio to osmolality during a fasting and a 
non-fasting day 
Time of day 
7.00 9.00 12.00 14.00 16.00 18.00 
s-IgA secretion rate (µg·min- 1) 
77.I; 76.6; 74.6; 65.7; 71.0#; 78.9; 
fasting 
39.3 - 174.4 49.2 - 106.2 40.0 - 95.0 26.8 - 105.0 25.5 -118.I 27.2 -128.0 
non- 35.5; 81.4; 50.8#; 58.7#; 55.9; 49.4; 
fasting 21.6 - 149.7 37.9 - 124.3 29.7 - 72.7 21.2-113.7 26.4 - 111.8 30.6- 122.7 
s-IgA:osmolality ratio (mg·m0smor1) 
2.3; 1.9; 1.6; 1.2*; 2.0; 1.4*#; 
fasting 
1.4 - 4.3 1.4-4.1 1.5 - 2.8 0.8 - 2.7 1.0 - 3.1 0.8 - 2.2 
non- 1.9; 1.8; 1.4*#; 1.7; 1.7; 1.3*#; 
fasting 1.2 - 5.0 I.I - 3.5 1.1 - 2.0 1.3 - 2.9 0.9- 2.5 0.9 - 2.2 
All data are median and 95% confidence limits for the median. The positions of the 95% confidence 
limits for the median in the sorted datasets were set as the position of the median plus and minus the 
square root of N with the lower limit rounded down and the upper limit rounded up to the nearest integer 
((Snedecor and Cochran, 1980, page 137). 
P < 0.05: * Significant difference with early morning sample (7:00); #Significant difference with the 
preceding sample; t Significant difference with corresponding sample on fasting/non-fasting day. 
49 
20.30 
55.0; 
39.9 - 83.· 
81.8; 
40.3-198 
l.5t*; 
0.8 - 1.8 
l.4t#; 
1.2 - 4.5 
700 
- 600 c 
"i§ 
c, 500 
2: 
G> 
...... 400 CU 
..... 
c 
0 
:;:= 300 G> 
..... 
u 
G> 
en 200 <( 
EJ 
u, 100 ~ # 
0 
7:00 9:00 12:00 14:00 16:00 18:00 20:30 
a 
10 
-0 8 E 
en 
0 
E 
-C> 6 g 
>-
:!:::: # 
CU 
0 4 
E 
en 
0 
<( ~# EJ 2 u, > 
0 
7:00 9:00 12:00 14:00 16:00 18:00 20:30 
b 
Figure 5: Changes in s-JgA measured in 7 saliva samples during a normal (non-fasting) 
day (N = 16). There were some changes in s-JgA secretion rate (a) and s-lgA:osmolality 
ratio (b /throughout the day: * indicates a significant differences with the 7:00 sample 
and# indicates a significant differences with the preceding sample (P < 0.05). The 
distribution of data is-shown as box-and whisker plots, based on the average, median, 
quartiles, and extreme values. The box represents the inter-quartile range, which 
contains the 5 0% of values. The line across the box indicates the median and the 0 
represents the mean. The "whiskers" extendfrom the box to the highest and lowest 
values. Because the data sets were small, no outliers were removed 
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2.3.6.2 The effect of eating a meal on salivary lgA 
There was some evidence of a post-prandial effect. Post-prandial s-IgA 
concentration (see Appendix B), and s-IgA:osmolality ratio was lower after all meals 
but there was no change in s-IgA secretion rate after any of the meals (Figure 6). S-
lgA:osmolality ratio in samples taken at 9:00, 14:00 and 20:30 respectively was either 
no different or higher than in the pre-prandial samples. Therefore, post-prandial s-
lgA:osmolality ratio declines were never sustained for more than 2 hours. 
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Figure 6: Eating a meal resulted in a significant reduction of s-lgA:osmolality ratio (b) 
qfter all meals, but not s-JgA secretion rate (a): t indicates a significant decrease from 
pre-prandial samples (P < 0. 05). The presentation of data is similar to Figure 5. 
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2.4 Discussion 
2.4. 1 Assay performance 
Instead of the more traditional ELISA method, a commercial Dade Behring 
ProSpec nephelometer and a particle enhanced nephelometric immunoassay (PENIA) 
were used to measure lgA and albumin concentration in saliva. As this equipment is 
generally used to measure lgA in serum and in CSF and albumin in urine, the available 
assays had to be optimised. 
To fall within the measurable range of the available assays, saliva samples had to 
be diluted with diluent. The assay precision for lgA was best at a dilution of 1 :50. The 
intra-assay and inter-assay CV A of 1.8% and 5.2% were lower or similar to those 
specified by Dade Behring in the product data sheet for the N Latex lgA kit (3.3-6.6~ 
and 3.5-10.1 % respectively) and better than those obtained previously by our laboratory 
using a Dade Behring BNA II nephelometer (4.5% and 5.7% respectively) (Pacque, 
2001 ). The precision for the albumin assay was best at sample dilutions of 1: 10 and 
1 :25. The intra-assay and inter-assay coefficients of variation of~ 3% and 6.5% were 
higher than those specified by Dade Behring for the N antiserum to human albumin 
(2.2% and 2.6% respectively). As saliva samples were analysed for lgA and albumin in 
the same analytical run, a 1: 10 bench top dilution, combined with machine dilutions of 
1 : 5 for lgA and 1: 1 for albumin were recommended. Although this was expected to 
produce a valid result for the majority of samples, it was envisaged that some samples 
would need to be re-analysed at a smaller dilution if initial results were below detectable 
level. 
The assay linearity for IgA was good but showed considerable bias for 
concentrations in the assay range of 4-103 mg/L. There was less bias for the assay range 
4-10.3 mg/L. In saliva samples with a bench top dilution of 1: 10, this corresponds with 
a range in saliva of 40 to 103 mg/L, which adequately covers the reference interval (22 -
145 mg/L) established previously by this laboratory (Pacque, 2001). The accuracy of 
the methods was very good with an inter-assay CV A of 4.9% for lgA and 8.3% for 
albumin. These are within the confidence intervals proposed by the manufacturer for 
quality control (assigned value± 20% for the lgA control or± 15% for the protein 
control). Because there was no commercial control available to test the accuracy oflgA 
and albumin measurement in saliva, data on accuracy were obtained from control 
material designed for serum measurements. 
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It has been proposed that an assay has a desirable perfonnance if CV A< 0.50 CV1 
and that its perfonnance is optimum if CV A< 0.25 CV1 (Fraser, 2001)). Based on the 
data from Table 2 and Table 4, the CV A:CV1 ratio for the IgA assay at a 1 :50 sample 
dilution was 0.09, which corresponds with an optimum perfonnance. Therefore, a 1:50 
sample dilution was used for the reminder of this study. 
2.4.2 Salivary lgA stability 
The addition of sodium azide as a preservative to saliva samples did not interfere 
with the IgA or albumin assay. This was expected as Dade Behring uses sodium azide 
( < 1 g· L-1) as a preservative in their reagents. The addition of sodium azide made no 
difference to the stability of s-IgA at storage temperatures ranging :from -4°C to +28°C. 
Therefore, sodium azide was not added to any saliva samples for the remainder of this 
study. 
Sometimes saliva samples are collected in situations where the ambient 
temperature is high and no cold storage facilities are immediately available. In such 
circumstances saliva samples are only useful provided s-IgA remains stable until the 
samples arrive at the laboratory for analysis or can be frozen. It was found that s-IgA 
was stable for at least six hours when stored at 28°C or room temperature (21°C) but 
there was a decline after 24 hours. Changes in albumin over the same period were 
minimal. This result confinned previous anecdotal evidence from our laboratory. The 
observed (temporary) increase in albumin concentration after six hours was possibly 
due to a methodological error, such as an erroneous dilution prior to analysis. The 
observed changes under these conditions were smaller or only marginally bigger than 
the coefficients of variation for the assays. 
The large increase in s-IgA concentratfon in samples stored at 4°C and -4°C in the 
first two to six days was unexpected especially since they were much larger than the 
small increases in concentration observed for the samples stored at higher temperatures. 
This was contrary to Butler et al. (1990) who found that s-lgA activity decreased 
significantly in the first 24 h when stored at 4°C. The increase in concentration can not 
be explained by an evaporation of saliva water as the samples were stored in sealed 
containers. Neither could it be attributed to the expected variation in assay results as the 
percentage changes were much larger than the assay variations. It is possible that a 
physical change occurred in the samples caused by the chilling and reheating process. 
Secretary IgA in saliva exists as a dimer, made up of two IgA molecules linked together 
by a polypeptide (J chain). The breakdown of these IgA complexes into smaller 
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subunits (monomers),could have exposed extra binding sites which would have been 
inaccessible to the lgA antibodies in the original dimeric form of the lgA proteins. 
Storage of saliva samples at very low temperatures is advised to prevent 
proteolysis. Even so, storage at -20°C or -30°C might not be enough. For instance in one 
study, s-IgA concentrations remained stable for up to 3 months at -30°C, but decreased 
by more than 10% in a majority of samples after 8 months (Ng et al., 2003). Similarly, 
s-lgA activity to Streptococcus mutans in samples stored at -20°C decreased 
significantly after one week and was completely lost after 18 months whereas storage at 
-70°C prevented loss of antibody activity (Butler et al., 1990). In this study s-lgA 
concentration declined significantly in samples stored at -80°C after~ 70 weeks, 
whereas albumin concentration did not change in the same samples. Consequently it is 
recommended that for the determination of lgA in saliva, samples be analysed within a 
year of collection 
Repeated freeze-thawing did not seem to affect s-IgA and albumin concentration, 
which was in accordance with a previous observation (Mortimer and Parry, 1988). 
However, from the third freeze-thaw cycle onwards samples showed a visible physical 
change. They became "cloudy" and a precipitate formed, which could possibly have 
been caused by a denaturation of proteins in the sample. It has also been observed by 
others that albumin concentration can decrease by 10% with each additional thaw (M. 
Gleeson, personal communication 01/09/02). It is therefore recommended to avoid 
repeated freeze-thaw cycles. 
The speed at which samples are frozen has been shown to affect s-IgA 
concentration. In samples which were not frozen immediately s-IgA concentrations 
declined by approximately 30% as compared to samples snap-frozen in liquid nitrogen 
(Nurkka et al., 2003). However, the advantage of snap freezing samples was lost if not 
applied immediately after collection of the saliva. 
2.4.3 Biological and diurnal variation 
The large within-subject (CV1) and between-subject (CV a) variability for all s-IgA 
measures were similar to those reported in the literature. For instance Brathall and 
Waldenstrom found a 15-fold difference in s-IgA concentration between individuals 
(Bratthall and Widerstrom, 1985). These differences are not surprising as s-IgA 
concentration and secretion rate are affected by a multitude of factors such as nutrition, 
health, fitness and activity levels, environment, stress etc. This study also supported the 
observation made by Butler et al. (1990) that daily variations in s-IgA are more 
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characteristic of the subjects than the time of sampling. Some subjects displayed 
relatively unehanged s-lgA levels throughout a day (see Figure 3; e.g. subject 14), 
whereas [Qr others they fluctuated widely (e.g. subject 8). This is reflected by the 
individual CV1 which for s-IgA concentration on the non-fasting day ranged from 24% 
to 137% and for s-IgA secretion rate from 26% to 98%. For some subjects the results on 
both days were very similar (e.g. subject 6), whereas for others they were dissimilar 
(e.g. subject 10). The most consistent phenomenon was the post-prandial effect with 8 
subjects out of 13 showing a reduced s-IgA concentration after all 3 meals (see 
Appendix B). 
Although the times of day with the highest and lowest CV a were different for the 
various measures there was a trend. On the fasting day, variability seemed highest in the 
morning and lower in the afternoon. On the non-fasting day variability seemed lowest 
around 12:00 and highest late in the evening. The best time of day to collect saliva 
samples for the measurement of s-lgA therefore seems to be between midday and 
afternoon. As the highest variability was observed in the morning and late in the 
evening, sampling at these times should be avoided. 
This study failed to provide conclusive evidence that s-lgA is subject to diurnal 
variation but there was some evidence of a post-prandial effect. Several authors have 
reported a morning high for s-IgA concentration (Gleeson et al., 1990; Hucklebridge et 
al., 1998; Liu et al., 2003; Richter et al., 1980). In these studies morning samples were 
generally taken before breakfast after an overnight fast. It was therefore postulated that 
fasting for a considerable period and/or eating a meal could affect s-IgA levels. 
However, the present study found no evidence that fasting for one day had an effect on 
measures of s-IgA as there were no differences in the s-IgA secretion rate and s-
lgA:osmolality ratio between a fasting and a non-fasting day. This suggests that the act 
of fasting in itself is not a major contributor to changes in s-IgA and that the morning 
high observed by others is not due to the overnight fasting. Our observations suggest 
that pre-analytical factors, such as increased viscosity of saliva samples due to cellular 
debris and mucus, could be a more likely explanation of the increased variability of 
measured s-IgA and apparent changes in saliva concentrations in early morning 
samples. Generally, first morning samples were unreliable because they were often not 
suitable for analysis. 
In post-prandial samples taken shortly after each meal, S-lgA concentration and s-
IgA:osmolality were significantly lower as compared to the pre-prandial samples. Post-
prandial declines were sustained for less than 1.5-2 hours and more research is needed 
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to determine their exact duration and magnitude. S-lgA secretion rate did not change as 
a result of eating a meal. The cause of the-post-prandial effect has not been precisely 
identified. Factors could include the complex series of hormonal and metabolic changes, 
which enable digestion of food, absorption of nutrients and the stimulus to produce 
saliva. 
The significant post-prandial fall in s-lgA concentration after breakfast could have 
been caused by the "waking" effect suggested by Hucklebridge et al. (1998), but only if 
breakfast was taken immediately after waking. Unfortunately this was not recorded and 
to provide further proof for this theory, it would be useful to conduct a study with 
volunteers observing different sleep-wake patterns (e.g. with subjects to "sleep in" late 
or being woken up in the middle of the night). 
2.4.4 Reference interval 
The finding that there was a post-prandial decline of s-lgA supports the suggestion 
that separate reference intervals should be used for fasting and non-fasting subjects 
(Gleeson et al., 1990). However, as long as samples are collected at least 1.5 - 2 hours 
post-prandial, a fasting reference interval should suffice. 
Reference intervals for the various s-IgA measures were calculated based on 
samples taken from 134 subjects at least two hours after a meal (Table 10). Early 
morning (pre-breakfast) or evening samples were avoided. The lower reference value 
for s-JgA concentration was above the detection limit of the PENIA assay (0.25 mg/L). 
The reference interval for s-lgA concentration (15 .9 - 414.5 mg/L ), is similar to the 25 -
600 mg/L published by Gleeson et al. for subjects after an overnight fast but greater 
than the 9 - 125 mg/L for "non-fasting" subjects in the same study (Gleeson et al., 
1990). Discrepancies in the reference ranges of various studies can possibly be explained by 
differences in the sample size, methodology (e.g. laboratory methods such as equipment, assay 
method, antisera, etc) and statistical analysis (removal of outliers). 
The large biological variation of s-lgA is the main reason for the large range of 
these reference intervals. This casts serious doubts on their usefulness and is reflected 
by their low indices of individuality (II). The II reflects the degree of ~ndividuality for a 
measurement within a population and is commonly used for assessing the usefulness of 
reference values (Fraser, 1994; Solberg, 1994). In general, the lower the II, the higher 
the degree of individuality. Reference intervals are most helpful when the index is> 1.4 
but this is rarely the case for biological analytes. If the II is below 0.6, a population-
based reference interval is considered of low utility as a criterion for detecting a 
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significant change in serial results for an individual. It introduces a high scope for error 
when comparing an individual's results with the reference interval and-the risk of 
finding "false" positives or negatives is increased. The II in this study were 0.56 for s-
IgA concentration, 0.48 for s-IgA secretion rate, 0.64 for s-IgA:albumin ratio, and 0.60 
for s-IgA:osmolality ratio. 
Figure 3 illustrates the problems associated with using a population based 
reference interval for analytes with a small II. For an individual, significant clinical 
changes could occur, even when serial results are all within the reference interval, and 
consequently remain undetected. It is also possible that results change from inside to 
outside reference intervals without clinical significance. Strong individuality implies 
that a subject-specific reference interval would be preferable over a population-based 
range to assess changes in serial measurements for that individual. Originally it was 
planned to undertake a project to establish individual reference intervals for a group of 
subjects. However it was estimated that a very large number of samples would be 
needed from each subject to obtain a valid reference range. Such a study would also 
require the control of the many factors which could possibly affect s-IgA and this was 
beyond the scope of this project. 
The large range of the ·calculated reference in this study is partly due to the 
statistical method used. Outliers were removed based on Reed's principle. As is clear 
from Figure 4, data were highly skewed and the use of a different criterion for the 
removal of outlying data in the right tail of the distribution could have yielded a more 
narrow reference interval. Despite the fact that more subjects were used than the 120 
recommended by the IFCC, the relatively small number of subjects are possibly a 
limitation of this study. It is possible that a more representative "healthy" reference 
interval would have been obtained from a larger cross-section of people. 
Among the factors, other than time of day and nutritional status; which could 
affect the reference interval for any biological analyte, are gender, age and smoking 
status. This study showed that separate reference intervals for males and females are not 
necessary. This confirmed previous work done at the DSTO laboratory (Pacque, 2001), 
which also found no need for stratification of the s-IgA reference intervals between 
smokers and non-smokers, or (5-year) age groups. 
2.4.5 Uncertainty of measurement 
There are many and varied sources of variation that can become embedded in a 
laboratory result. They fall under the broad headings of pre-analytical variation (CV p ), 
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analytical variation (CV A), and biological variation (CV1). Together they contribute to a 
degree of uncertainty about the validity of any test result. 
Pre-analytical variation occurs externally to the laboratory and is mostly outside of 
its control. Pre-analytical variation in this study was minimised by standardising sample 
collection, handling and storage methods. Whenever possible, saliva samples were 
collected in the presence of the investigator. For those collected otherwise, subjects 
were given detailed and specific instructions. 
Sources that contribute to analytical variation may include calibrators, reference 
materials, equipment, and changes of operator. Further contributors are the precision, 
bias, interference, linearity, and detection limits of the assay. Analytical variation in this 
study was limited by standardising all laboratory work and, with a few exceptions, all 
analyses were carried out by the same operator. 
The biological variation of many biological analytes has been quantitated by a 
number of workers and J. Westgard has compiled an exhaustive list 
(http://www.westgard.com/biodatabasel.htm). As it is not included in this list, a CV,1 for 
s-lgA concentration was calculated, using the samples from the subjects of the "diurnal 
variation" experiment. Ignoring post-prandial samples, the CV1 for individuals ranged 
from I 7% to 129%, with an average of 55% (see Append"ix B).This is of the same order 
as the average CV1 (42.5%) for a group of21 subjects who provided an early morning 
saliva sample three times a week for eight weeks (Pacque, 2001). Unfortunately, this 
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study was unable to control for the many factors that might affect biological variation, 
such as diet, stress, hydration, hormonal factors, etc. It has also been suggested that the 
CV1 depends on the aerobic fitness and activity level of an individual, as in a study 
comparing groups of elite swimmers, active individuals, and sedentary individuals, the 
CV1 was 43%, 25% and 24% respectively (Francis et al., 2005). 
Despite the differences between individuals, CV1 seems to be the main contributor 
to the total variation. Assuming pre-analytical variation is minimised, CVp is irrelevant 
and total variation can be calculated as CVT =(CV l + CVi2)112 (Fraser, 2001). With a 
CV A of -5% and the group mean of 55% for CVi, the total variation would be -55%, 
meaning that the CV A is practically irrelevant as well. 
The considerable total variation has serious implications when it comes to 
interpreting changes in s-JgA. For serial results to be analytically and biologically 
different at the 95% confidence limit, they need to differ by 2.77 x (CV l + CVi2)112 or 
2.77 x CVT (Fraser, 2001, page 73). Thus, using the 55% group mean for CVT, a change 
of~ 152% would be required for serial s-lgA concentration measurements to be 
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significantly different. However, the wide range of CV1 between individuals makes it 
questionable that the use of the group mean for CVr is the best way to calculate the% 
change required to "diagnose" a significant change in s-IgA. Instead it seems better to 
calculate the CVr for each individual. For instance for the individual subjects in the 
diurnal variation study, the CV r for s-IgA concentration ranged from ~ 18% to ~ 129%. 
Consequently, for the individual at the lower end of the range, a significant change 
would be ~50%, whereas for the individual at the top end of the range it would be 
~360%. This reasoning reflects the observation made earlier that individual reference 
intervals should be used to evaluate changes in serial measurements for an individual. 
2.4. 6 Recommendations 
The measurement of s-lgA by particle enhanced nephelometric immunoassay was 
found to be a good alternative to other methods as it is automated, rapid, accurate and 
precise. Based on the results of the work undertaken, following recommendations can 
be made, which were adhered to for the remainder of this PhD project. 
• Care needs to be taken when collecting, storing and analysing saliva samples. 
• The time of day at which saliva samples are taken should be accurately recorded 
and repeat samples should be collected at the same time of day if required for -
comparison. 
• Whenever possible, sample taking should be supervised, especially when accurate 
timing is needed to calculated s-IgA secretion rate. If this is not possible subjects 
should be provided with detailed instructions. 
• Saliva samples should be taken either before a meal or at least 1.5-2 hours post-
prandial. Samples immediately after a meal, early morning (fasting) and late 
evening should be avoided because of the larger variability at these times, unless 
required for specific reasons. Early morning samples were often found to be 
unreliable as they were more likely to contain mucous and contaminants (e.g. cell 
debris). 
• Saliva samples should be analysed as soon as possible after collection. If this is 
not possible they should be frozen immediately, either by snap-freezing in liquid 
nitrogen, by placement in dry ice or in a -80 °C freezer. Long-term storage at -
80°C can retard the degradation of s-lgA but not indefinitely. Storage in a home 
freezer (at -4°C or even -20°C) or in normal ice is only useful as a temporary 
measure. 
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• In the laboratory, samples can be left at room temperature for a limited time as, 
even without the addition of a preservative, s-IgA is reasonably stable for a short 
period. 
• Limited freeze-thawing is acceptable but not advisable. 
Although s-IgA levels can be expressed in several different ways it is clear from 
previous work that by doing so a clear pattern often fails to emerge. Depending on the 
measure used, statistical significance is either obtained or not, and findings are 
sometimes contradictory. This makes it extremely difficult to reach a definitive 
conclusion relating to any intervention on s-IgA. To avoid confusion, and to reduce the 
volume of this work, only s-IgA secretion rate and s-IgA:osmolality ratio are reported in 
the following experimental chapters. 
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IMMUNE CHANGES AND UPPER RESPIRATORY 
TRACT INFECTIONS AFTER AN ULTRA-
ENDURANCE RUN 
3.1 Introduction 
This main purpose of this study was to develop methods for the collection, storage 
and transport of saliva samples under "field conditions". This study also provided 
information on the effects of an ultra-endurance running race on mucosa) and humoral 
immunity and assessed if changes in s-IgA and serum IgA correlate with changes in the 
incidence of upper respiratory tract infection (URTI). It was also assessed if training 
volume and/or race time was correlated to changes in s-IgA. There is evidence of a 
relationship between endurance exercise and infections from a large epidemiological study 
which found that of 2311 participants in a marathon, 12.9% reported an infection during 
the week after the race in comparison to only 2.2% of similarly experienced runners who 
had applied to participate in the race but did not do so (for reasons other than sickness) 
(Nieman et al., 1990a). In a similar study that followed runners during the two weeks after 
a 56 km ultra-marathon, the overall incidence of URTI was twice as high in participants as 
compared to age-matched control subjects living in the same household (Peters and 
Bateman, 1983). This last study also showed a qualitative dose-response relationship 
between incidence of illness and training volume, a finding which was confirmed in a 
subsequent study that surveyed a mixed group of 530 runners (Heath et al., 1991). It was 
therefore hypothesised that the 82 km Cradle Mountain Run would cause a significant, 
albeit transient immunosuppression. 
3.2 Methods 
3.2.1 The race 
The Cradle Mountain Run (CMR) is an 82 km trail run, traversing Tasmania's Cradle 
Mountain - Lake Saint Clair National Park. Runners are required to carry a minimum 
amount of safety equipment and clothing and are responsible for their own nutritional 
requirements. The weather was ideal for running - overcast in the morning, clearing to a 
partly cloudy day with minimal rain. The temperature ranged between 5°C and 18°C. High 
winds were encountered in an early exposed section of the race. 
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3.2.2 Subjects 
Of the 45 entrants in the CMR, thirteen males and four females were recruited into 
the study. It was asstnned that in order to participate in a race of this kind, participants needed to be 
healthy. Therefore, no exclusion criteria were formulated and no health screening implemented. 
Subjects were between 27 and 52 years old (mean± SD; 41.5 ± 8.2), had a body mass index 
between 20.8 and 23.8 kg·m-2 (22.3 ± 1.2) and their race time ranged from 8h 27min to 14h 
· 20 min (11:25 ± 1:32). To estimate their level of physical activity, subjects kept a detailed 
training diary for a typical week other than the week immediately prior to the race. 
Activities of daily living were not included. Their average weekly training load was 
between 4.5 and 15.0h per week (9.5 ± 3.5). 
3.2.3 Saliva collection and analysis 
Because of the late evening arrival of the subjects at Cradle Mountain, the very 
early start of the race (6:00am) and the impossibility to obtain samples during the race, 
saliva samples were limited to late evening and early morning samples. Timed saliva 
samples were collected in Salivettes the evening before the CMR (18:00 - 20:30), the 
morning of the race (05:05 - 05:35), as soon as practicable after the race (3 - 30 min after 
finishing), 2 hours after the race, and the next morning (07: 10 - 09:30, before breakfast) 
(Figure 7). The samples taken the evening before the CMR were collected either before or 
after the evening meal and the pre-race samples were taken either before or after breakfast. 
It was not possible to control whether these samples were collected before or after a meal 
and no record was made of this. Samples were temporarily frozen at -20oC and then stored 
at -80oC until analysis. The method of collection, storage and analysis of saliva samples 
was as described in detail in Chapter 2. S-lgA levels are reported as secretion rate and s-
lgA:osmolality ratio. 
Saliva and Saliva Saliva and Saliva Saliva and 
blood sample sample blood sample sample blood sample 
l 11 RACE l l l 
6pm 12am 6am 12pm 6pm 12am 6am 12pm 
Pre-race day Race day Post-race day 
Figure 7: Timing of saliva and blood samples during the Cradle Mountain Run study. 
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3.2.4 Blood collection and analysis 
Blood samples were collected from the median cubital vein the evening before the 
race, as soon as practicable post-race and the next morning (around breakfast time). It was 
not recorded whether samples were collected before or after a meal. Whole blood was 
collected in 4 ml Vacuettes (Vacuettes, Greiner Bio-One GmbH, Kremsmuenster, Austria) 
with anti-coagulant (EDTA). Samples were stored immediately in ice water and processed 
within 8 hours. A full blood count was performed with a haematology analyser (Coulter 
MaxM, Beckman Coulter, Fullerton, CA, USA). To obtain serum, blood was collected in 5 
ml Vacuettes with a clot activator and serum separator. To allow clot formation, samples 
were left to stand at room temperature for 20-30 min before being centrifuged. Serum was 
temporarily frozen at -20°C and then stored at -80°C until analysis. Serum IgA 
concentration was determined by the same nephelometric immunoassay as described for 
saliva. All samples were analysed in a single batch. To take into account dehydration, 
adjustments were made for changes in blood volume (Dill and Costill, 1974). 
3.2.5 Upper respiratory tract infections 
In the two weeks before and the two weeks after the race each subject recorded the 
number of days with URTI symptoms, using a self-report questionnaire similar to that used 
previously (Dick et al., 1987) (Appendix C). Symptoms were defined as common cold 
symptoms (runny or blocked nose, sore throat, coughing, sneezing, coloured nasal 
discharge, sinus infection) or influenza symptoms (fever, headache, general aches and 
pains, fatigue and weakness, chest discomfort, severe cough). 
3.2.6 Medication 
It is not uncommon for runners in ultra-endurance events to take non-steroid anti-
inflammatory drugs (NSAID) to reduce muscle soreness. Subjects were asked to report any 
such medication taken during the r~ce because of the unknown effect on s-lgA. 
3.2. 7 Statistical Analysis 
Normality of the raw data was tested by the Kolmogorov-Smimov test. Data for 
saliva flow rate, serum lgA concentration and lymphocyte counts were normally 
distributed and descriptive statistics for these data are reported as mean ± SD, range and 
95% confidence intervals. Data for s-IgA secretion rate, s-IgA:osmolality ratio, and counts 
of leukocytes, neutrophils and monocytes were not normally distributed. Analysis of these 
variables was performed on natural logarithm (Jn) transformed data and descriptive 
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statistics are reported as the geometric mean with back-transformed 95% confidence 
intervals. 
The overall effect of time was evaluated by repeated measures analysis of variance 
(ANOV A). Differences between individual time-points were assessed by paired t-test. To 
test correlations between variables, the parametric Pearson's or non-parametric 
Spearman's correlation coefficients were used. To compare differences between groups of 
subjects, independent t-tests or the non-parametric Wilcoxon signed-rank test were used. 
In several instances, lack of sphericity of the data necessitated an adjustment of the degrees 
of freedom by applying the Huynh-Feldt epsilon (s) coefficient. For all tests, P < 0.05 was 
considered statistically significant. 
3.3 Results 
3.3. 1 Salivary lgA 
Data from two subjects who failed to return all saliva samples were excluded from 
the analysis of s-IgA. The CMR had a significant effect on s-lgA secretion rate (FM6 = 
10.658; P < 0.001) and s-IgA:osmolality ratio (F23.322 = 13.847; P < 0.001). Both 
measures of immune function were depressed immediately post-race (P < 0.01). In 
addition the S-IgA secretion rate remained depressed until the next morning (P = 0.009), 
while the s-IgA:osmolality ratio had returned to pre race values. Descriptive data are 
summarised in Table 12 and represented in figure 8. 
Table 12: Changes in s-IgA as a result of the Cradle Mountain Run. 
Variable 
Evening 
Pre-race Post-race 2hr recovery 
Morning 
before after 
s-IgA concentration 206 299 192 82** 235 
(mg·L.1) (134 - 317) (207 - 432) (131 - 281) (58-116) (162 - 338) 
s-lgA secretion rate 159 252 106* 66** 161* 
(µg·min.1) (93 - 274) (148 - 428) (58- 194) (43 - 100) (IOI - 257) 
s-IgA:osmolality ratio 2.2 2.1 0.9* 0.9* 2.4 
(mg·m0smor1) (1.5 - 3.2) (1.5 - 2.9) (0.6 - 1.4) (0.6 - 1.2) (1.7 - 3.4) 
Serum lgA concentration 2142±817 1640± 766* 892±353** 
n/a n/a (mg·L-1) (1690 -2595) (1216-2065) (696-1087) 
Data for serum lgA are mean ± SD (95% confidence interval). All other data are geometric mean (95% 
confidence interval). 
§ P < 0.05, * P < 0.01, ** P < 0.001, significantly different to pre-race (saliva) or evening before (serum). 
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Figure 8: The effect of the Cradle Mountain Run on various measures of immune function. 
Post-race s-IgA secretion rate (a) and s-IgA:osmolality ratio (b) were lower than pre-race. 
Two hours post-race s-IgA secretion rate had further decreased The next morning, s-
lgA:osmolality ratio had recovered, while secretion rate remained depressed(* P < 0.01 
significant difference with pre-race). Immediately following the CMR, a significant decline 
in serum IgA concentration (c) was recorded, which had not returned to normal the next 
morning (* P < 0. OJ change from evening before). Saliva data are represented as the 
(geometric) mean± 95% corifidence intervals and serum JgA as the mean± SEM 
3.3.2 Serum lgA 
Data from two subjects who were unable to donate blood after the race were 
excluded from the analysis. Serum lgA concentration declined significantly as a result of 
running the race (F2,28 = 26.713; P-< 0.001) and declined further during the 24 hour post-
race period (P < 0.001) (Table 12, Figure 8). To take into account the effects of 
dehydration, all post-race and recovery samples were corrected for changes in blood 
volume. However, most subjects finished the race well hydrated and there were no changes 
in haemoglobin and haematocrit. 
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There was a significant correlation between s-IgA and serum IgA concentration 
(Spearman's rho= 0.679, P = 0.008) when measured the evening before the Cl'v1R. 
Subsequent changes in serum lgA concentration did not appear to influence s-IgA since 
the two parameters were not correlated either immediately after the race or the morning 
after. Neither was there a correlation between their rates of change from pre-race to post 
race. 
3.3.3 Leukocytes 
There were significant changes in white cell concentrations across the pre- to post-
race period for total leukocytes (F2,28 = 209.5, P < 0.001), neutrophils (F2•28 = 370.2, P < 
0.001) and lymphocytes (F2•28 = 10.493, P < 0.001). While the total leukocyte and 
neutrophil counts increased immediately post-race then partially recovered, the 
lymphocyte counts showed the opposite pattern, declining immediately post-race then 
partially recovering (Figure 9, Table 13). Monocyte counts had not changed immediately 
following the race, but were elevated the next morning. 
18 
15 
Evening before Post-race* Morning after* 
Figure 9: The effect of the Cradle Mountain Run on leukocyte subsets. Total leucocytes 
(+), neutrophils (•),and lymphocytes (Ji..) but not monocytes (o) had changed significantly 
by the end off the Cradle Mountain Run. None had recovered the morning after the race. # 
indicates a significant difference (P < 0. 05) with the evening before. *Post-race and 
morning after data were adjusted for changes in blood plasma volume. 
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Table 13: Leukocyte subset counts before and after the CMR 
Variable (109 L-1) Evening before Post-race Morning after 
Total leukocytes 7.0 (6.4 - 7.6) 15.8 ** (14.7 - 16.9) 9.2** (8.3 - 10.1) 
Neutrophils 3.7 (3.2 - 4.3) 13.2** (11.9 - 14.6) 6.2** (5.5 - 7.1) 
Monocytes 0.5 (0.4 - 0.5) 0.5 (0.3 - 0.9) 0.6· (0.5 - 0.8) 
Lymphocytes 2.4 ± 0.6 (2.1 - 2.8) 1.6 ± 0.8** (1.2 - 2.1) 2.0 ± 0.7# (1.7 - 2.4) 
Data for total leukocytes, neutrophils and monocytes are geometric mean (95% confidence interval). Data for 
lymphocytes are mean± SD (95% confidence interval). 
* P < 0.05, # P < 0.01, ** P < 0.001, significant change from evening before 
3.3.4 Upper respiratory tract infections 
During the two weeks before the CMR, 4 subjects recorded a total of 34 days with 
common cold symptoms. During the two weeks after the CMR, 3 subjects recorded 18 
days with similar symptoms. No influenza symptoms were recorded. There was, however, 
no statistically significant difference in the incidence of common cold symptoms between 
the two periods (P = 0.416). Comparison of subjects with or without URTI symptoms 
showed no statistically significant differences at any time in s-IgA measures (see Table 
14). 
Table 14: Differences in s-IgA between subjects with or without URTI symptoms 
URTI two weeks before CMR URTI two weeks after CMR 
Variable 
Pre race Post race Morning after Pre race Post race Morning after 
s-IgA secretion rate p = 0.327 p = 0.641 p = 0.371 p = 0.966 p = 0.526 P=0.646 
s-lgA:osmolality p = 0.491 p = 0.799 P= 0.443 R = 0.602 p = 0. 858 p = 0.415 
3.3.5 Medication 
Nine subjects reported using non-steroid anti-inflammatory drugs (NSAID) during 
the race, seven said they did not and one subject failed to report on this. Drugs taken were 
ibuprofen, diclofenac, piroxicam and paracetamol. There was no difference in-s-IgA, 
serum IgA or leukocyte, lymphocyte and neutrophil numbers between those who took 
NSAID and those who did not (see Table 15). However, the morning after monocyte 
numbers were lower in the subjects who took NSAID (P = 0.049). 
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Table 15: Differences in serum IgA or leukocyte, lymphocyte and neutrophil numbers 
between those who took NSAID and those who did not 
Post race Morning after 
Variable 
NSAID NoNSAID Significance NSAID NoNSAID Significance 
Serum lgA (mg. L-1) 1772 1444 P= 0.437 833 980 p = 0.451 
Leukocytes (109 L-1) 16.2 15.4 P= 0.391 9.1 9.6 p = 0.401 
Lymphocytes (109 L-1) 1.8 1.5 p = 0.455 2.0 2.1 P=0.640 
Neutrophils (109 L-1) 13.6 13.1 P= 0.710 6.4 6.4 P=0.995 
Monocytes (109 L-1) 0.8 0.6 p = 0.403 0.6 0.8 P=0.049 
3.3. 6 Weekly training volume and race time 
There was no evidence that weekly training volume correlated with race times (see 
3.2.2) or changes in s-IgA. There was, however, a weak but significant negative correlation 
between race time and post-race s-IgA secretion rate (Spearman's rho= -0.589, P = 
0.021 ). There was no such significant correlation at any other time points. More complete 
data on the correlations with race time and training volume can be found in Appendix D. 
3.4 Discussion 
The CMR had a significant effect on mucosa) and humoral immunity. The decreases 
in s-IgA secretion rate and s-IgA:osmolality ratio were almost identical to those reported 
previously for a l 60km ultra-marathon (Nieman et al., 2003) and similar to those reported 
for a variety of other activities (Gleeson et al., 2000b; Mackinnon et al., 1993a; 
Steerenberg et al., 1997). In comparison to pre-race values, post-race saliva samples were 
less voluminous, s-lgA secretion rate declined by 58% and s-IgA:osmolality ratio by 57%. 
Recovery was slow; in the two hours post-race s-lgA secretion rate declined further and s-
lgA-osmolality remained depressed. S-lgA secretion rate failed to return to normal by the 
next morning. As the morning-after sample was the last one collected, it is impossible to 
conclude how Jong it took for full recovery to take place. 
The experiments described in Chapter 2 found no conclusive proof of a diurnal 
variation in s-lgA secretion rate or s-IgA:osmolality ratio. Therefore, there is no reason to 
believe that a diurnal effect would have contributed to the decrease in these measures 
during the CMR. The fact that s-IgA secretion rate was still low the morning after the 
CMR shows the recovery from the effects of the CMR was slow. A significant design fault 
in this study is the lack of information on meal times in relation to saliva collection times 
and of particular concern whether the subject was fasting. As this study was carried out 
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before the study on diurnal variation (see Chapter 2), we were, at the time of this study, not 
aware of the recommendations that would be made later. It is possible that some of the pre-
race samples were taken after breakfast. Unfortunately this was not recorded. As described 
in Chapter 2, a post-prandial effect could have resulted in a lower s-IgA:osmolality ratio in 
these samples than if they had been taken before breakfast. 
The negative correlation between race time and post-race s-IgA secretion rate 
indicates that mucosal immune function was more compromised in the slower competitors. 
This was a short-term effect as there was no such correlation the morning after the race. 
This finding suggests that for an ultra-endurance activity, exercise duration has an effect 
on the magnitude of the decrease in s-IgA but does not affect the rate of recovery. The 
effect of exercise intensity in the present study could not be assessed with validity. It is 
possible that, regardless of race time, the decline in s-IgA was greater in subjects who ran 
at a higher intensity. However, exercise intensity was not measured directly (e.g. V02 or 
heart rate). Moreover, race time is not necessarily a fair measure of exercise intensity. To 
complete a race of this duration, most subjects probably ran at a moderate intensity 
throughout. While no measurements were taken, it was estimated that the average rate of 
energy expenditure during the race was 50-75% of the subjects' maximal aerobic capacity. 
If this assumption is correct, the results of this study suggest that mucosa! 
immunosuppression can occur as a result of moderate intensity exercise. 
For all subjects, pre-race serum IgA was within the clinically normal reference range 
(700-4000 mg·L-1; Northern Tasmanian Pathology Service). This agrees with a previous 
finding in 20 marathon runners (Green et al., 1981 ). Others, however, have found resting 
serum lgA in athletes after long-term training at an intensive level to be lower than those 
of control subjects or clinically normal ranges (Gleeson et al., 1995). The acute response of 
serum IgA to ultra-endurance running has not been extensively studied. Poortmans and 
Haralambie (1979) found no changes in serum IgA concentration immediately after a 100 
km race, which is in contrast with the present study. A 23.4% decrease of serum IgA 
concentration immediately after the CMR was recorded, with a further decrease to less 
than half the resting concentration the next morning. Although these changes were highly 
significant, these depressed values remained within the quoted normal reference range for 
all but five participants. It is unlikely that such a decline in serum IgA had any adverse 
health effect, particularly since the incidence ofURTI during the two week post-race 
period did not change, and did not correlate with either pre- or post-race serum IgA 
concentrations. Furthermore, recent studies suggest that there is maintenance of 
appropriate antibody response to antigenic challenge despite low serum immunoglobulin 
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levels in athletes (Mackinnon, 1999a). The clinical significance of the findings of the 
present stud¥ is therefore unclear. 
Although salivary and serum IgA concentrations (data not reported) were correlated 
the evening before the race, s-IgA had partly recovered the morning after the race, whereas 
there was a continued decrease in serum lgA concentration. This suggests that the 
measurement of s-IgA can be used as a substitute for serum lgA determinations only when 
subjects are at rest and have fully recovered from exercise. This proposition needs further 
investigation. 
The resting circulating leucocytes count was normal when compared with clinical 
norms ( 4-11 x 109 L-1) and with non-athletes (Nieman et al., 1995). However, for twelve 
subjects the resting leukocyte count was in the lower half of the clinical range. It is 
possible that their training regime prior to the race caused leukocyte suppression as long 
periods of intense training have previously been associated with a low resting leukocyte 
count in distance runners (Lehmann et al., 1997). 
The magnitude and time course of changes in leukocyte count as a result of exercise 
is complex. In general, the increase is higher for more intense and longer exercise, changes 
can continue even after the end of exercise, and cell counts may remain elevated for 
several hours after prolonged exercise (Shek et al., 1995). In this study, the magnitude of 
post race leukocytosis and lymphopenia were consistent with the results of the few 
previous studies of ultra-endurance runners. Participants in the 90km South African 
Comrades marathon (Peters et al., 2001) and in a IOOkm ultra marathon (Gabriel et al., 
1994) experienced immediate post-race leukocytosis, lymphopenia and neutrophilia, 
whereas those in the l 60km Western States Endurance Run showed increased counts of 
leukocytes, neutrophils and monocytes but no changes in lymphocytes (Nieman et al., 
2003). 
Recovery to resting values was slow: the morning after the CMR, total leukocyte, 
neutrophil and monocyte counts were still higher than resting values, and lymphocyte 
count remained low. No further samples were obtained. Only two of the other studies on 
ultra-endurance runners monitored their subjects for an extended period oftime. In the 
South African study, all blood counts had returned to resting values within 24 hours 
(Peters et al., 2001). Gabriel et al. (1994) found a 300% increase in leukocyte count, which 
remained at that level for three hours post exercise. No_ further samples were obtained 
Since blood samples were taken at three time points only, it was not possible to 
establish the time course of the changes during and after the CMR. It is possible that 
leukocyte counts in the circulation peaked during the race at levels higher than the post-
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race values. During the days following the CMR there could also have been a further 
decline in leukocyte counts below resting.counts. Many of the runners experienced severe 
delayed onset muscle soreness (DOMS) during that period (personal communications) and 
exercising for several hours may cause a prolonged suppression of leukocyte counts 
because of a migration from the circulation, possibly to damaged muscle tissue (Galun et 
al., 1987). Full recovery to pre-race levels could possibly have taken several days. 
Leukocytosis and a change in the subset distribution of leukocytes in the circulation 
after exercise have been attributed to an endocrine response. A release of hormones, such 
as catecholamines, corticosteroids, and some cytokines such as IL-1, cause the release of 
leukocytes from the spleen and changes in the adhesion to the vascular endothelium 
(Mackinnon, 1999a). It is also possible that cells are simply swept out of the peripheral 
vessels when blood flow in these vessels increases. 
There was no increase in the incidence ofURTI following the CMR. This is in 
contrast with previous findings. Increased symptoms of UR TI have been reported in up to 
68% of subjects in the two weeks after marathon and ultra marathon races (Nieman et al., 
2003; Peters and Bateman, 1983; Peters et al., 1993). This discrepancy could be explained 
in two ways. First, it should be noted that this study, like some others, relied on "self-
·report" questionnaires, with possible under- or over-reporting of symptoms or errors in 
diagnosis. For example URTI symptoms may be confused with allergic reactions (e.g. hay 
fever). Second, the lower incidence of post-race URTI in this study than in others may 
possibly be explained by conditions at the finish and the movements of competitors after 
the race. The window of opportunity for infection post-race as a result of mucosa! 
immunosuppression is limited (Pedersen et al., 1996); there were few participants or 
spectators, the race was in an isolated environment, and most runners left the finish area 
soon after completing the race - so their potential exposure to airborne pathogens during 
the window of opportunity was low. This would be different from many other race 
situations where participants were more likely to congregate in numbers after the race, 
with a greater likelihood that someone with an URTI would infect a large number of 
fellow competitors. Consequently, the low rate of infection could have been due to lack of 
pathogens rather than any immune effect. 
This study did not confirm the finding from some of the studies referred to earlier 
that the incidence ofURTI after ultra-endurance runs increases with "pre-race" training 
distance (training volume) and race pace. Of the three subjects who presented symptoms of 
URTI in the two weeks after the CMR, one had the lowest and another had the second 
highest training volume. Among them were also the third fastest and third slowest 
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finishers. Because of the low number of subjects in this study, the significance of these 
findings is limited. 
It is not uncommon for runners in ultra-endurance events to take NSAID to reduce 
muscle soreness. Because it wasn't ruled out that these drugs could have an attenuating 
effect on (humoral) immunosuppression, subjects were asked to report NSAID taken 
during the CMR. Although it was observed that monocyte numbers were significantly 
lower (30%) after the CMR in the group ofNSAID takers, this result has to be treated with 
some caution. A wide range of drugs was taken, not all of which have the same anti-
inflammatory effects. Because of the present focus on drugs in sport, it is also quite 
possible that some subject did not admit to taking NSAID. A better-controlled study is 
therefore needed before any significance can be attached to this finding. 
A study of the relationship between s-IgA and URTI requires a large number of 
subjects because of the large biological variation of s-IgA. Therefore the number of 
subjects in this study was too small to look seriously at the issue of the incidence ofURTI 
and the statistical power for the reported measurements is low. However, the primary 
purpose of this study, which was to develop protocols for the collection, transport and 
storage of saliva sample, was achieved. 
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HYPERTHERMIA AND THE MUCOSAL IMMUNE 
RESPONSE TO LOAD CARRIAGE 
4.1 Introduction 
To be able to march long distances, whilst carrying heavy equipment is a 
fundamental aspect of soldiering. Heavy loads are common. Soldiers have been 
observed carrying loads of up to 81 kg on long-range patrols in the Pilbara (Lau et al., 
1999) and Armour Corp soldiers are required to carry loads of 61 kg over variable 
terrain for up to 5 km (personal communication, M. Paterson, DSTO Melbourne). 
Heavy load carriage has been shown to lead to an increased incidence of 
musculoskeletal injuries and increased metabolic cost (Knapik et al., 2004; Patton et al., 
1991). Very high levels of physiological and perceived strain have been reported by 
soldiers carrying modest loads in mildly heat-stressful conditions. In a study by Cotter 
et al. (2000), only 18 of 31 infantry soldiers who attempted to march 20 km with 35 kg 
total load finished and only half of these were within the 4 hours time limit. Forty eight 
of 51 soldiers were able to march 5 km in 55 minutes with a 20 kg load, which is 
considered relatively light. In both cases heat strain was-generally high to severe even 
though the environmental heat load was not considered high for the location 
(Townsville, Queensland; average temperature of27.5°C). 
Soldiers often carry loads in more extreme climatic conditions of heat and 
humidity (e.g. in the tropics). As discussed in section 1.7.4, this could contribute 
considerably to the physiological stress of exercise. Also to be considered is the 
problem of heat elimination, when full body cover, such as a Disruptive Pattern Combat 
Uniform (DPCU), is worn (Shephard, 1998). When fully clothed, the efficiency of 
evaporative cooling at the skin surface tends to decrease as the sweat accumulates in the 
clothing, saturates it and has to evaporate from the clothing surface. Once this point has 
been reached, further sweat secretion has little or no additional cooling effect (Aoyagi et 
al., 1997). Some of the sweat secreted during load carriage wi11 accumulate under the 
clothing because of the presence of a backpack. As this surface area is lost to the 
cooling process, the discomfort and heat stress associated with exercise increases and 
body temperature will increase. Not surprisingly, heavy training schedules, the carrying 
of 30-kg packs and the use of protective equipment, including clothing, has lead to 
many incidences of heat _illness among military trainees (Shephard and Shek, 1999b). 
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The first purpose of this study was to detennine whether soldiers marching with 
heavy loads would experience decreased mucosa} immunity, increased physiological 
and thermal strain, whether any changes would persist after completion of the exercise 
and whether mucosa} immunity is related to changes in theqnal strain or perceived 
thermal strain. The effects of exercise on mucosa! immune function were reviewed in 
section 1. 7. 
As load carriage is often performed in extreme heat and humidity, the second 
purpose of this study was to determine whether environmental conditions affect the 
changes in these variables. The effects of exercise in heat and humidity and immune 
responses to physical activity in a hot and humid environment have been reviewed in 
section 1.7.4. It has been proposed that part of the immunosuppressive response to 
exercise may be due to the elevation of body core temperature associated with exercise 
(Brenner et al., 1995). It was therefore anticipated that a combination of exercise and 
environmental stress could have an additive immunosuppressive effect and that the 
greater hyperthermia, as a result of increases in temperature and humidity, would induce 
greater immunosuppression. 
The third purpose of the present study was to investigate whether the baseline 
physiological variables of age, body mass, body composition or fitness (V02max) are· 
related to the changes in physiological strain, perceived thermal strain and mucosa] 
immunity. 
It was postulated that heavy load carriage in soldiers would result in temporarily 
decreased s-IgA secretion rates; that this immunosuppressive effect would be greater in 
the more stressful environmental conditions; and that the immunosuppressive effect 
would be greater in the unfit subjects and those with a higher body mass index. 
The effect of heavy physical work such as load carriage on soldiers' immune 
function is of particular interest to the Australian Defence Force (ADF) because it could 
have a direct effect on the health of their personnel and, therefore, their performance in 
the field. An infection resulting from immunosuppression in soldiers is likely to reduce 
performance and operational readiness, just as URTI in athletes may have a negative 
effect on their ability to compete optimally (Pyne, 1999). The information from this 
study will give the ADF an insight into the immunological response to a typical field 
activity and will provide information pertaining to the degree of adjustments in load 
mass and/or marching speed necessary to maintain operational effectiveness. This study 
also contributes further to the understanding of s-IgA as a potential biomarker to assess 
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mucosal immune function or as a predictor of excessive physiological strain and 
diminished performance, not only in soldiers but also in the general population. 
4.2 Methods 
This project was conducted in the Human Performance Laboratory at James Cook 
University, Townsville. Additional approval for this project was obtained from the 
James Cook University Human Research Ethics Committee. 
4.2.1 Subjects 
Seventeen apparently healthy male infantry soldiers from the 1 st Royal Australian 
Regiment (1 RAR), stationed in Townsville, Queensland, participated in this study. 
They were informed of the purpose, risks and benefits of their participation in the 
project and their decision to participate was entirely voluntary. 
4.2.2 Demographics, anthropometrics and fitness 
Subjects attended the laboratory for a 1-hr period in the morning in a rested state 
(i.e. no physical training or physical work was done prior to the assessment). They were 
familiarised with the experimental equipment and provided with a detailed explanation 
of the procedures to be used during the three subsequent trials. 
Anthropometric measures were obtained according to the guidelines of the 
International Society for the Advancement of Kinanthropometry (Norton and Olds, 
1996): height, body mass (BM), and nine skinfolds (triceps, sub-scapular, biceps, iliac 
crest, supraspinale, abdominal, front thigh, medial calf and mid-axilla) (Table 16). Body 
mass index (BMI), % body fat (BF%), body density (BD) were calculated using the 
LifeSize software (Olds and Norton, 2000). The mean BMI was in the "healthy weight" 
range as defined by the Australian National Heart Foundation 
(http://www.heartfoundation.com.au/, accessed 29/04/05). None of the subjects were 
"underweight" (BMI < 18.5) and 7 were "overweight" (BMI > 25). However, several of 
these were quite muscular and no-one had a BF% greater than 20%. 
Cardio-respiratory fitness, taken as the maximum rate of oxygen consumption 
(V02max), was assessed by an incremental exercise test on a motorised treadmill 
(Trackmaster, JAS Fitness System, Carrollton, TX, USA, or Quinton Q65, Quinton 
Instrument Company, Bothell, WA, USA) using open-circuit spirometry. After a 5-min 
warm-up, the test was initiated with a 2-min run at 11-14 km/h with subsequent 
increases of2% incline every 2 min until voluntary exhaustion. Expired gas samples 
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were measured continuously using a Cortex Metamax I gas analyser (Cortex Biophysik 
GmbH, Leipzig, Germany). Mixing chamber derived gas exchange data were averaged 
over 10-sec time intervals. Calibration was performed prior to each test according to the 
manufacturer's instructions. Heart rate was measured every 5 sec using a telemetric 
system (Polar Accurex, Polar Electro Oy, Kempele, Finland). V02max was defined as the 
highest 30-sec average recorded during the test. V02max was "average" to "excellent" 
for males 19 to 25 years old (Shvartz and Reibold, 1990). 
Table 16: Demographic, anthropometrical and fitness characteristics of the subjects 
Variable Mean±SD Range 
Age (years) 21.4± 2.0 19-25 
Body mass (kg) 78.8±9.0 64.7-98.8 
Height (m) 0.178 ± 0.006 0.164- 0.189 
BMI (kg·m-2) 24.7 ± 2.1 20.0-28.4 
Skinfolds (sum of9) (mm) 98.6± 30.3 53.5 -151.2 
% Body fat (BF%) 13.8± 3.9 7.6-19.4 
Body density (BD) 1.067 ± 0.009 1.055 - 1.082 
V02max (mL·min"1·kg-1) 53.7± 5.0 44.l - 63.6 
HRmax (bpm) 192 ± 8 175-203 
4.2.3 Exercise tests 
Subjects attended the laboratory on three occasions at the same time of day at least 
three days apart. In the 24-hr period prior to every trial they refrained from strenuous 
physical activity, ate a diet high in carbohydrates and drank at least 1 litre of water 
before going to bed the night before. In the 12-hr period prior to the trial they abstained 
from nicotine, alcohol and caffeine ingestion. 
The subjects were tested using the ADF's Combat Fitness Assessment (CF A) 
protocol which requires soldiers to march a set distance at a prescribed pace with a 
requisite set of equipment. Three subjects were tested simultaneously on three 
motorised treadmills positioned in a custom built climate controlled chamber. On each 
occasion, subjects completed a two hour marching trial at a fixed speed of 4.2 km·h-1 on 
a level treadmill. 
Subjects carried 50 kg(± 0.05 kg) of equipment, comprised ofDPCU, combat 
boots (~3.5 kg), weapon (~3.5 kg), webbing (~12 kg), loaded pack (~31 kg), and several 
pieces of body-function monitoring equipment which was not uncomfortable and did 
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not interfere with the marching activities ( < 1 kg). Unloaded walking at a speed of 4.2 
- km-h-1 is a moderate intensity activity, equating to 3-3.3 METS (Ainsworth et al., 1993; 
Ainsworth et al., 2000). 
Trials were terminated if one of the following criteria was attained: completed 2 hr 
of walking; heart rate exceeded 90% of the subject's maximum heart rate for 3 minutes; 
body core temperature reached the safe maximum level (39.5°C); the subject indicated 
their desire not to continue (e.g. due to discomfort or fatigue), felt nauseous or became 
disoriented; or at the discretion of the investigators due to concern for the subject's 
welfare. 
4.2.4 Environmental conditions 
The three marches were done in a random order in three different environments: 
temperate (T), hot-dry (HD) and hot-wet (HW). These conditions are typical of those 
encountered in areas of northern Australia where combat-ready troops operate (Table 
17). 
Table 17: Environmental conditions during the temperate, hot & dry, and hot & wet 
marches 
Temperature (0C) Temperate (T) Hot & Dry (HD) Hot & Wet (HW) 
DB: Dry bulb 
(ambient) temperature 
GB: Globe 
temperature 
'WB: Wet bulb 
temperature 
WBGT*: Wet Bulb 
Globe Temperature 
19.6 ± 0.9 (17.6- 23.7) 
20.9 ± 0.9 ( 19.4 - 23.7) 
14.4 ± 0.6 ( 13.0 - 16.2) 
16.2 ± 0.7 (14.8 -18.4) 
28.5± 1) (25.1-31.4) 
29.6 ± 0.9 (27.3 -31.9) 
20.4 ± 1.0 (17. 7 - 23.5) 
23.0± 0.9 (20.6- 25.8) 
* WBGT = 0. IDB+ 0.2GT + 0.7 WB. All data are mean± SD (range) 
30.2 ± 1.2 (27.3 - 33.6) 
31.0 ± 1.2 (28.3 - 33.9) 
25.9 ± l'.3 (22.5 - 30.3) 
27.4 ± 1.2 (24.2 - 33.3) 
Environmental conditions were monitored by a heat stress monitor (MS3700, 
Metrosonics, Oconomowoc, WI, USA), composed of three thermometers: a wet bulb for 
humidity determination, a globe (black ball) measuring radiation and a thermometer 
measuring the temperature. It allows the calculation of the Wet Bulb Globe 
Temperature (WBGT) as a measure of humidity, temperature and radiation. Air-
movement, matched to walking speed, was generated by electric fans (Pedestal Air 
Circulator 81 Omm diameter blade, FanQuip, NSW, Australia), and heat radiation, 
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provided by infra red lamps, was held constant at 500 Watts/m2 by a solar radiation 
sensor (Pyranometer SRl,-Kipp & Zonen, Netherlands). 
4.2.5 Saliva collection and analysis 
Subjects provided a 2-minute timed saliva sample (baseline) during the 
preliminary visit, at the start and end of each trial, and 45 min after each trial. Samples 
were collected, stored and analysed according to the procedures recommended in 
Chapter 2. All sampling was supervised by the investigators. At the end of the project 
all frozen samples were transported from Townsville to Scottsdale (Tasmania) packed 
in dry ice. Samples for each environment were analysed in one batch. S-IgA is 
expressed as secretion rate and ratio to osmolality. 
4.2.6 Fluid loss assessment 
Subjects began each trial in a euhydrated state. Nude body mass (BM) was 
obtained at the start and end of each trial. Hydration status was assessed at 30-min 
intervals by determination of changes in BM. Subjects stoped walking for 
approximately 1 min when BM was assessed. They were re-hydrated during the trial at 
15 min intervals to match fluid losses. Considering some sweat was absorbed in the 
clothing and equipment, not all fluid lost was replaced during the trial. Subsequently 
any residual dehydration evident at the end of the trial was eliminated by replacement of 
fluid equal to 120% of that lost before leaving the laboratory. Subjects also donated a 
urine sample before and after each trial, to further estimate dehydration levels from the 
volume and density of urine. 
Measurement of urine osmolality would have provided a more accurate 
assessment of hydration status. A better measurement of fluid loss would also have.been 
provided by the haematocrit of the subjects. However no blood samples were obtained 
to achieve this. This was a minor flaw in the design of the study. 
4.2. 7 Physiological measurements 
Energy expenditure (metabolic rate) was estimated by calculating oxygen 
consumption during marching. Expired air was sampled through a half-face-mask for 5-
minute periods at 30 min intervals during the trial and analysed for oxygen, carbon 
dioxide and flow rate in a Cortex MetaMax, gas analyser. 
Subjects were monitored continuously for physiological markers of heat-related 
strain. Core body temperature (Tcore) was measured at I min intervals using gastro-
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intestinal radio pills that were swallowed at least 2 hours before the start of work (Pill 
sensor: HQinc, USA, Logger: BCTM4, Fitsense, MA,-USA). Pills were not recovered 
after use. Heart rate was measured at 1 min intervals, using a sealed transmitter (Polar 
Accurex, Polar Electro Oy, Kempele, Finland), strapped to the subjects' chest. After 
/ 
completion of each trial, subjects were monitored until core temperature had returned to 
within 0.4°C of the resting, pre-trial baseline (36.6-37.5°C). 
4.2.8 Psychophysical measurements 
· Perceptions of effort and thermal strain were recorded at 10 min intervals. 
Subjects rated their perceived work intensity using Borg's 20-point Rate of Perceived 
Exertion (RPE) scale (ranging from "no exertion at all" to "maximal exertion") (Borg, 
1982). Body temperature was rated on a 13-point thermal sensation scale (ranging from 
"l - unbearably cold" to "13 - unbearably hot") and a 5-point thermal discomfort scale 
(ranging from "l - comfortable" to "5 - extremely uncomfortable") (Gagge et al., 1967). 
Because the validity of these assessment instruments relies on the compliance of the 
subjects and the accuracy of their answers, test subjects were thoroughly briefed on their 
proper use and it is assumed that they were honest in their evaluation. 
4.2.9 Data ana/ysi$ 
Outliers in the saliva data were removed according to Reed's criterion, as 
previously explained. Normality of the raw data was tested by the Kolmogorov-
Smirnov test of normality and by coefficients of skewness and kurtosis. Descriptive 
statistics for normally distributed data are reported as mean± SD. Non normally 
distributed data were transformed by natural logarithm (In) and analysed parametrically, 
or alternatively a non-parametric test was used. Descriptive statistics of these data are 
reported as the geometric mean with back-transformed 95% confidence intervals. 
The effect of time and environment was evaluated by repeated measures analysis 
of variance (ANOV A). Lack of sphericity of data was corrected by the application of 
the Huynh-Feldt epsilon (e) coefficient. Post-hoe analysis of the effect of the 
-environmental conditions was performed by multiple comparisons with Least 
Significant Difference (LSD) adjustment. Differences in variables between sampling 
times or between corresponding sampling times during the three environments were 
assessed by paired samples t-test or by Wicoxon signed ranks test. To test correlations 
between predictor and response variables, the Pearson's correlation coefficient was 
used. For all tests, P < 0.05 was considered statistically significant. 
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4.3 Results 
Of the 17 subjects, 15 did the T march, 16 the HD march, and 15 the HW march. 
Only twelve subjects completed all three marches. On several occasions subjects 
stopped prematurely because of extreme discomfort (T - 1 case; HD - 2 cases; HW - 2 
cases) or because their heart rate was above their theoretical maximum for 3 minutes 
(HW - 1 case). Partial data from these subjects have been included where appropriate 
4.3. 1 Physiological variables 
Physiological data are summarised in Table 18 and Figure 10. The change in body 
mass (BM) corrected for fluid intake and micturition, was significant (P < 0.001) in all 
three environments. All subjects lost BM during each trial with the exception of three 
subjects who gained some BM (:S 0.2 kg) during T. The BM loss after HW was greater 
than after T (P < 0.05). There were no changes in the urine specific gravity f<?r any of 
the three marches. Fluid intake was greater during HW than during T (P = 0.045) but 
there was no difference between T & HD, and between HD & HW. 
Table 18: Physiological measurements in three different environments 
Temperate Hot& Dry Hot& Wet 
Variable 
(N = 15) (N = 16) (N = 15) 
Change in body mass Gross (kg) 1.60± 0.65 2.14± 0.93 2.83 ± 0.51 
(BM) Absolute (kg)# 0.36±0.63 0.91±0.73 1.39 ± 0.40 
Relative (% of pre-test 
0.51 ±0.94 1.16 ± 0.99 1.74± 0.48 
body mass)# 
Urine specific gravity 1.018± 1.016± 
Pre-test 1.015 ± 0.008 
0.008 0.006 
LOIS± 1.013 ± 
Post-test 1.022 ± 0.024 
0.007 0.007 
Fluid intake (mL) 1206±203 1231±373 1437 ± 280 
Body core temperature Start of march 37.2 ± 0.3 37.1±0.3 37.2± 0.2 
(Tcore) (0 C) End of march 37.5 ± 0.4* 37.8 ± 0.5* 38.6 ± 0.5* 
Heart rate (HR) (bpm) Start of march 83± 14 87± 13 82± 12 
End of march 116 ± 9* 133 ± 15* 159 ± 14* 
0/o ofHRmax 61 ±6 69±9 84± 8 
Relative energy Early in march (10 min) 36.0± 5.9 36.3 ± 6.0 36.2±4.7 
expenditure 
End of march 38.2± 5.1 * 39.7±5.6* 44.3 ± 5.6* 
(% ofV02maxl 
*Significantly different from "start of march··. #Change in body mass corrected for fluid intake and 
micturition. All data are mean± SD. 
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The mean body core temperature (Tcore - Figure lOa) was identical at the start of 
all three trials. There was a significantly effect of time (F25,747 = 48.71; P < 0.001) and 
interaction of time and environment (F5 o,149 5 = 16.58; P < 0.001) on Tcore· During the T 
and HD trial, Tcore increased in the first 20min or 30min respectively, and then remained 
constant, whereas Tcore gradually increased throughout the HW trial. There was no 
difference in Tcoreat any time between the T and HD trials but during the HW trial Tcore 
was higher than during T and HD after 40min. 
0 39.51 
0 I 
- I Cl) I 
"-
I 
* ::::I 38.5 #3 .... #2 
* CU 
"-Cl) 
c. 
E 37.5 Cl) 
.... 
Cl) 
"-0 
0 36.5 
* 
0 20 40 60 80 100 120 
Time (min) 
a 
180 
-E 1.60 
c. * * * 
* 
* 
.c 
- 140 Cl) 
.... 
CU 
"-
t:: 
120 
n:s 
Cl) 100 ::c 
80 
0 20 40 60 
Time (min) 
80 100 120 
b 
Figure 10: Changes in core body temperature (a) and heart rate (b) as a result of a 2 
hour march in temperate (+), hot & dry(•) and hot & wet ( '1.) environments. * 
indicates a significant (P < 0. 05) change from the previous measurement. The start of 
significant differences (P < 0. 05) between the T and HD, T and HW, or HD and HW 
conditions, which were sustained for the remainder of the trials, are indicated by #1, 
#2, and#3. 
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The mean heart rate (HR - Figure 1 Ob) was identical at the start of all three trials. 
HR increased significantly over time (F2_8,105 2 = 194.01; P < 0.001) and the increase in 
HR was highest in the HW environment (F57 ,2104 = 23.54; P < 0.001). Apart from a 
sharp rise in the first 10 minutes, heart rate remained constant during the T trial but 
there was a significant cardiac drift during the HD trial and even more so during the 
HW trial. After 120min, heart rates were 61 % (T), 69% (HD) and 84% (HW) of the 
subjects' maximum. Indicative of the increased severity of the HW trial was that several 
subjects showed distress towards the end and one subject was stopped early because his 
heart rate exceeded 90% ofHRmax for over 3 minutes. 
Relative exercise intensity, expressed as a percentage of the subjects' V02max, was 
identical at the beginning of each trial but had increased by the end in all three (P < 
0.05). There was no difference between the relative energy expenditure during T and 
HD but it was higher during HW (P < 0.01). At the end of the trials, V02 was 38.2% 
(T), 39.7% (HD) and 44.3% (HW) of the subjects' V02max· · 
4.3.2 Psycho-physiological variables 
Physiological data are summarised in Table 19. Ten minutes into each of the trials, 
the RPE ranged from "very, very light" to "somewhat hard". There was a significant 
effect of time (F2 6,96 6 = 33.24; P < 0.001) and interaction oftime and environment 
(Fs 2,193 2 = 3.68; P = 0.006) on RPE. By the end of each trial, RPE had increased (P < 
0.005), although there was no difference between T ("very light" to "somewhat hard") 
and HD ("very light" to "hard"). HW ("very light"" to "very, very hard") was perceived 
to be harder at the end (P = 0. 001) than the other t\vo. 
From the start, thermal sensation during HW ("cool" to "slightly warm") was 
higher (P = 0.028) than during T ("cool" to "neutral") but not during HD ("cool" to 
"slightly warm"). Thermal sensation increased gradually during all three trials (P < 
0.05) and by the end was different for all three (P < 0.005) (T - "cool" to "warm"; HD -
"neutral" to "hot"; HD - "warm" to "extremely hot"). 
At the start of each trial, thermal comfort was "comfortable" for all subjects. 
During T it remained unchanged, whereas during HD ("comfortable" to "very 
uncomfortable") and HW ("comfortable" to "extremely uncomfortable"), it had changed 
(P < 0.01) by the end and was different between all three trials (P < 0.05). 
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Table 19: Psycho-physiological measurements in three different environments 
Temperate Hot& Dry Hot& Wet 
Variable 
(N= 15) (N = 16) (N = 15) 
RPE Early in march (10 min) 9.7±1.9 10.5 ± 1.5 10.5 ± 1.6 
End of march 11.4± 1.3* 12.4± 2.0* 14.5 ± 2.8* 
Thermal sensation Start of march 5.7± 0.9 6.2 ± 1.3 6.9 ± 1.1 
End of march 6.9± l.4* 9.0±0.8* 10.3 ± 0.8* 
Thermal comfort Start of march 1.0± 0.0 1.0 ± 0.0 1.0 ± 0.0 
End of march 1.1±0.4 1.8 ± 0.9* 2.5 ± 1.3* 
* Significantly different from "start of march" or "early in march". 
There was little evidence that body composition (body mass, height, BMI, % body 
fat, skinfolds, and waist:hip ratio) and fitness (V02max) are good predictors of perceived 
heat strain and effort (Tcore, HR, relative V02, RPE, thermal sensation, and thermal 
comfort) as there were few significant correlations between these variables for all 
environmental conditions. Those that were significant are shown in Table 20. 
Interactions between predictor variables were not considered in the data analysis. 
Table 20: Significant correlations between body composition or fitness and perceived 
strain or effort at the end of 2h of load carriage 
Predictor variable 
Body mass 
Height 
% Body fat 
Skinfolds (sum of9) 
4.3.3 Salivary /gA 
Response variable 
at the end of 2 hours 
of load carriage 
Tcore 
HR 
Thermal sensation 
Tcore 
HR 
Thermal sensation 
Thermal sensation 
Thermal comfort 
Thermal comfort 
RPE 
Environment Pearson's r p 
HD - 0.645 0.007 
HD - 0.548 0.042 
HW 0.527 0.043 
HD - 0.787 < 0.001 
HD - 0.564 0.036 
T 0.598 0.019 
HW 0.638 0.011 
T - 0.559 0.030 
T - 0.518 0.048 
T 0.584 0.028 
Based on samples obtained during the preliminary visit, the group means (± SD; 
median) of the s-lgA secretion rate was 122 (± 70; 100) µg·min- 1 and s-lgA:osmolality 
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ratio 3.1 (± 1.8; 2. 7) mg·m0smor1• These baseline values are different to the three pre-test 
values on the three testing days as listed in Table 21. There is ample evidence in the literature 
(and this was confirmed by the present study) of the very large variability in s-IgA. The 
difference in baseline values and pre-test values can be explained by this normal within-subject 
variation between resting values on the various testing days. 
Table 21: Changes in saliva flow rate and s-IgA during a two hour march in three 
different environments 
Variable Time Temperate Hot& Dry Hot& Wet 
Saliva flow rate Pre-test 0.71±0.30 0.71 ±0.29 0.71±0.26 
(ml·min·1) Post-test 0.69± 0.31 0.57±0.24 0.47 ± 0.25* 
45 min recovery 0.68 ± 0.32 0.67±0.29 0.60 ± 0.31 
ANOV A results F2•28 = 0.122; F2•3o = 2.424; F 2,28 = 6.932; 
P=0.886 P=0.106 P=0.004 
s-IgA secretion Pre-test 149.9 ± 66.I 205.6 (155.9- 270.3) 203.5 ± 101.8 
rate (µg·min- 1) Post-test 146.2± 82.6 168.5 (112.0-253.4) 83.0± 47.2 * 
45 min recovery 166.4 ± 69.8 185.6 (143.8 - 239.3) 139.8 ± 78.0 * 
ANOV A results Fi.26 = 0.506; F2,3o = 0.781; F1 6,zo 3 = 11.569; 
P=O. 609 P=0.467 p = 0.001 
slgA:osmolality Pre-test 2.5 ± 1.2 6.4± 3.4 4.0±2.2 
ratio Post-test 2.3 ± 1.0 4.6±2.6 1.6± 0.9* 
(mg·m0smor1) 45 min recovery 2.8 ± 1.0 5.0±2.3 3.0± 1.3* 
ANOV A results F1 J,1s o = 0.964; 1'2.3o = :u 1 Y; F1 4,16 s = 10.840; 
P= 0.363 P=0.059 p = 0.002 
Data are represented as mean± SD for normal distributions of data or as geometric mean (95% 
confidenc~ interval) if data were not normally distributed.* Significant difference with pre-test value (P 
< 0.05). 
The changes in s-IgA secretion rate and s-IgA:osmolality ratio during the various 
trials are summarized in Table 21 and Figure 11 and individual data are presented in 
Appendix E. Several outliers were removed using Reed's criterion (3 for s-IgA 
secretion rate, and 4 for s-IgA:osmolality ratio). There were no changes in s-IgA 
secretion or s-IgA:osmolality ratio as a result of the march in the temperate and hot & 
dry environments. However, both were lower at the end of the march in hot & wet 
environment and had not recovered 45min later. 
84 
Temperate 
0 12 
E (3 
E 9 
c;, 
.s 
;!;' 
n; 
0 
E 
.,, 
0 
<i. 
.2' 
Temperate 
$ 
.;, 0 +-------r-----..------, 
Pre-exercise End of exercise 45 min recovery Pre-exercise End of exercise 45 min recovery 
Hot & Dry Hot & Dry 
12 
9 
3 
O -l-------r-----~----~ 
Pre-exercise End of exercise 45 min recovery Pre-exercise End of exercise 45 min recovery 
500 
.2 250 
e 
(.) 
~ 
<{ 
.2' 
.;, 
Hot &Wet 
O +-----~-----~----...., 
Hot &Wet 
12 
* 
Pre-exercise End of exercise 45 min recovery Pre-exercise End of exercise 45 min recovery 
a b 
Figure 11: Changes in s-lgA secretion rate (a), and s-lgA :osmolality ratio (b) as a 
result of a 2 hour march in temperate, hot & dry and hot & wet environments. There 
were no significant changes in any of the variables as a result of the march in the 
temperate and hot & dry environments. S-lgA secretion rate and s-IgA:osmolality ratio 
were lower at the end of the march in hot & wet environments and had not recovered 
45min later (* P < 0. 05, difference with pre-exercise value) . The presentation of data is 
similar to that of Figure 5 in Chapter 2. 
The fitness level (V02max) of the subjects was not a good predictor of baselines-
IgA or changes in s-IgA measures from pre- to post-test. Likewise, baseline s-IgA was 
not a good predictor of an individual's response to exercise o r perception of work (Tcore, 
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HR, relative V02, RPE, thermal sensation, and thermal comfort). Finally, an individual's 
response to exercise or perception ofw-0rk was not a good predictor of post-test s-lgA 
or changes in s-IgA. Only the few significant correlations between fitness or metabolic 
response and immune status are shown in Table 22. 
Table 22: Significant correlations between fitness levels (V02max), response to exercise 
and perception of work (Tcore, HR, relative V02, RPE, thermal sensation, and thermal 
comfort) at the end of2h ofload carriage and post-test s-IgA or changes in s-IgA 
Predictor variable Response variable Environment Pearson's r p 
V02max Change in s-IgA osmolality T 0.570 0.042 
Relative V02 Change in s-IgA secretion rate HD - 0.535 0.033 
Thermal comfort Change in s-IgA secretion rate HD - 0.507 0.045 
Relative V02 Change in s-IgA secretion rate HW - 0.548 0.043 
HR Post-test IgA:osmolality ratio HW - 0.761 0.011 
4.4 Discussion 
Core body temperature, relative energy expenditure, heart rate, thermal sensation, 
· and perceived exertion all increased during each of the load-carriage marches. Thermal 
comfort decreased during the HD and HW marches only. The change in Tcore, relative 
energy expenditure, and perceived exertion was similar in the temperate and hot dry 
conditions. There was strong evidence that the increase in all factors was greatest for the 
hot-wet environmental condition. All of these findings are in accordance with well 
documented responses to exercise in general and more specifically to exercise in 
extreme environmental conditions (Gagge et al., 1967; Sutton, 1994). 
There was no evidence that marching at 4.2 km·h-1 with a 50 kg load in temperate 
or hot dry conditions altered the mucosa) immune function of fit well-trained male 
soldiers. However, when these soldiers undertook this activity in a hot-wet environment 
there was strong evidence for a decline in mucosa) immune function (36% for s-lgA 
concentration, 59% for secretion rate and 60% for s-lgA:osmolality ratio by the end of 
the march). It appears that the added stress of the hot wet environment resulted in 
suppression of these measures of mucosa} immunity in fit, well trained soldiers. As the 
study design did not examine the ability of the mucosa] immune system to respond to 
pathological challenge, the results reflect that these parameters were suppressed and not 
mucosal immunity per se. 
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The s-IgA secretion rate and s-IgA:osmolality ratio remained low 45min after the 
completion of the HW march. Several previous studies have shown-that s-IgA levels 
return to resting levels within one hour of cessation of exercise (Cameron and Priddle, 
1990; Ljungberg et al., 1997; McDowell et al., 1992a). However, as no further samples 
were obtained, it was impossible to establish the period needed for full recovery. 
This study differs from previous investigations into the effect of environment on 
mucosa! immunity (Housh et al., 1991; Laing et al., 2005; Pacque, 2001). A previous 
experiment conducted by the author (Pacque, 2001 ), which recruited less fit Army 
Reserve soldiers in Launceston, Tasmania (mean daily maximum temperature 16.9 °C; 
mean 9 am relative humidity 65%; - http://www.bom.gov.au/weather/tas/IauncestonL) 
provided evidence that mucosa! immune function was adversely affected by 2h of Ioad-
carriage at 5km·h-1 with a 20kg load in both cool-dry (19°C; 51 % RH) and hot-wet 
(28°C; 80% RH) environments. However, there was no difference between the two 
conditions. In another study, s-IgA secretion rate decreased equally after 2h of 
stationary cycling at 63% ofV02max in both a hot (30.0°C; 76% RH) and temperate 
(20.4°C; 60% RH) environment (Laing et al., 2005). Neither was there a significant 
temperature effect on s-IgA concentration after a 30-minute treadmill run at 80% of 
V02max in temperatures of approximately 6, 19, and 34°C (Housh et al., 1991). The 
usefulness of this last study is limited as only a change in s-IgA concentration was 
reported. This reflects hydration status and the effect of the exercise on saliva flow rate 
rather than on any effect on s-IgA production and secretion (Mackinnon, 1999b). 
There are several possible reasons why the results of this study differ from 
previous experiments. The participants in this study were well-trained soldiers (above 
average aerobic fitness). The fitness level and the "training history" of subjects might 
affect changes in s-IgA as a result of exercise (Gleeson et al., 2004; Francis et al., 
2005). The aerobic fitness of subjects in this study (V02max: 53.7 ± 5.0 mL·min-1·kg-1) 
closely matched those of Housh et al (51.3 ± 4.5 mL·min-1·kg-1) but was lower than 
those of Laing et al (62.2 ± 2.4 mL·min-1·kg-1). While their V02max was not correlated 
with baseline s-IgA or changes in any of the s-lgA measures from pre- to post test, it is 
possible that their high level of fitness and familiarity with this type of exercise 
influenced the results. Load carriage is an important component of their regular physical 
training. 
It was not recorded how long the subjects had been stationed in Townsville and 
thus it is not known to what extent they were acclimatised to the local climate which is 
often hot and humid (mean daily maximum temperature 28.8 °C; mean 9. am relative 
87 
humidity 67%; - http://www.bom.gov.au/weather/gld/townsvilleD. The lack of 
infonnation on prior acclimation to the hot environment is a serious limitation of this study. It 
is possible that any immunosuppressive effect in extreme environments is affected by 
the degree of acclimatisation. This might have influenced the results and could explain 
why the subjects in this study were less immunosupressed in the T and HD conditions. 
The degree of acclimatisation possibly also contributed to the variability in results 
between individuals. A subsequent experiment investigating the effect of fitness and 
acclimation to heat and humidity seems warranted. 
Several methodological limitations of this study may have affected the results. It 
was recommended that saliva samples collected for comparative purposes should be 
collected at the same time of day (Chapter 2). Although this was achieved for each 
individual subject in this study, this was not possible for the group as a whole. The 
small sample size (N = 17), combined with the large biological variation of s-IgA, 
meant that the power of the statistical tests was low and this might have limited the 
ability to detect real differences. 
The median baseline measurements were in the lower half of the reference 
intervals established in Chapter 2 (Table 10). Although it is possible that regular 
physical activity had an effect on both the resting s-lgA and on its response to the load 
carriage exercise, too little data was collected to substantiate this suggestion. Results of 
past research are equivocal. Regular exercise had a cumulative suppressant effect on 
resting s-lgA concentration in elite cross-country skiers (Tomasi et al., 1982) and in 
Russian Olympic athletes (Levando et al., 1988). Conversely, resting s-lgA was higher 
in trained rowers than in non-athletes (Nehlsen-Cannarella et al., 2000) and in a group 
of elite swimmers compared to a moderately exercising control group (Gleeson et al., 
l 999a). Other authors, however, have found no difference in resting s-IgA between 
competitive cyclists and age matched untrained control subjects (Mackinnon et al., 
1987). It seems that some cumulative changes in mucosa! immunity may occur after 
extended periods of moderate to intense regular exercise. This means that it cannot be 
excluded that the acute s-lgA changes observed in this study were influenced by the 
somewhat lower resting s-IgA levels resulting from chronic immunosuppression 
(Nieman, 1997). However, as only one baseline sample was collected for each subject, 
and in view, of the fact that s-IgA generally displays a large biological variation, this 
suggestion requires further investigation. The collection of a larger number of 
"baseline" s-lgA measurements for each subject would be necessary to confirm if it has 
a predictive effect. 
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Various mechanisms could possibly explain the observed "hot-wet" effect. By 
increasing the environmental stress (heat and humidity), the marches were progressively 
made more demanding physiologically. This was substantiated by the various psycho-
physiological measurements and by differences in energy expenditure, heart rate 
response and core body temperature. The RPE and thermal sensation were generally 
higher in the HW environment from the start and the ratings of thermal comfort from 
the halfway point. At the end of the trials, the RPE was higher in the HW environment 
than in the other two. Thermal sensation and thermal comfort were also rated higher 
with increasing environmental stress. Several subjects exhibited distress in the final 
stages of the HW trial: four subjects found the effort "very hard" or above on the RPE 
scale with one of them also feeling "extremely uncomfortable" and "extremely hot". 
The various physiological measures concurred with the psycho-physiological data. 
The increase in environmental stress resulted in an increasingly higher average energy 
cost of walking. Average oxygen consumption at the end of the trials was 38.2% (T), 
39.7% (HD) and 44.3 % (HW) ofV02max· There was also a significant cardiac drift 
during the HD trial and even more so during the HW trial with heart rates 61 %.(T), 69% 
(HD) and 84% (HW) of the subjects' maximum at the end of the trials. 
The more severe environmental conditions during the HW trial resulted in greater 
hyperthermia. During the T and HD trials, Tcore remained relatively unchanged after an 
initial rise, whereas during the HW trial it rose gradually to 38.6 °C (± 0.5 °C), with two 
subjects exceeding 39 °C by the end of the trial. It has been proposed that moderate 
hyperthermia (3 7°C < body temperature < 40°C) enhances the immune system; 
however, beyond the "therapeutic range" ofhyperthermia, immune function becomes 
compromised (Brenner et al., 1995). The greater decline in s-lgA in the HW 
environment in this study confirmed that this is to some extent the case for the mucosal 
immune system. 
It is possible that some of the changes in s-lgA were temperature-induced 
(Brenner et al., 1995) because some of the effects ofhyperthermia on the immune 
system are similar to the changes observed in exercising subjects (Hoffman-Goetz and 
Pedersen, 1994; Shephard and Shek, 1999b ). However, as studies on the effects of 
exercise on s-lgA rarely recorded changes in Tcore, there is little evidence to substantiate 
this claim. The design of the present study made it also impossible to separate the 
individual effects of the physical activity and hyperthermia and it is impossible to 
conclude that it was the sole cause. 
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One other factor that could have contributed was the increased psychological 
stress as the environmental conditions became more taxing. The subjects' ability to cope 
psychologically with the load and the heat and humidity was probably important. As 
psychological stress has been found to result in changes in mucosa} immunity, it is 
likely that there was an additive response to the combined stimuli ofhyperthermia, 
physical activity, and mental stress. This is possibly mediated by changes in the 
endocrine system, i.e. an increase in the blood concentration of stress hormones 
(Hoffman-Goetz and Pedersen, 1994; Kappel et al., 1997; Kappel et al., 1991). While a 
minimum increase of body temperature might be needed to initiate a significant 
temperature-induced stress hormone response (Hoffman-Goetz and Pedersen, 1994), it 
is possible that the heat exposure in the HW environment in this study was above the 
threshold needed or at least magnified the response. More well designed studies are 
necessary to separate the individual effects of psychological stress, exercise and 
hyperthermia on s-IgA. 
There was no evidence that body composition or fitness are good predictors of 
perceived heat strain and effort during load carriage in a :fit and healthy population. This 
might not be the case in a population group where there is greater variability in fitness level and 
body composition measures. It was assumed that the fitter and/or "bigger" subjects would 
cope better with the load, but not necessarily with the heat and humidity. This was not 
consistently observed across the three environments. Neither was there any evidence 
that fitness is a good predictor of resting s-IgA secretion rate or changes in s~lgA 
secretion rate as a result of load carriage. Finally, there was no evidence that resting s-
IgA secretion rate would be useful as predictors of a person's perception of work in any 
environment. Because of the inconsistent findings, it is possible that the few significant 
correlations in Table 21 and Table 22 could have occurred by chance rather than-being 
indicators of real associations. 
As the interpretation of the data in this chapter is based on group means, this can overlook 
important information when individual subjects are assessed. As shown in the table with 
individual results (Appendix E), a considerable within-subject and between-subjects 
variability in s-IgA responses was observed. For instance, changes from pre-test to post-
test s-lgA secretion rate varied between a 93% decline to a 58% increase for the HW 
environment. Of the 12 subjects who completed all three marches, only a few responded 
consistently, showing either a decline or an increase in s-lgA levels in all three 
environments (2 for s-IgA secretion rate; 4 for s-IgA:osmolality). The reason(s) for the 
considerable variability in s-lgA responses found in this and other studies remain to be 
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clarified. None of the factors, such as psychological stress, nutrition, and improper 
hygiene that have been associated with immunosuppression (Nieman, 1997) were 
controlled for in this study. Individual differences could also be due to different 
endocrine responses to exercise at various temperatures (Housh et al., 1991). The 
findings of this study do not support the suggestion that differences in fitness might 
account for the range of responses (Mackinnon, 1996) as no correlations were found 
between the aerobic fitness (V02max) of the subjects and their resting s-IgA or s-IgA 
changes. 
In summary, the present work identified a transient decrease in mucosal immunity 
and increased stress in response to two hours ofload carriage in a hot-wet environment. 
It is recommended that soldiers involved in militruy training and military operations in similar 
conditions are regularly monitored for excessive signs of fatigue and dehydration, 
which could compromise their physiological and cognitive performance. Although there 
could be a degree of extra risk of infection associated with the type of 
immunosuppression observed in this study, it is doubtful that s-IgA is a suitable marker 
for regular monitoring of mucosa) immune function. 
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SALIVARY IgA, MILITARY TRAINING AND 
OVERTRAINING SYNDROME 
5.1 Introduction 
The Army Recruit Training Centre (ARTC) is located at Blarney Barracks, 
Kapooka, near Wagga Wagga in New South Wales. The primary role of the ARTC is to 
provide basic training for new recruits for the Regular Army and the Army Reserves of 
the Australian Defence Force (ADF). The 45-day Army Common Recruit Training 
(ACRT) course is essentially the same for male and female recruits and involves 
activities ranging from 40-minute lessons (sit-down classes, weapon handling and 
firing, first aid, drill, navigation, communication, physical training sessions and field 
craft) to longer training sessions in the field. Some of the more arduous activities are 
marches in full combat gear and bayonet drills. Training is conducted continuously over 
the 45 days with most days commencing at 06:00 h and finishing at 22:00 h. The ACRT 
culminates in a 3-day field exercise called "Exercise Dusty Warrior" (EX DW - days 
39-41) followed by "The Challenge" (day 42), lasting 5Yz hours (6 am to 11 :30am). 
During these exercises, the recruits' stamina, determination and ability to work in a 
team and their ability to put all the field craft skills they have learnt into practice is 
tested. The ACRT course is both physically and psychologically demanding, leaving 
recruits with very little time to recover from training and relax. All activities, including 
personal recreational time, are scheduled rigorously so that the demanding requirements 
of the course can be met within the 45-day timeframe. Recruits often face a variety of 
stressful situations. These can be caused by any number of factors such as injury, the 
very full time table, the limited personal time and privacy, the pressure to perform; a 
bad relationship with superiors, etc. Not surprisingly, most recruits require long 
recovery times after physically demanding activities and have difficulty remaining alert 
during classroom based lessons. Some recruits fail to complete the course because of 
choice, stress, illness or injury. 
Overtraining syndrome (OTS) is a condition often used to describe athletes 
suffering from prolonged fatigue and impaired athletic performance. It could possibly 
also occur in response to demanding training or workloads in population groups such as 
army personnel. As OTS has previously been associated with inimunosuppression 
(Budgett, 1990) and a high rate ofURTI in athletes (Fitzgerald, 1991), the first aim of 
this study was, therefore, to assess ifthere were changes in mucosa] immunity during 
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the ACRT course and if these were related to an increase in the incidence ofURTI. An 
overview of the relationship between salivary lgA and the susceptibility to URTI can be 
found in section 1.5 and section 1.8.3 deals with the association of OTS with changes in 
salivary lgA and susceptibility to URTI. There is also some evidence that s-IgA is 
suppressed in athletes during prolonged periods of intense exercise training leading to 
OTS. For instance, among 14 elite swimmers over a 6-month season, s-lgA levels were 
lower in overtrained swimmers compared with those who did not show signs of 
overtraining (Mackinnon and Hooper, 1994). As there is possibly an increased risk of 
URTI among endurance athletes, and a dose-response relationship between training 
volume and incidence ofURTI, it appears that both OTS and URTI could result from a 
common cause: excessive training with insufficient rest and possibly a lack of variety in 
training. Because the recruits at the ARTC are engaged in a six-week intensive training 
program, and as there was anecdotal evidence from the instructors and officers at the 
ARTC that the demands of the ACRT course cause many recruits to suffer from various 
manifestations of fatigue, it was postulated that recruits could be susceptible to OTS. 
This study was part of a much larger study conducted by the Defence Science and 
Technology Organisation (DSTO) investigating if army recruits display symptoms of 
overtraining. The larger study was the subject of a DSTO report (Skiller et al., 2005b) 
and a journal article in "Military Medicine" (Booth et al., 2006). The purpose of this 
study was not to investigate if soldiers showed any symptoms of OTS. The question this 
study aimed to address was whether s-lgA would be a potential alternative marker of 
overtraining syndrome. An overview of the various markers that have been associated 
previously with OTS is presented in section 1.8. The second aim of this study was 
therefore to investigate ifthere was an association between s-IgA measures (or changes 
in those measures) and the variables (or changes in those variables) identified by the 
DSTO as possible indicators of OTS: these include physiological variables (weight, 
physical performance); fatigue; mood states; and haematological and biochemical 
variables (leukocytes; neutrophils; lymphocytes; monocytes; neutrophil to lymphocyte 
ratio; C-reactive protein; TNFa; haemoglobin; ferritin; free testosterone; cortisol; 
FTCR). To allow this question to be answered, some of the results of the larger DSTO 
study were reproduced (with permission from the DSTO). 
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5.2 Methods 
5.2.1 Subjects 
Of the 58 recruits (51 males, 7 females) who volunteered for the study, 43 (38 
males, 5 females) completed the ACRT course and the study. Nine males were cigarette 
smokers. The gender bias in this study reflects the fact that the proportion of females in 
the Army is generally less than 20%. Except for the health checklist all tests and 
activities associated with this study were scheduled into the formal ACRT timetable. 
5.2.2 Physiological measurements 
5.2.2.1 Anthropometry 
Body mass and height were recorded before breakfast on days 1, 33 and 43. 
Subjects were asked to drink at least 0.5 L of water the previous night to ensure a good 
hydration status. The methods for recording anthropometric data were based on those of 
the International Society for the Advancement of Kinanthropometry (Norton and Olds, 
1996). 
5.2.2.2 Energy expenditure 
Total Energy Expenditure (TEE) was estimated by the factorial method based on 
observations of activities and assigning values for the energy costs of each observed 
activity (Ainsworth et al., 1993; Ainsworth et al., 2000). Detailed records of recruits' 
activities were made on days 9, 35 and 38 and during The Challenge and have been 
described in a related publication (Skiller et al., 2005a). It was not possible to directly 
observe subjects during EX DW for security reasons; therefore TEE was estimated. 
using information and advice from ARTC staff about the mode, intensity and duration 
of the exercise. To estimate the mean daily TEE, each day's activities were classified as 
intense (e.g. physical training lessons, marching to and from lessons, endurance 
marches, obstacle courses, field-training lessons involving high levels of exertion), 
moderate (e.g. daily tasks, military activities such as drill, training in living 
accommodation and other tasks allocated by training instructors), and sedentary (e.g. 
lectures, eating, resting while waiting for lessons, sleep and similar activities). The TEE 
for each day was estimated based on the breakdown oftime spent on the various 
activities and by use of subjects' calculated basic metabolic rate (BMR). 
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5.2.2.3 Physical fitness 
Fitness testing was conducted on days 3 and 32 during regular physical training 
sessions under the supervision of the physical training instructors at ARTC. A 2.4 km 
run was used as a measure of aerobic capacity and endurance (Burger et al., 1990), 
maximum number of push-ups as a measure of upper body strength and standing 
vertical jump as a measure of leg muscle power (Suni et al., 1996). 
5.2.3 Psychological and health measurements 
5.2.3.1 Fatigue 
Fatigue was assessed on days 1, 6, 13, 20, 27 & 34 by the 30-item 
Multidimensional Fatigue Symptom Inventory (Short Form) (MFSI-SF; Appendix F). 
This is a validated questionnaire sensitive enough to detect changes in fatigue over the 
short period of time in the present study (Stein et al., 2004). It contains no reference to 
medical conditions so it can be used by both healthy and ill individuals. It does not 
assume the presence of fatigue, so it can be used to gather baseline data before an 
expected fatigue-inducing event/activity. The subscales can be compared. For example 
individuals may be free of physical fatigue symptoms but have symptoms of other 
fatigue dimensions such as emotional fatigue. Subjects rated their experien9e of each 
symptom on a 5-point Likert scale as how true they were for them in the past 7 days 
(i.e. not at all, a little, moderately, quite a bit or extremely). The item scores combine to 
produce five subscales measuring different dimensions of fatigue: general fatigue, 
physical fatigue, emotional fatigue, mental fatigue and vigour. 
5.2.3.2 Mood 
Changes in mood state were monitored on days 1_,, 6, 13, 20, 27 ~ 34 by the 
-"' 
Profile of Mood States (POMS) questionnaire (Mc Nair et al., 1971). Subjects rated the 
65-item list of words relating to how they had been feeling during the past week, 
according to a 5-point Likert scale. The POMS was scored for each of the factors, 
tension-anxiety, depression-dejection, anger-hostility, fatigue-inertia, confusion-
bewilderment, and total mood disturbance. 
5.2.3.3 General health 
Subjects completed a daily health diary every morning, using a simplified 9-point 
health checklist, which included symptoms of URTI (Appendix G). 
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5.2.4 Biochemical measurements 
5.2.4.1 Saliva collection and analysis 
Although saliva samples were collected for all 58 subjects, only the samples of30 subjects 
who provided a complete set of samples were analysed. This was both for financial and statistical 
reasons. Analysing all samples was beyond our budgetmy means and incomplete sets would have 
complicated statistical calculations. A total of 690 saliva samples were collected from 30 
subjects (23 samples each): 
~ Early morning samples (before breakfast;~ 6:00 h) on days 1, 2, 13, 27, 32, 38, 
39, 40, 41 & 43. 
• Late afternoon samples (before dinner;~ 17:35 h) on days 2, 3, 4, 5, 6, 20, 34, 
38, 39, 40, 41, & 43. 
• Before and after The Challenge on day 42. 
Saliva was temporarily stored in a -80°C freezer and transported to the DSTO 
laboratory in Scottsdale, Tasmania on dry ice. Otherwise all saliva samples were 
collected, stored and analysed as described in Chapter 2. S-lgA levels are reported as a 
secretion rate and as a ratio to osmolality. 
To assess the overall effect of the ACRT on s-lgA, 4 time points were considered: 
week 1, day 20, day 34 and week 6. To this effect, the results of the pre-dinner saliva 
samples of week 1 (days 2, 3, 4, 5 & 6) and week 6 (days 38, 39, 40, 41 & 43) were 
averaged for each subject. The reason for deciding to average the data of the first and 
last week was that there is a large within subject variability in s-lgA. Despite the fitct 
that week 6 included the three samples collected during the strenuous training period 
and three on other days, the average was deemed to give a better idea of an individual's 
representative s-IgA status, rather than the results from a single day. 
The most strenuous period of the ACRTwas from day 39 to day 42 with Exercise 
Dusty Warrior, followed by The Challenge. Early morning (pre-breakfast) and late 
afternoon (pre-dinner) saliva samples were compared with samples taken on day 38 
(baseline) and day 43 (recovery sample). 
5.2.4.2 Blood collection and analysis 
Blood samples were collected after an overnight fast (before breakfast) on days I, 
33 and 43 from a superficial antecubital vein into an EDTA tube (10 mL, BD 
Vacutainer, Becton Dickinson, Franklin Lakes, NJ, USA) and a plain serum tube, 
containing a clot activator and a gel separator (9.5 mL, Vacutainer SST Gel & Clot 
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Activator, Becton Dickinson, Franklin Lakes, NJ, USA).'A basic haematological profile 
(haematocrit, haemoglobin concentration, red and white cell counts) was performed on 
whole EDTA blood within 10 hr of collection by use of routine methods (Beckman 
Coulter MAXM automated analyser, Miami, Florida, USA). The ratio of neutrophils to 
lymphocytes was calculated as a suggested index of the physiological stress on the 
immune system (Nieman et al., 1999). The serum free testosterone to cortisol ratio 
(FTCR) was used to determine the onset of overtraining (Chicharro et al., 1998a). Other 
indicators of overtraining, namely ferritin (Frt), C-reactive protein (CRP) and in vivo 
inflammatory cytokine (tissue necrosis factor alpha, TNFa.) were also measured from 
the serum sample. 
Samples were batch analysed, ensuring that each subject's samples were analysed 
within the same day. Reagents from the same production batch were used throughout 
the analysis. Standard commercial methods were used in the analysis of all blood 
analytes: free testosterone (Coat-A-Count Radioimmuno assay, DPC Cirrus Inc, Los 
Angeles, California, USA), TNFa. (Accucyte competitive enzyme immunoassay, 
Cytimmune, Maryland, USA), Frt and high-sensitivity CRP (ProSpec auto-analyser, 
Dade Behring, Marburg, Germany), and cortisol (Vitros Eci, Johnson & Johnson 
Clinical Diagnostics Inc, Rochester NY,USA). 
5.2.5 Statistical analysis 
Descriptive statistics are presented as means, standard deviations, and range or 
95% confidence interval. Data was initially checked for outliers using Reed's criterion 
(Fraser, 2001). Normality of the raw data was tested by the Kolmogorov-Smirnov test, 
the Shapiro-Wilk or the Lilliefors tests. Where needed, normality was achieved by In or 
log transformation. Significance was accepted at P < 0.05. Associations between 
variables were assessed by Pearson's correlation coefficient or by multiple linear 
regression analyses. For some relationships Spearman's rank correlation was used if the 
complex natures of the relationships precluded the use of parametric regression 
methods. Comparison of means was achieved by use of the paired t-test with Levene's 
test used for comparison of variance. Repeated measures analysis of variance (ANOV A) 
was used for procedures with serial measurements. The results of all within-subject F-
tests were based on Huynh-Feldt corrected P-values. Two forms of contrasts were used 
in the comparison of variables across time: (1) comparison of each time against a 
baseline was used as the primary contrast, and (2) comparison with the previous time 
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was used to increase an understanding of where changes occurred. Contrasts were only 
used when there was evidence of a difference across time from the primary test. 
To establish the predictive capability of s-lgA measures on changes in other 
variables, regression analysis was employed using the non-saliva variables as the 
response variables and the saliva variables as predictors. The predictive role of s-lgA 
measures was examined both as individual predictors and as collective predictors 
through the use of multiple linear regressions with stepwise fitting of variables. The 
response variables were formed as the difference between the baseline response and 
responses at selected times during the study. Differences in saliva variables were 
calculated to cover the corresponding time periods. 
5.3 Results 
5.3.1 Subjects 
The mean age of subjects was 22.0 years for males (range 18 - 33) and 29.5 years 
for females (range 19 - 46). Mean height was 179.5 cm (range 164 - 196) for males and 
165.0 cm (range 160 - 171) for females. Mean body mass for males was 78.8 kg (range 
60 - 104) and females 64.5 kg (range 57 - 74). The mean BMI was 24.3 kg.m-2 (range 
20. l - 29.4) for males and 24.3 kg.m-2 (range 21.1 - 28.6) for females. Of the 38 males 
and 5 females who completed the study, 14 and 2 respectively were overweight (BMI ~ 
25) and none were obese (BMI ~ 30). 
There was a small but significant body mass loss among the males (mean= -2.5 
kg; P < 0.001) and a non-significant loss among females (mean= -2.0 kg; P = 0.095) 
who finished the course. 
5.3.1.1 Energy expenditure 
On any day most recruits were possibly engaging in a greater level of physical 
activity than would have been normal for them prior to their participation in the ACRT. 
The recruit's average daily total energy expenditure (TEE) was l 6.5MJ.day-1, which 
would be considered extremely high for their relatively sedentary civilian peer. During 
the first four weeks the intensity level was relatively stable, with the TEE 16.5 MJ.day-1 
and 12.4 MJ.day-1 for males and females respectively. In weeks 5 and 6 and at the 
beginning of week 7 there was an increase in the physical activity level, particularly 
during EX DW. On the most arduous day of EX DW the energy expenditure was 
approximately 28 MJ for male recruits (Table 23). 
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Table 23: The total daily energy expenditure (TEE) of male and female recruits during 
the 45-day ACRT 
TEE ,(MJ,day-1) 
Males Females 
Day Type (number of days) Mean (Range) Mean (Range) 
Standard day (33) 16.3 (14.0-18.6) 12.l (11.7 -12.6) 
Day with increased physical 
18.0 (15.5-20.6) 13.4 (12.9-14.0) 
activity (8) 
Day of the Challenge (1) 22.3 (19.2-25.5) 16.6 (16.0 - 17.3) 
EX DW - Day 1 (1) 19.7 (16.9 - 22.5) 14.6 (14.1-15.2) 
EX DW - Day 2 (1) 27.6 (23.8 - 31.6) 20.6 (19.8-21.4) 
EX DW -Day 3 (1) 22.3 ()9.2-25.5) 16.6 (16.0-17.3) 
All days combined (45) 17.2 (15.1 -19.4) 12.8 (12.5 -13.2) 
5.3.1.2 Physical fitness 
There was an increase in upper body strength (P < 0.001, push-up test) and leg 
muscle power (P < 0.001, standing vertical jump) but a small decline in aerobic 
capacity (P < 0.001, 2.4 km run) (Table 24). 
Table 24: Physical fitness ofrecruits during the ACRT 
Variable 
Upper body strength ( number 
of push ups) 
Leg muscle power (standing 
vertical jump in cm) 
Day 3 (N=58) 
33 ± 12 (11 - 69) 
67 ± 17 (27 - 100) 
Day 32 (N = 40) 
40 ± 11 * (16- 69) 
72± 18* (28-100) 
Aerobic capacity {time for 2.4 
km run in min.sec-1) 
10:11±1:13 (8:09-13:17) 10:32± 1:02* (8:44-13:28) 
Data are mean± SD (range) for males & females combined; * Significant change from day 3 
5.3.2 Biological variation of salivary lgA 
The pre-dinner saliva samples from days 2 to 6 were used to calculate the 
between-subject and within-subject variability and the indices of individuality of the s-
IgA measures (Table 25). The individual.data for all subjects has been included in table 
format in Appendix H. Figure 12 graphically represents the spread of individual data for 
each subject and compares them with the reference ranges calculated in Chapter 2 
(Table 10). Mean s-IgA secretion rates differed by up to 18-fold between subjects. 
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Figure 12: Mean(+) and absolute range ?f s-IgA secretion rate (a) and s-
IgA:osmolality ratio (b) for 30 healthy subjects during the first week of the ACRT 
course. The horizontal lines represent the reference range calculated in Chapter 2. 
Table 25: Biological variation oflate afternoon s-IgA during week 1 of the ACRT 
s-lgA measure 
lgA secretion rate (µg·min- 1) 
lgA:osmolality ratio (mg·m0smor1) 
53% (± 25%) 
42% (± 16%) 
CVG 
80% 
58% 
5.3.3 Changes in salivary lgA during the ACRT 
II 
0.66 
0.72 
There was strong evidence that the measures of s-lgA changed across the 
selected set of sample time points (week 1 average, day 20, day 34, and week 6 
average): pre-dinner s-IgA secretion rate (F27,3 = 14.356, P < 0.001) and s-
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lgA:osmolality ratio (F25,3 = 55.373, P < 0.001). The statistical analysis was performed 
on the mean-of-the-means for weeks I -and 6 and on the group mean for days 20 and 34. 
The nature of change was similar for both s-IgA measures, a decrease from week I to 
day 20 that was sustained until week 6 (Table 26, Figure 13). Both s-lgA measures were 
lowest on day 20. There were no differences between day 34 and week 6. The raw data 
for all subjects has been included in table format in Appendix I. 
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Figure 13: Changes in pre-dinner s-lgA secretion rate (a) and s-IgA:osmolality ratio 
(b) during the ACRT Both had decreased by day 20. On day 34 and during week 6 all 
measures of s-JgA were higher than on day 20, but still lower than during week I . * 
Indicates a significant difference with week I (P < 0. 05). The statistical analysis was 
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Table 26: Changes in pre-dinner s-lgA measures over the course o£the ACRT 
s-lgA measure Average week 1 Day20 Day34 Average week 6 
s-lgA secretion rate 120± 69 55 ± 35* 83 ± 49# 81±32# 
(µg·min- 1) (94-145) (42-68) (64-101) (70-93) 
s-lgA:osmolality ratio 3.4 ± L3 1.1±0.5* 1.9 ± 0.7* 2.0±0.8* 
. (mg·m0smor1) (2.9-3.9) (0.9-1.4) (1.6 - 2.1) (1.7 - 2.3) 
Data are represented as mean± SD (95% confidence interval);* P < 0.001; ** P < 0.005; # P < 0.05, 
significant change from week I (N = 28-30). 
The patterns displayed in Figure 13 are based on mean s-IgA levels for all 
subjects. Given that the practical interest lies in assessing changes in an individual's s-
lgA levels as well as from a group of subjects, the temporal correlations for the various 
pre-dinner s-IgA measures were assessed. High temporal correlations would mean there 
was a consistent change over time among individuals. The fact that correlations for an 
individual across time were not high for any of the variables (Table 27) indicates that 
the strong pattern observed using mean responses for all subjects was not consistent 
across individuals. 
Table 27: Correlations across time for pre-dinner s-IgA variables (N= 28-30) 
s-lgA secretion rate Week 1 average Day 20 Day34 Week 6 average 
Week 1 average 1.0 0.5 0.7 0.2 
Day 20 1.0 0.4 0.3 
Day 34 1.0 0.5 
Week 6 average 1.0 
s-lgA:osmolality ratio Week 1 average Day 20 Day34 Week 6 aver:age 
Week 1 average 1.0 0.5 0.6 0.5 
Day 20 1.0 0.4 0.2 
Day 34 1.0 0.5 
Week§ average 1.0 
5.3.4 Effect of Exercise Dusty Warrior on salivary lgA 
During the period of EX DW, there was no change in pre-breakfast s-lgA secretion rate 
(F4,68 = 1.296,P = 0.280) or s-IgA:osmolality ratio (F4,60 = 1.716 ,P = 0.158). There 
was, however, a significant decline in pre-dinner s-IgA secretion rate (F4,J04 = 5.933, P 
< 0.001) and s-IgA:osmolality ratio (F35, 883 = 6.458, P < 0.001) (Table 28, Figure 14). 
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Compared to baseline (day before the start of EX DW), s-lgA secretion rate was lower 
at the end of each day. S-lgA:osmolality ratio was lower at the end of days two and 
three. Both had recovered two days after EX DW. The individual data for all subjects 
has been included in table format in Appendix J 
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Figure 14: Changes in pre-dinner s-IgA secretion rate (a) and s-IgA:osmolality ratio 
(b) during Exercise Dusty Warrior. Both decreased, and then returned back to pre-
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the evening before the start of EX DW (P < 0. 05). The presentation of data is similar to 
Figure 5. 
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Table 28: Effect of Exercise Dusty Warrior on early morning and evening s-lgA 
measures 
Baseline: Recovery: 
s-IgA measure day before EX DW day 1 EXDWday2 EXDWday3 2 days after 
EXDW EXDW 
Early morning (pre-breakfast) 
s-lgA secretion rate 95 ±56 13I ± 79 88±45 72 92±47 
(µg·min-1) (7I - I20) IOI - I62) {67 - 105) (54 - 96) (72- II2) 
s-IgA:osmolality ratio 2.5 3.9 ± 1.9 2.6 ± 1.2 2.5 ± 1.5 3.2 ± 1.6 
(mg·m0smor1) (2.1 - 3.I) (3.I - 4.6) (2. I - 3.0) (1.9-3.1) (2.6 - 3.2) 
Evening (pre-dinner) 
s-lgA secretion rate 87 70±34* 55* 5I* I03 ± 54 
(µg·min-1) (72- I07) (57 - 83) (44 - 69) (4I -64) (82-I23) 
s-IgA:osmolality ratio 1.9 1.7 1.2* 1.3* 2.1 
(mg·m0smor1) (1.6 - 2.4) (1.3 - 2.2) (0.9- 1.6) (I.O - 1.7) (1.7 - 2. 7) 
Normally distributed data are represented as mean± SD (95% confidence interval). Not normally 
distributed data are reported as geometric mean (95% confidence interval). * Significant difference with 
the day before Exercise Dusty Warrior (P < 0.05) (N = 30). 
5.3.5 Effect of the Challenge on salivary lgA 
Participation in The Challenge caused a reduction in the s-lgA:osmolality ratio (P 
< 0.001). However, there was no change in the s-lgA secretion rate (P = 0.487) (Table 
29). 
Table 29: Effect of the Challenge on s-IgA measures (N = 30). 
s-lgA measure 
s-IgA secretion rate (µg·min-1) 
s-lgA:osmolality ratio (mg·m0smor1) 
Pre-Challenge 
84(62-114) 
2.9 (2.3 - 3.7) 
Post-Challenge 
77 (59-101) 
1.6* (1.3 - 2.1) 
Data are reported as geometric mean (95% confidence interval). * Significant difference with pre-
Challenge (P < 0.05). 
5.3.6 URTI 
Of the 30 subjects who donated saliva samples, 18 reported self-assessed 
symptoms ofURTI or influenza (Table 30) between days 1and38. The recording of 
health problems was considered unreliable after day 38, as subjects became reluctant to 
fill in forms conscientiously (see Appendix G).The individual data for all subjects have 
been included in table format in Appendix K. There were no significant correlations (as 
assessed by Pearson's correlation coefficient) between the total number ofURTI and 
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influenza symptoms between days 1 and 33 (initial training period) or between days 34 
and 38 (final training period) and any of the s-IgA measures on day 1, day 34, week 1 or 
week 6 except for a weak correlation between these symptoms in the day 1 to 33 period 
and the s-IgA secretion rate on day 34 (P = 0.041, r = 0.381). 
Table 30: Number of days with self-recorded URTI and influenza symptoms per recruit 
during initial and final training periods for all subjects (N = 30) 
Number of days 
Number of days with URTI symptoms 
Number of days with flu symptoms 
Days 1-33 
Mean, median (range) 
5.6,3.5(0-31) 
0.7,0(0-11) 
5.3. 7 Indicators of overtraining 
5.3.7.1 Fatigue 
Days 34-38 
Mean, median (range) 
0.3, 0 (0- 5) 
None recorded 
General fatigue (P < 0.001), physical fatigue (P = 0.001), emotional fatigue (P = 
0.002) and mental fatigue (P = 0.013) had increased significantly by day 6 of the ACRT 
course but there was no change in vigour (Table 31). At the end of the course, general 
fatigue and physical fatigue were still elevated, whereas emotional, mental and total 
fatigue were not different from day 1. The individual fatigue scores for all subjects have 
been included in table format in Appendix K. 
Table 31: Fatigue during the ACRT as measured by Multidimensional Fatigue 
Symptom Inventory-Short Form 
Psychological 
Day 1 Day6 Day13 Day 20 Day27 Day34 
factor 
Vigour 16.7 ±4.7 16.1±4.4 16.8 ± 5.1 17.0±4.5 15.7 ± 5.0 15.5 ± 5.0 
General fatigue I0.3 ±4.7 14.2 ± 5.0* 11.8 ± 5.1 11.6±5.2 11.4 ± 4.5 13.1±6.5* 
Physical fatigue 8.4 ± 2.6 12.0 ± 5.1 * 9.9±4.0 11.2± 4.5* 10.7±4.7* 11.8 ± 5.3* 
Emotional fatigue 10.4 ± 4.1 11.4±5.2 9.4 ± 4.5 8.9 ± 3.4* 9.3 ± 3.7* 9.5 ±4.6 
Mental fatigue 10.5 ± 4.4 13.4 ± 4.3* 11.7 ± 4.2 11.0 ± 3. 8 10.9±4.2 10.7 ± 4.7 
Total fatigue 11.3 ± 5.0 13.4 ± 5.1 11.9 ± 5.2 12.0±5.1 11.6 ± 4.9 12.l ± 5.6 
Data are mean ± SD; * Significant difference with day 1 (P < 0.05). 
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5.3.7.2 Mood 
There were significant changes in POMS scores for tension-anxiety (P < 0.001), 
depression-dejection (P = 0.026), anger-hostility (P = 0.004), fatigue-inertia (P < 
0.001), confusion-bewilderment (P < 0.001) and total mood disturbance (P = 0.022) 
during the ACRT (Table 32). All were highest early during the course (day 6) with the 
exception of tension-anxiety. The individual POMS scores for all subjects have been 
included in table format in Appendix K. 
Table 32: Changes in negative mood states during the ACRT as measured by POMS 
Psychological factor Day 1 Day6 Day 13 Day20 Day27 
Tension-anxiety 12.3 ± 5.4 11.9 ± 6.4 7.3 ± 4.5* 7.0±4.5* 6.4 ± 4.2* 
Depression-dejection 7.1±10.0 10.0±10.0* 4.8 ±7.6* 5.9 ± 7.7 6.5 ± 9.0 
Anger-hostility 4.8 ± 6.3 8.9 ± 7.5* 5.3 ±6.7 6.0± 6.8 5.8±7.0 
Fatigue-inertia 6.8 ± 6.1 9.5 ± 5.2* 6.4 ± 5.4 6.8 ± 6.2 5.3 ± 5.2 
Confusion-bewilderment 7.3 ± 4.5 8.9±4.6* 6.8 ± 3.8 6.1±3.7* 5.2± 3.9* 
Total mood disorder 22.3 ± 33.6 32.9±28.7 12.9± 26.1 17.4 ± 28.1 13.3 ± 27.9 
Data are mean ± SD; * Significant change from day 1 (P < 0.05). 
5.3. 7 .3 Hormonal changes and markers of inflammation 
Day34 
5.9 ± 3.7* 
6.9±9.8 
6.2 ± 6.4 
6.9±7.2 
5.6± 3.5* 
16.0 ± 29.5 
There was a gradual decrease in both free testosterone and cortisol during the 
ACRT that became significant at the last sample point (P < 0.001) (Table 33). At the 
end of the ACRT, 24 of the recruits (56%), including 1 female experienced a decline in 
FTCR greater than 30%, which has been suggested as being symptomatic of OTS. 
There was a significant increase in the serum concentration of C-reactive protein (CRP) 
(P = 0.001) and tissue necrosis factor a (TNFa) (P = 0.002) during the ACRT (Table 
33) which have also been implicated with OTS. The individual data for all subjects have 
been included in table format in Appendix K. 
5.3.7.4 Humoral immune function 
Total white blood cell count, neutrophil, lymphocyte and monocyte count declined 
from day 1 to day 33 of the ACRT, but there was no change in these measures between 
days 33 & 43 (Table 33). There was also a decrease in the neutrophil to lymphocyte 
ratio between days 1 & 33 (P = 0.003). The individual data for all subjects have been 
included in table format in Appendix K. 
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Table 33: Changes in hormonal and humeral indicators of overtraining and 
inflammation during the ACRT 
Variable Day 1 Day33 Day43 
Free testosterone (males ) 67±23 43 ± 15* 37±11** 
(pmol·L-1) (N = 37) (26- 118) (10-88) (10-57) 
Cortisol (nmol· L"1) 469 ± 142 438± 63 413 ± 72* 
(N=44) (196-750) (293-602) (298- 578) 
FTCR (males) 0.15 ± 0.10 0.10 ± 0.04* 0.09± 0.03* 
(N=37) (0.04 - 0.40) (0.02 - 0.21) (0.02 - 0.14) 
C-reactive protein (mg·L-1) l.2 ± l.7 l.6 ± 2.9 2.1±3.7* 
(N = 41) (0.2- 9.4) (0.2 - 17.1) (0.3 - 23.5) 
Tissue necrosis factor a (µg·L-1) 2.8 ± 1.3 3.2 ± l.9 4.8 ± 2.7* 
(N=40) (0.9 - 5.7) (0.9 - 10.6) (1.6 - 14.7) 
Total leukocyte count (x 109) 8.l ± 1.9 6.1±1.4* 6.3 ± 1.4* 
(N =40) (4.7 - 11.9) (2.6- 9.2) (3.5 - 9.8) 
Neutrophil count (x 109) 5.5 ±2.2 3.3 ± 0.9* 3.6 ± l.O* 
(N=37) (2.1 - 12.9) (l.5 - 5.8) (1.9 - 6.1) 
Lymphocyte count (x 109) 1.8 ± 0.5 1.6 ± 0.4* 1.7 ± 0.4 
(N =43) (0.9- 3.1) (1.0 - 2.8) (1.2 - 2.8) 
Monocyte count (x 109) 0.8 ± 0.4 0.6± 0.1* 0.6 ± 0.2* 
(N =38) (0.4 - 2.3) (0.3 - 1.0) (0.3 - 1.2) 
N eutrophil to lymphocyte ratio 3.3 ± 1.7 2.3 ± 1.5* 2.1±0.8* 
(N =43) (l.2 - 8.6) (0.8 - 9.5) (0.3 - 4.2) 
Haemoglobin males (g·L-1) 154± 9 141±8* 135 ± 9** 
(N =38) (134-174) (120-158) (116- 161) 
Haemoglobin females (g·L-1) 137±2 126 ± 3* 125 ± 4* 
(N=5) (134-138) (120-128) (120-130) 
Ferritin-maies (µg·L-1) i20 ± 67 72±31" 85 ± 37"'. 
(N =38) (38-368) (31 -171) (24-171) 
Ferritin-females (µg·L-1) 67±30 39 ± 10* 48±5* 
(N=5) (34-105) (27-53) (43 - 55) 
All data are mean± SD (range);* significant change from day 1; **significant change from day 33 (P < 
0.05). Unless otherwise specified data are for males and females combined. 
5.3.7.5 Haematology and iron status measurements 
There was a consistent decline in haemoglobin and ferritin during the ACRT (p < 
0.001) (Table 33). Ferritin (Frt) levels were significantly higher in males than in females 
at all sample points (P < 0.001), however, there was no difference in the pattern of 
change between males and females. These findings must be treated with caution as there 
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were only 5 females in this analysis. The individual data for all subjects have been 
included in table formatJn Appendix K. 
5.3.8 Salivary lgA and indicators of overtraining 
To assess if s-IgA measures were correlated with the indicators of overtraining on 
corresponding days, linear regression analyses for the variables listed in Table 34 were 
used. The left hand column shows the psychological, haematological and biochemical 
response variables (e.g. general fatigue and cortisol) which were correlated with the s-
JgA secretion rate and s-JgA:osmolality ratio as predictor variables (in the right hand 
column). Because this resulted in a very large number of comparisons, only those which 
resulted in a significant correlation were included in Table 35. The high levels of 
physical fatigue and mental fatigue were not correlated with s-IgA throughout the 
ACRT. The high levels of depression, anger and confusion at the end of the lst week 
were not correlated with any of the s-IgA measures. Correlations with other indicators 
of overtraining including hormonal changes, an increase in inflammation, and a 
decreased iron status, were equally absent or inconsistent. Although more than half the 
recruits experienced a clinically significant decline in FTCR of greater than 30%, this 
was not correlated to s-lgA at all. Although TNFa was positively correlated s-
lgA:osmolality ratio on day 33, this occurred before the increase in TNFa. There were 
only a few weak correlations between the haematological parameters and s-IgA. 
Tu ~valuate if changes in s-JgA predicted changes in indicators of overtraining, the 
difference between the initial test result and each of the results at subsequent testing 
times were treated as a response variable and the two s-IgA variables as predictor 
variables in a multiple linear regression equation. Using stepwise fitting, only the 
variables for which a significant relationships were established are listed in Table 36 
together with the percentage of variation explained. The same regression analysis 
method was used to determine ifthe baseline values of s-IgA measures (average of 
week 1) were predictive of changes in other variables. Only the analyses that produced 
significant associations are listed in Table 37. Only a small percentage of the changes in 
a few indicators of overtraining during the ACRT were explained by the baseline (week 
I) s-IgA measures or by changes in s-IgA measures. 
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Table 34: List of psychological, haematological and biochemical variables that were 
used as response variables and s-lgA predictor variables (or the base variables from 
which response and predictor variables were calculated) 
Physiological 
Fatigue 
Mood(POMS) 
Markers of 
inflammation 
Haematology 
Hormones 
Immunological 
Response variable 
Weight 
General 
Physical 
Emotional 
Mental 
Vigour 
Tension 
Depression 
Anger 
Fatigue 
Confusion 
Total mood 
C-reactive protein 
TNFa 
haemoglobin 
Ferritin 
Free testosterone 
Cortisol 
FTCR 
Leukocyte count 
Neutrophil count 
Monocyte count 
Neutrophil:lymphocyte 
ratio 
Day I, day 43 
Predictor variables: s-IgA 
secretion rate; s-lgA:osmolality 
ratio 
Week I average, week 6 average 
Days I, 6, 13, 20, Week I average, days 6, 13, 20, 
27,34 
Days I, 33, 43 
27, 34, week 6 average 
Week I average, day 34, week 6 
average 
109 
Table 35: Significant correlations between s-lgA and indicators of overtraining on 
corresponding days during the ARTC 
Day Predictor variables Response variables r p 
s-lgA secretion rate Cortisol - 0.455 0.017 
33 s-IgA:osmolality ratio TNFa 0.505 0.009 
s-IgA secretion rate Total leukocytes 0.461 0.020 
s-lgA:osmolality ratio Total leukocytes 0.409 0.047 
s-lgA:osmolality ratio Neutrophils 0.475 0.017 
s-lgA:osmolality ratio Lymphocytes 0.462 0.020 
33 s-lgA:osmolality ratio Ferri tin -0.421 0.029 
Table 36: Changes in s-lgA measures that predicted changes in indicators of 
overtraining during the ACRT 
% variation 
Predictor variable 
Change in s-lgA secretion rate -
week I to day 34 
Response variable 
Change in physical fatigue - day I to day 34 
Change in s-lgA:osmolality ratio - Change in total mood - day 1 to day 34 
week 1 to day 34 
Change in s-lgA secretion rate -
week I to day 34 
Change in s-lgA secretion rate -
week 1 to day 34 
Change in s-IgA secretion rate -
week 1 to week 6 
Change in neutrophil count - day 1 to day 33 
Change in neutrophil:lymphocyte ratio - day 1 to 
day 33 
Change in ferritin - day 1 to day 43# 
explained 
(Rz)* 
12 
19 
22 
12 
26 
*Percentage of variation observed in the response variable associated with the variation in the s-lgA 
measure. 
#Unfortunately (but beyond our control) there was a one day lag between the blood sample (day 33) and 
the saliva sample (day 34). 
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Table 37: Baseline s-IgA measures that predicted changes in indicators of overtraining 
during the ACRT 
Predictor variable % variation 
(average of week 1) 
Response variable 
explained (R2)* 
s-lgA:osmolality ratio Change in total mood - day 1 to day 13 27 
s-lgA secretion rate Change in white blood cell count - day I to 28 
day 33 
s- lgA secretion rate Change in neutrophil count - day I to day 28 
43 
s-lgA secretion Change in cortisol - day I to day 33 14 
s-IgA secretion Change in FTCR- day I to day 33 16 
s-IgA secretion Change in FTCR - day I to day 43 15 
* Percentage of variation observed in the response variable associated with the baseline value of the s-lgA 
measure 
5.4 Discussion 
The subjects in this study engaged in daily physical activity over a six week 
period, some of which was prolonged and/or intense. Indeed, the mean daily energy 
expenditure for the ACRT course was 16.5 MJ. This is similar to the energy expenditure 
determined by doubly-labelled water method during 12 weeks of strenuous US marine 
corps training (17 ± 4 MJ·dai1 for males and 10 ± 1.3 MJ·day-1 for females) (Bathalon 
et al., 2002). The workload was highest at the end of the course when the Challenge and 
EX DW were conducted. On the most arduous day of EX DW the energy expenditure 
was approximately 28 MJ for male recruits. On any day recruits were probably 
engaging in a greater level of physical activity than would have been normal for them 
prior to their participation in the ACRT. The recruit's average energy expenditure of 
l 6.5MJ would be considered very high for their relatively sedentary civiiian peers. It 
was, therefore, postulated that the subjects would present with some symptoms of 
overtraining. It was also postulated that the ACRT would result in decreased levels of s-
lgA. Investigating how these changes in s-IgA would relate to the indicators of 
overtraining was the main purpose of this study. 
Although the results suggest that in general recruits responded favourably to 
physical fitness training, there was some evidence for a decline in aerobic endurance by 
the last week of the course. This could have been due to the higher levels of physical 
fatigue and might be suggestive of some overtraining. The officers and instructor of 
ARTC expressed the concern that recruits were having difficulty maintaining 
concentration throughout the day and were taking a long time to recover after physically 
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demanding activities (personal communication). The tests of physical performance used 
in this study gave only a rough estimate of the changes in fitness of the recruits and are 
not necessarily reliable. Testing was conducted by the ARTC physical fitness 
instructors rather than by the investigators and the methods for recording results and 
time-of-day were not standardised. It was impossible to ascertain if recruits performed 
to the maximum of their ability. For instance ifthe subjects were losing their motivation 
by the end of the trial, the results of a 2.4 km run would not have given a good indication of 
maximal aerobic power. 
_ The small loss of body mass experienced by most recruits was not clinically 
significant. At the end of the ACRT, no recruits had an unhealthy B:MI, and without 
data on body composition, the extent of fat or muscle loss could not be estimated. 
All fatigue variables showed a peak in the second week of the ACRT and general 
fatigue and physical fatigue were elevated at the end of the sixth week (Booth et al., 
2006; Skiller et al., 2005b). This was expected given the increasing demands of the 
course and the effect of an accumulation of reduced sleep. During the most strenuous 
days at the end of the ACRT (especially week 6), there were significantly less hours 
available for sleep. 
After a fairly easy first week, the ACRT course becomes more challenging in the 
second week. This was reflected by a peak in the negative mood scores (depression, 
anger, fatigue, confusion and total mood disorder) during that week, indicating an 
increase in stress (Booth et al., 2006; Skiller et al., 2005b ). This might be desirable to 
achieve the required training effect as the ACRT is deliberately challenging in order to 
indoctrinate recruits. The decrease in negative mood scores in the following weeks 
indicated that the training tempo/stress was moderated in subsequent weeks. Mood 
disturbances have been shown to increase with training load in an apparently dose-
related manner (Morgan et al., 1988) and an athlete's mood state is at present considered 
to be a promising indicator of overtraining (McKenzie, 1999). 
The findings of the previous chapters in the present work indicate thatphysical 
activity of different duration and intensity, such as ultra-endurance runs (Chapter 3) and 
load carriage (Chapter 4), have a transient effect on mucosal immunity. Not 
surprisingly, the ACRT course as a whole and several of its individual components 
resulted in significant (albeit transient) changes in s-IgA. By day 20, all s-IgA measures 
were below the week 1 average, and although they recovered partly, they remained low 
until the end of the course. This finding confirms that of previous studies. In Canada, an 
18.5. week infantry training program resulted in lower s-IgA concentration at the end of 
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the course (Brenner et al., 2000) and s-IgA concentration and s-IgA:protein ratio 
declined after a 5-day military course following 3 weeks of combat training in France 
(Gomez-Merino et al., 2003). In the present study, the patterns for individuals showed 
considerable variation and the large between- and within-subject biological variation 
observed in the first week were similar to those reported in the literature and similar to 
the findings in Chapter 2 (Table 2 and Table 3). 
After the fitness testing on day 32, the s-IgA secretion rate was significantly lower 
than pre-test. The strenuous Exercise Dusty Warrior resulted in significant declines in 
all late afternoon s-IgA measures, although this was not the case for the s-IgA measures 
taken in the early morning. Without exception, pre-breakfast s-lgA measures were 
higher than the previous evening. As there was no proof (see Chapter 2) that early 
morning s-IgA is necessarily higher, this suggests that there was an overnight recovery. 
A day later, the Challenge caused a decrease in s-IgA:osmolality but not in the secretion 
rate. Two days after completion of EX DW, all values had returned to the levels 
measured a day before its start. 
The low number of subjects makes it difficult to make very useful deductions about the 
correlation between changes in s-IgA and the occurrence ofURTI. Data on URTI we~ obtained 
from daily self-report questionnaires and were not assessed by a physician. At no stage of the study 
was the investigator present when these fonns were filled out Therefore it is difficult to discuss the 
nature of these symptoms and whether the URTI were truly infections or more likely a response to 
inflammation. Although a considerable number ofrecruits reported symptoms of URTI 
and influenza, there was no evidence that those with a depressed mucosa} immune 
function at the start of the ACRT had a greater risk of UR TI during the ACRT. Baseline 
(week 1) s-IgA measures were not correlated to URTI symptoms during the ACRT. The 
positive correlation between symptoms of URTI and influenza in the period from day -1 
to day 34 and the s-lgA secretion rate on day 34 (P = 0.041, r = 0.381; see section 5.3.6) 
suggest there was an immune response. in the form of an increase in antibody secretion 
in recruits with URTI symptoms. In similar studies, an increase in URTI in French 
Army cadets during a 4 week commando course was not related to s-IgA (Tiollier et al., 
2005) and an 18.5-week infantry training program had no adverse effect on the health 
status of Canadian recruits despite a decrease in s-IgA concentration by the end of the 
course (Brenner et al., 2000). 
Increased confusion is a common symptom reported by overtrained individuals 
(Mackinnon, 2000). The mean level of confusion was higher than that experienced by 
personnel completing either the Royal Australian Air Force survival course (Carins and 
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Booth, 2002) or a combat training exercise in far North Queensland (Booth et al., 2003). 
The other negative mood scores in this study were similar to these other military 
activities despite a lower score for fatigue (Booth et al., 2006; Skill er et al., 2005b ). 
Over the course of the ACRT 56% of the recruits experienced a decrease in FTCR 
of more than 30% which is higher than the 24% incidence reported for a similar 8-week 
recruit-training program conducted in Spain (Chicharro et al., 1998a). As prolonged 
intense training of initially unfit individuals is most likely to cause a drop in circulating 
serum hormone levels and to affect FTCR (Adlercreutz et al., 1986), the data of this 
study suggest that some of the recruits did not have sufficient initial fitness to cope with 
the demands of the ACRT and possibly were overtrained by the end of the six week 
period. 
The intense physical activity during the final and most strenuous week of the 
ACRT course clearly elicited an inflammatory response as evidenced by the marked 
increase in the serum concentration of markers of inflammation (CRP, TNFa) (Booth et 
al., 2006; Skiller et al., 2005b). This finding is consistent with the so-called cytokine 
hypothesis of overtraining (Smith, 2000), which argues that high tempo training without 
adequate rest will result in muscle and/or joint trauma and a release of injury-related 
cytokines. These cytokines then activate monocytes to produce large quantities of pro-
inflammatory cytokines (e.g. TNFa) producing systemic inflammation, an acute phase 
response with production of proteins such as CRP and a hypercatabolic state, all of 
which have a negative impact on immune function. 
Markers of hum oral immune function (total leukocytes, neutrophils, monocytes, 
and the neutrophil:lymphocyte ratio) had declined by the end of week 5 of the ACRT 
course (Booth et al., 2006; Skiller et al., 2005b ). This is contrary to the observations of 
Gomez-Merino et al who found that total leukocyte and neutrophil counts had increased 
while total lymphocytes were unchanged after three weeks of basic military training 
followed by a 5-day combat course (Gomez-Merino et al., 2005). Although suppression 
ofhumoral immune function during prolonged periods of intense exercise training is a 
common finding - but not necessarily indicative of overtraining (Mackinnon, 2000) - it 
is rare for individuals to become clinically immunosupressed during regular physical 
training. The most likely risk is an increased incidence of URTI (see 1.5). The negative 
correlation between the self-recorded symptoms URTI and the neutrophil to lymphocyte 
ratio at the start of the ACRT suggests that recruits with decreased immune function at 
the start of the course were indeed more likely to experience URTI. 
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Both mean haemoglobin and serum ferritin concentrations declined across the 
training period, with some evidence for recruits becoming iron deficient (Booth et al., 
2006; Skiller et al., 2005b ). This is in accord with previous studies which have shown 
that the iron-status of soldiers declines over the course of routine military field exercises 
(Booth, 2003; Booth et al., 2003). Although mild anaemia, low serum ferritin levels and 
iron-deficiency have been suggested as physiological indicators of overtraining 
(Gastmann et al., 1998; Mackinnon, 2000), the evidence that a reduction in iron stores, 
associated with increased exercise, adversely affects physical performance is equivocal, 
except where iron deficiency anaemia is present. 
The results of this study do not support the suggestion that s-IgA would be useful 
as a single biological marker to detect overtraining (McKenzie, 1999). There is no doubt 
that, as a result of the ACRT, recruits experienced several symptoms which have been 
associated with overtraining (Booth et al., 2006; Skiller et al., 2005b) and that all s-IgA 
measures were depressed from day 20 onwards. However, despite the fact that changes 
in s-IgA measures seemed to reflect changes in most of the indicators of overtraining, 
only limited and inconsistent associations were found between them. 
A few examples illustrate this. The high levels of physical fatigue and mental 
fatigue were not correlated with s-IgA throughout the ACRT. The high levels of 
depression, anger and confusion at the end of the 151 week were not correlated with any 
of the s-IgA measures. Friendliness was correlated positively with s-IgA secretion rate 
and s-IgA:osmolality ratio on day 13 only. Correlations with other indicators of 
overtraining including hormonal changes, an increase in inflammation, and a decreased 
iron status, were equally absent or inconsistent. Although more than half the recruits 
experienced a clinically significant decline in FTCR of greater than 30%, a criterion 
used previously to diagnose OTS, this was not correlated to s-IgA at all. Although TNFu 
was positively correlated to s-IgA concentration and s-IgA:osmolality ratio on day 33, 
this occurred before the increase in TNFu. Only a small percentage of the changes in a 
few indicators of overtraining during the ACRT were explained by the baseline (week 
1) s-IgA measures or by changes in s-IgA measures (Table 36 and Table 37). It is not 
inconceivable that many, if not all, of the relations listed in these 2 tables could have 
arisen by chance and as a result of sampling variation rather than being indicators of 
real associations. None of the associations were strong enough to suggest that any of the 
s-lgA values (baseline or otherwise) or changes over time in s-IgA would be useful as a 
predictor of indicators of OTS or their changes across time. Such relationships as 
existed showed a level of association that is far too low to be of practical use. For any s-
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IgA measure to be reliable as a predictor of any response variable an R2 value in excess 
of 95% would be required. Therefore,-it-does not seem appropriate to use s-IgA as an 
alternative to any of these other indicators. 
Nevertheless, the fact that any associations were found at all, given the restrictions 
of the experimental design, is encouraging. To obtain a better understanding of the 
relationship between s-IgA and indicators of OTS further research seems warranted. As 
the large within-subject and between-subject biological variation of s-IgA reduces the 
likellhood that significant changes in an individual become apparent, a much larger 
group of subjects and a much larger number of saliva samples per individual would be 
required. 
A design flaw of this study is that contrary to the recommendation made in 
Chapter 2 (section 2.4.6), some early morning samples were collected for this study. As 
the sample collection times had to fit in with the very busy schedule of the subjects (16 
hour a day), these were to a large extent beyond our control. At the time the study was 
designed we were also unaware of the conclusions relating to biological variation as 
presented in Chapter 2. 
It was concluded "that the combined demands of ACRT, which included physical 
and psychological stresses, resulted in a significant prevalence of overtraining 
symptoms. However, recruits were not pushed so hard that physical performance 
deteriorated greatly" (Booth et al., 2006) There was however no evidence that s-IgA is 
a useful biomarker to monitor recruits for the risk of infection despite the fact that the 
ACRT resulted in a high incidence of mucosa} immunosuppression and self-reported 
symptoms of URTI. Although the ACRT also resulted in a significant prevalence of 
OTS symptoms there was no evidence that s-IgA is a useful stand-alone biomarker to 
monitor recruits for early states of OTS as a result of military training. Several 
recommendations to reduce the risk ofURTI and OTS in recruits can be found in the 
general discussion. 
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GENERAL DISCUSSION AND CONCLUSION 
The purpose of this project was to evaluate the usefulness of s-lgA as a biomarker 
of stress and immunosuppression for use in military training. A simple diagnostic test to 
assess the effect of physical and psychological stress on mucosa! immune function and 
subsequent vulnerability to illness or early states of OTS would be very useful, not only 
to the military, but also to the exercising population at large. 
As reviewed in the Introduction (Chapter 1), work by previous authors on s-lgA 
raised some concerns regarding its reliability and its validity as an indicator of mucosa! 
immune function and subsequent risk or incidence of infection. Weaknesses identified 
were the possible effects of diurnal variation (section 1.3.7), the large biological 
variation (sections 1.3.8 and 1.3.9), the standardisation of the s-IgA assay (section 
1.3.3), and the collection, handling and storage methods of saliva samples (sections 
1.3.4 and 1.3.5). These issues were addressed by several preliminary experiments. 
At present, there are no quick, simple and inexpensive field- or laboratory-testing 
methods for the detection of s-lgA. Using s-lgA as a biomarker for regular routine 
testing would only be feasible if a robust and cheap method of analysis was available. 
The development of such a method should be possible as antisera to human lgA are 
readily obtainable and s-lgA was shown to be stable for a limited time under field 
conditions (section 1.3.5). This study found that the measurement of s-lgA by particle 
enhanced nephelometric immunoassay is a good alternative to other methods as it is 
automated, rapid, accurate and precise. Care needs to be taken when collecting, storing 
and analysing saliva samples. 
This study does not offer an explanation for the large biological variation that 
seems inherent to this marker. Because it is unlikely that any study will be able to 
control each of the many possible contributing factors, one will always have to take into 
account that the changes in s-lgA observed as a result of, for instance physical exercise, 
may in fact be largely due to normal biological variation. The large degree of 
-
uncertainty of any s-lgA measurement is therefore its main drawback. Even though pre-
analytical and analytical variation can be minimised, the large biological variation has 
serious implications when changes in s-lgA are interpreted as large changes are required 
for serial results to be statistically and biologically different. 
Although no proof of a diurnal variation in s-lgA was found, it is recommended 
that the time of day at which saliva samples are taken should be accurately recorded and 
that repeat samples should be collected at the same time of day if required for 
comparison. The degree of uncertainty can be reduced somewhat by obtaining samples 
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at the time ofleast variability, which seems to be around mid-day. As there was a 
significant post-prandial effect, it is recommended that saliva samples are taken either 
before a meal or at least 1.5-2 hours post-prandial. Samples immediately after a meal, 
early morning (fasting) and late evening should be avoided because of the larger 
variability at these times, unless required for specific reasons. 
As there is a wide range in the biological variation of s-IgA between individuals, 
evaluating an individual's s-lgA levels against a population based reference interval is 
of limited use. The establishment of a personal reference interval seems more 
appropriate to determine "normal" values and to detect significant changes in serial 
measurements for individuals. The usefulness of personal reference intervals needs to be 
proven and would necessitate further study. Originally it was planned to undertake a project 
to establish personal reference intervals for a group of subjects. However it was estimated that a 
very large number of samples would be needed from each subject to obtain a valid reference 
range. This was beyond the scope of this project Although the recommendation is made for 
future research, this would require considerable effort and expense, and therefore it is doubtful 
that this method will become used widely. 
S-IgA levels can be expressed in different ways (section 1.3.6). The results of this 
study confirm that s-lgA secretion rate and s-lgA:osniolality ratio are the most valid and 
meaningful. S-lgA secretion rate most accurately describes the amount of s-IgA 
available at the mucosal surface and by expressing s-lgA as a ratio to osmolality, 
changes in saliva flow and evaporation are corrected for. In addition, the biological 
variation of the s-IgA:osmolality ratio was found to be among the lowest. 
The various experiments of this study confirmed previous findings that physical 
stress can result in significant changes in mucosa} and humoral immunity. There was a 
transient decrease in s-lgA (and changes in several other immune parameters) in 
response to an 82 km ultra-endurance run, two hours of heavy load carriage at a 
constant speed, and during a six week army common recruit training course. 
Nevertheless, more study is needed to determine the effect of volume, duration and 
intensity of physical activity on s-IgA, and at what combination of these factors exercise 
becomes a negative stressor. Although the results of the CMR study suggest that 
mucosal immunosuppression can occur as a result oflong-duration, moderate intensity 
exercise, only the hottest, most humid environment resulted in a significant decline of s-
lgA during the load carriage study. It seems that if exercise at an intensity that by itself 
does not cause a significant mucosa! immunosuppression is performed in a harsh 
climate, the resulting hyperthermia can magnify the s-lgA response. In practical terms, 
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this indicates that by keeping the exercise intensity in a hot and humid environment 
constant, the additional physiological and psychological strain will possibly lead to a 
greater risk of immunosuppression. Alternatively, allowing someone to adjust the 
exercise intensity (by slowing down or by allowing self-pacing) or to acclimate to the 
local environmental conditions, the strain and consequently the magnitude of the 
immunosuppression could possibly be reduced. 
The relationship between s-IgA and the incidence ofURTI remains tenuous and it 
remains to be proven whether there are clinical implications associated with an exercise 
induced reduction in s-IgA (seqtionl.5). There was no evidence that participation in an 
ultra-endurance exercise like the C.MR is associated with an extra risk of infection -
there were few URTI symptoms pre- and post-race and there was no change in their 
incidence. Likewise, there was no evidence that s-IgA is a useful biomarker to monitor 
recruits for the risk of infection despite the fact that the ACRT resulted in a high 
incidence of mucosal immunosuppression and self-reported symptoms ofURTI. 
To investigate the potential of s-IgA as a predictor ofOTS, the relationship 
l?etween s-lgA and other possible indicators of OTS (e.g. fatigue; mood states; 
neutrophils to lymphocyte ratio; C-reactive protein; TNFa; haemoglobin; ferritin; 
FTCR) was examined (section 1.8). Although the ACRT resulted in a high incidence of 
mucosa! immunosuppression and a significant prevalence of OTS symptoms (such as 
fatigue, immune suppression, reduced iron status, and hormonal changes), there was no 
evidence that s-lgA is a useful stand-alone biomarker to monitor recruits for early states 
of OTS as a result of military training. Further evidence is needed to prove that 
declining s-lgA is a sign of OTS. 
In summary, although the results of these studies indicate that mucosa! immunity 
is affected by a range of military activities, this work does not lend strong support fo the 
notion that s-IgA could be a practical tool to monitor mucosal immune function or 
physiological strain in the military or that it would be a good predictor of ill health, 
excessive training or OTS. 
Several design limitations of the projects in this study were a result of working 
with the military. The number of available subjects was limited and access to subjects 
and information was sometimes restricted because of operational considerations. More 
research on a larger scale is needed to determine if immune changes caused by military 
activities are clinically significant. Therefore, the possible usefulness of monitoring s-
IgA during military activities such as load carriage or training courses should not be 
rejected without further investigation. A future study could for instance assess if a 
119 
modification of the ACRT course would result in maintenance or improvement of 
mucosa! immune function in soldiers. Another study could investigate if a reduction of 
the load or pace ofload carriage would have a similar effect. However, even if this were 
the case, it remains to be seen if the benefit of these changes would outweigh the 
disadvantages. It would make much more sense to introduce some basic strategies to 
maintain immunocompetence in soldiers. In order to reduce the risk of URTI and OTS 
in athletes, several recommendations have been made, most of which would equally 
apply to soldiers (Gleeson and Bishop, 2000; Nieman, 1994; Nieman, 1997; Pyne, 
1999; Pyne et al., 2000; Shephard, 1998; Walsh et al., 1999). Careful management of 
exercise volume and intensity, variety to overcome training monotony and strain, and 
provision of adequate rest and recovery periods are essential. If signs and symptoms 
indicate that an infection is impending, the volume and intensity of training should be 
reduced. The tempo of recruit training could be adjusted to minimize symptoms of 
overtraining. For example, the high levels of mental fatigue might be avoided by 
providing some personal time for recreation, relaxation, or rest. Practical measures to 
limit the stress of exercise in the heat include: restricting training loads of soldiers until 
acclimatised, scheduling training sessions for early morning or late afternoon, ensuring 
adequa~e fluid replacement, wearing appropriate clothing, and educating soldiers and 
officers in the signs.and symptoms of heat disorders. Soldiers should be taught self-
management and coping skills and ways to monitor their responses to stress. 
Behavioural changes include adopting a well balanced diet with adequate intake of 
macro- and micro-nutrients; limiting transmission of contagious illnesses by reducing 
exposure to common infections, airborne pathogens, and physical contact with infected 
individuals; avoiding excessive fatigue and obtaining adequate sleep. 
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APPENDIX A-A selection of studies related to s-IgA and exercise from 1982 to 2005 
Reference Subjects & fitness levels Exercise Saliva source Collection Method of analysis Antisera Referenced to lgA measurement and 
method CRM470 response 
(Laing et al., 2h stationary Unstimulated ELISA (refers to Rabbit anti- Increase in concentration; 12 trained cyclists cycling at 62% of Salivettes (Blannin et al., human IgA Not specified 2005) 
V02max whole 1998)) (Sigma I-8750) decrease in secretion rate 
(Nieman et al., 15 females accustomed to 30 min walking at Unstimulated No changes in 
2005) walking 60% ofV02max whole Expectoration ELISA Not specified Not specified concentration or secretion 
rate 
(Tiollier et al., 21 male cadets French army Unstimulated Expectoration Nephelometric Not specified Not specified Concentrat10n decreased 2005) commando training whole after combat training 
(Li and 8 recreationally active 2h stationary Unstimulated Rabbit anti- Increased concentration; 
cycling at 60% of Expectoration ELISA human IgA Not specified Gleeson, 2004) males 
V02max 
whole (Sigma 1-8760) no change in secretion rate 
(Palmer et al., 80 km ultra- Unstimulated Not specified but refers to methods Decrease in concentration, 28 ultra-marathon runners Expectoration ELISA of (Gleeson et al., 1999a; Gleeson secretion rate and ratio to 2003) endurance run whole 
et al., 2000b; Gleeson et al., I 999b) protein 
Not specified but refers to methods No change in (Nieman et al., 160 km ultra- Unstimulated concentration and ratio to 
2003) 45 runners endurance run whole Expectoration ELISA of (Gleeson et al., 1999a; Gleeson protein. Decrease in 
et al., 2000b)) 
secretion rate 
(Walsh et al., 2h stationary Unstimulated ELISA (refers to Rabbit anti- Decrease in secretion rate; 
2002) 15 trained male cyclists cycling at 70% of whole Salivettes (Blannin et al., human lgA Not specified no change in rate to 
V02max 1998)). (Sigma 1-8750) osmolality 
Not specified (but refers to methods Decrease in concentration, (Nieman et al., 98 competitive runners Marathon race Unstunulated Expectoration ELISA of (Gleeson et al., l 999a; Gleeson secretion rate and ratio to 2002) whole et al., 2000b; Gleeson et al., protein 1999b)) 
ELISA (refers to Goat anti- Decrease in secretion rate (Fahlman et al., 26 active females 30sec Wingate test Unstimulated Not specified (Mackinnon et al., humanlgA Not specified and ratio to protein; no 2001) whole 1993a)) (Sigma) change in concentration 
and ratio to osmolality 
Referenced 
Commercial against WHO (Gleeson et al., 22 elite swimmers 12 week training Unstimulated Not specified ELISA IgA-specific 67195 with Concentration decreased 2000b) cycle whole (Tago) conversion after training sessions factor to 
CRM470 
121 
(Fricker et al., Case study of a well 8 month training Not specified Not specified Not specified Not specified Not specified Concentratton decreased 1999) trained male swimmer period over study period 
(Gleeson et al., 7 month training Unstimulated Electro- Commercial Concentration decreased 25 elite swimmers Not specified immunodiffusion and (The Binding Not specified 1999a) season whole RID Site) after training sessions 
(Walsh et al., 8 well trained game High intensity Unstimulated Rabbit anti- No change in 
1999) players intervals on cycle whole Dribbling ELISA human IgA Not specified concentration & secretion 
ergometer (Sigma I-8760) rate 
Rabbit anti- Concentration and (Blannin et al., 18 males of mixed fitness Cycling at 55% and Unstimulated Saltvettes ELISA human IgA Not specified secretion rate increased; 1998) 80% ofV02max whole (Sigma I-8760) no change in ratio to protein 
(l-liibner- 16 day training Unstimulated RID (referred to Commercial No change in Wozniak et al., 6 elite wrestlers 
whole Not sp_ecified (Hilbner-Wozniak et (Dade Behring) Not specified concentration; decrease in 1998) camp al., 1997)) ratio to orotein 
Unstimulated Drooling or Immuno-fluor Concentration & secretion (Ljungberg et whole; stimulated rate increased in whole 
al., 1997) 20 well trained runners Marathon run whole; "SLURP'" technique (Bio-Rad Not specified Not specified saliva but not in parotid 
stimulated parotid cups Laboratories) saliva 
(Steerenberg et 19 competitive & 23 Olympic distance Rabbit anti- Concentration unchanged; 
al., 1997) recreational triathletes triathlon Stimulated whole Expectoration ELISA human IgA Not specified secretion rate & protein 
ratio decreased 
(Buckwalter et 30 min treadmill Unstimulated 30 untrained women walking/jogging at Not specified ELISA Not specified Not specified Concentration increased 
al., 1996) 60%ofHRmax whole 
(Mackinnon et Intense interval Unstimulated Goat anti- Secretion rate & ratio to 8 elite male kayakers Not specified ELISA human lgA Not specified 
al., 1993a) exercise whole (Tago) protein decreased 
(Mackinnon 12 young recreational Supra-maximal Unstimulated Goat anti- Concentration increased; 
and Jenkins, 
males intervals on cycle whole Not specified ELISA humanlgA Not specified secretion rate and ratio to 1993) ergo meter (Tago) protein decreased 
(McDowell et 29 moderately active male Incremental Unstimulated Rabbit anti-treadmill to Not specified ELISA human IgA Not specified Concentration decreased 
al., 1992a) college students 
exhaustion whole (Sigma) 
(Housh et al., 30 min treadmill @ Unstimulated Rabbit anti- No change in 9 males Not specified ELISA human IgA Not specified 1991) (80% V02max whole (Sigma) concentration 
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(McDowell et Treadmill tests of Unstimu lated Rabbit anti- No change in 18 male co llege students various duration Not specified ELISA human lgA Not specified 
al., 1991) 
and intensity whole (Sigma) concentration 
Concentration 
27 pre- and 23 post- Rabbit anti- Prepubescent: no change 
(Tharp, 1991) pubescent basketball Basketball practice Not specified Not specified ELISA human IgA (I- Not specified after practice but increase 
players and games 6008, Sigma) after games. Postpubescent: increase 
2x 
(Cameron and 13 male distance runners I0.5km fartlek run Unstimulated Not specified Rate nephelometry Not specified Not specified Concentration decreased Pridd le, 1990) at 70-90% HRmax whole I 
(Gleeson et al., 99 healthy subjects (5-75 Measured daily Whole Not specified Electro- Not specified Not specified Considerable daily 1990) v.o.) variability immunodiffusion variability 
(Tharp and 21 competitive male Several times Unstimulated Non specified Concentration decreased 
Barnes, 1990) swimmers during fall training whole Not specified ELISA Sigma reagents Not specified after each training session 
season 
(Schouten et 175 young recreational Incremental In house sheep Concentration decreased Stimulated whole Expectorating RID Not specified in females but increased in 
al., 1988) adults treadmill test anti-human IgA 
males 
(Mackinnon et 2 hr cycle Stimulated In house rabbit Concentration & protein 8 competitive male cycl ists ergometer @ 70- Curby cap ELISA Not speci tied 
al., 1987) 75%ofV02m .. parotid anti-human IgA ratio decreased 
(Bratthall and Concentration increased 4 females & 5 males 15 min run at full or decreased; secretion Widerstrom, (recreational/sedentary) speed Whole stimulated Not specified ELISA Not specified Not specified rate, no change; protein 1985) 
ratio decreased 
(Tomasi et al., 8 elite cross country skiers Cross country race Whole & Expectoration RID In house anti- Not specified Concentration & protein 1982) parotid or Curby cup human JgA ratio decreased 
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